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Abstract
The use of pharmaceutical products has steadily increased in the United States from 2
billion prescriptions in 1999 to 3.9 billion in 2009. Half of patients do not comply with
the recommended prescription regimen and dispose of unused drugs in the environment.
The U.S. Environmental Protection Agency and many researchers have highlighted the
human-health risks associated with improperly disposing of pharmaceutical products.
This quantitative cross-sectional study examined the potential correlations between
people’s actual disposal practices and their knowledge of the impact of disposal practices
on the environment and human health, and availability of disposal options. The
conceptual framework selected for this study comprised 2 models: the health belief model
and the theory of planned behavior. Respondents to an online survey were 485 residents
of the northeast United States, polled from the general population. Descriptive statistics
and logistic regression were used to model responses from the dependent variable actual
disposal practice (ADP) across the independent variables, and analysis of variance
explored whether ADP differed across demographic variables. Statistically significant
associations emerged among individuals’ knowledge of environment and human-health
impact, recommended disposal practices, disposal options, and that person’s likelihood to
practice recommended disposal. Demographic variables did not impact disposal behavior.
To promote positive social change, it is recommended that policymakers plan and
implement the expansion of convenient drug disposal options, as well as information
campaigns on proper disposal practices. In parallel, health care professionals should
stress to their patients the importance of complying with prescribed regimens, thus
minimizing the amount of unused or expired medications.

Knowledge and Barriers to Safe Disposal of Pharmaceutical Products
Entering the Environment
by
Aldo F. Fidora

MS, New Jersey Institute of Technology, 1997
MPH, University of South Florida, 1991
BS, State University of New York, 1990

Dissertation Submitted in Partial Fulfillment
of the Requirements for the Degree of
Doctor of Philosophy
Public Health—Epidemiology

Walden University
December 2017

Dedication
This dissertation is dedicated to those people who feel there is an unequivocal
need to restore the ecological balance of our planet. Humans need to make it a goal to
support the health of the myriads of ecosystems that make up our planet’s global health.
Proper disposal of pharmaceutical products in the environment requires a social-change
approach at different levels, as well as strong dedication from all involved.
Although the topic of this dissertation may be viewed as a minuscule contribution
toward our planet’s global health, its recommendations, if implemented, could still
provide meaningful improvements.
This dissertation is also dedicated to those people who, for whatever reason, are
not yet seeing the “big picture”: the one where humans, animals, skies, oceans, the flora,
and all their related ecosystems contribute to “global health.” It is my hope that this
dissertation will at least inspire these people to ask questions, demand answers, and
further develop their own awareness.

Acknowledgements
I would like to thank my chair, Dr. David Anderson, and my content expert
committee member, Dr. Timothy Radak, for their guidance and expertise in supporting
my research and dissertation goals. I have appreciated their very timely reviews, content
and methodology suggestions, and incredible support throughout my dissertation journey.
Special thanks also to Dr. Tammy Root for her prompt responses to my dissertation
process questions, especially at the onset of my dissertation journey; this was
instrumental in getting me onto the right process track.
A “thank you” goes also to my academic advisor, Ms. Jennifer Rothamel, who
was always very prompt and helpful in following up on both my administrative and
process-related questions.
Last, but not at all the least, I would like to thank all the Walden University
faculty who have supported my growth as a researcher and content expert, through welldesigned coursework and residencies.
Although my PhD journey is at its conclusion, I feel that my research process will
and must continue. I have the tools, the methodology, and the expertise to do it.

Table of Contents
List of Tables .......................................................................................................................v
List of Figures .................................................................................................................... vi
Chapter 1: Introduction ........................................................................................................1
Problem Statement .........................................................................................................7
Purpose of the Study ......................................................................................................9
Significance of the Study .............................................................................................10
Theoretical Framework ................................................................................................14
Background of the Study .............................................................................................19
Research Questions ......................................................................................................23
Research Hypotheses ...................................................................................................24
Nature of the Study and Study Design .........................................................................25
Research Design.....................................................................................................25
Dependent and Independent Variables ..................................................................26
Survey Instrument ..................................................................................................26
Population and Sample ..........................................................................................28
Data Collection ......................................................................................................29
Data Analyses ........................................................................................................30
Definition of Key Terms ..............................................................................................30
Brief Review of the Literature .....................................................................................32
Disposal Practices Among Nurses .........................................................................32
Disposal Practices Among Patients .......................................................................33
Drug Take-Back Programs ....................................................................................34
i

Assumptions.................................................................................................................36
Limitations ...................................................................................................................36
Chapter 2: Literature Review .............................................................................................39
Search Strategy ............................................................................................................42
Organization of the Literature Review ........................................................................44
Theoretical Framework ................................................................................................45
Theory of Planned Behavior ........................................................................................45
Health-Belief Model ....................................................................................................48
Toward Managing Pharmaceutical Disposal ...............................................................53
Environmental Impact: Empirical Evidence ................................................................57
Analytical and Research Techniques ...........................................................................61
Types of Drugs and Effects..........................................................................................65
Evolution of Medication Disposal Policy and Practice ...............................................67
Attitudes and Behavior of Health Professionals and Patient Health Care Facilities ...73
Intervention ..................................................................................................................75
Nurses ..........................................................................................................................76
Pharmacists ..................................................................................................................80
Patients .........................................................................................................................83
Drug Take-Back Programs ..........................................................................................86
Pre-DEA Involvement in Take-Back Programs ..........................................................87
Post-DEA Involvement Take-Back Programs .............................................................89
Recycling and Environmental Protection ....................................................................96
Summary and Conclusions ..........................................................................................99
ii

Chapter 3: Research Method............................................................................................101
Introduction ................................................................................................................101
Research Design and Rationale .................................................................................102
Methodology ..............................................................................................................103
Population ............................................................................................................103
Sampling and Sampling Procedures ....................................................................103
Procedures for Recruitment, Participation, and Data Collection .........................104
Instrumentation and Operationalization of Constructs ........................................105
Data-Analysis Plan.....................................................................................................107
Threats to Validity .....................................................................................................110
Ethical Procedures .....................................................................................................112
Summary ....................................................................................................................113
Chapter 4: Results ............................................................................................................114
Purpose of Study ..................................................................................................114
Research Questions and Hypotheses ...................................................................114
Pilot Study..................................................................................................................116
Participants ...........................................................................................................117
Survey: Assessment of Legibility ........................................................................119
Data Collection ..........................................................................................................120
Results ........................................................................................................................123
Descriptive Statistics ............................................................................................123
Assumptions.........................................................................................................126
Research Questions 1–4 .......................................................................................127
iii

Research Question 5 ............................................................................................134
Kruskal–Wallis Rank-Sum Test (Nonparametric Equivalent of One-Way
ANOVA) ..............................................................................................................136
Summary ....................................................................................................................140
Chapter 5: Discussion, Conclusions, and Recommendations ..........................................142
Introduction ................................................................................................................142
Finding 1 ....................................................................................................................143
Finding 2 ....................................................................................................................144
Finding 3 ....................................................................................................................144
Finding 4 ....................................................................................................................144
Finding 5 ....................................................................................................................145
Discussion ..................................................................................................................145
Implications of the Findings: Potential Impact for Social Change ............................149
Limitations of the Study.............................................................................................152
Recommendations for Future Research .....................................................................153
Summary and Conclusion ..........................................................................................154
References ........................................................................................................................156
Appendix A: Survey Instrument Permission ...................................................................173
Appendix B: Survey.........................................................................................................174
Appendix C: Pilot Survey ................................................................................................181

iv

List of Tables
Table 1. Dependent and Independent Variable Key Characteristics ...............................123
Table 2. Questions 1–4: Variance Inflation Factors and Tolerance Values ....................126
Table 3. Question 5: Variance Inflation Factors and Tolerance Values ..........................127
Table 4. Actual Disposal Practices and Knowledge of Environment and HumanHealth Impact, Knowledge of Disposal Practices 1–4, and Availability of
Disposal Options ......................................................................................................128
Table 5. Model Coefficients for Logistic Regression ......................................................135
Table 6. Levene’s Tests for Demographic Changes in Actual Disposal Practices ..........137
Table 7. Shapiro-Wilk Tests for Demographic Changes in Actual Disposal Practices ...137

v

List of Figures
Figure 1. Participants in the Pilot Study. .........................................................................117
Figure 2. Pilot Study Participants by Age Group. ...........................................................118
Figure 3. Pilot Study Participants by Race/Ethnicity.......................................................118
Figure 4. Pilot Study Participants by Education Level. ...................................................119
Figure 5. Legibility Assessment by Question. .................................................................120
Figure 6. Study Participants by Age Group. ....................................................................121
Figure 7. Study Participants by Race/Ethnicity. ..............................................................122
Figure 8. Study Participants by Education Level.............................................................122
Figure 9. Proportion of Actual Disposal Practices by Knowledge of Environment and
Human Health Impact. .............................................................................................129
Figure 10. Proportion of Actual Disposal Practices by KDP1.........................................130
Figure 11. Proportion of Actual Disposal Practices by KDP2.........................................131
Figure 12. Proportion of Actual Disposal Practices by KDP3.........................................132
Figure 13. Proportion of Actual Disposal Practices by KDP4.........................................133
Figure 14. Proportion of Actual Disposal Practices by Available Disposal Options. .....134
Figure 15. Actual Disposal Practices by Education Level. ..............................................138
Figure 16. Actual Disposal Practices by Race. ................................................................138
Figure 17. Actual Disposal Practices by Age Group. ......................................................139
Figure 18. Actual Disposal Practices by Gender. ............................................................140

vi

1
Chapter 1: Introduction
For more than a century, indispensable elements of human and veterinary
medicine—pharmaceutical agents—have been entering the natural environment (de
Cazes, Abejou, Belleville, & Sanchez-Marcano, 2014). Notably, it was in the United
States that investigators first discovered evidence of the active ingredients of
pharmaceutical drugs in water, revealing the presence of analgesics, heart medications,
and contraceptive drugs in wastewater (World Health Organization [WHO], 2011). These
early studies (Garrison, Pope, & Allen, 1976; Hignite & Azarnoff, 1977; Tabak & Bunch,
1970), published in the 1970s, spurred ongoing domestic and international research,
documenting in detail not only the presence of pharmaceuticals in the environment, but
also their adverse effects on organic life. In fact, even miniscule concentrations of
pharmaceutical ingredients have been implicated in abnormalities found in fish
populations (Corcoran, Winter, & Tyler, 2010; Ortner & McCullagh, 2010). Beyond the
adverse effects on aquatic life, recent ecotoxicity studies, with more sensitive analytical
techniques, have demonstrated that pharmaceutical pollutants are capable of affecting the
growth, reproduction, and behavior of birds, invertebrates, plants, and bacteria, even at
very low levels of concentrations (de Cazes et al., 2014). Directly connected with food
and drinking water, trace concentrations in soils present a hazard to human health (de
Cazes et al., 2014). Moreover, the levels of pharmaceuticals in soils and sediments tend
to exceed concentrations detected in water (Fatta-Kassinos, Meric, & Nikoalaou, 2011).
Pharmaceuticals differ from other environmental pollutants in that they are
created to be biologically active and will interact with cell tissue following specific
absorption, distribution, metabolism, and excretion properties (Fatta-Kassinos et al.,
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2011). These properties can be beneficial at the prescribed dose, but they can have
adverse effects when dispersed into the environment or in uncontrolled concentrations, as
is the case when the drugs are flushed down the toilet or drained into the sink.
Furthermore, to boost their intended action, pharmaceuticals are designed to resist
biodegradation. Many drugs are extraordinarily potent. Oral chemotherapy agents, for
example, represent the new generation of cancer treatments (Lester, 2012). From a
consumer perspective, one of the many advantages of these drugs is that they allow
patients the convenience and comfort of taking their medication at home. At the same
time, the increasing presence of powerful pharmaceutical agents in U.S. homes
underscores concerns regarding safe and proper disposal.
The use of prescription drugs in the United States has been labeled an epidemic
(Maxwell, 2011). In the course of a decade, from 1999 to 2009, the number of drug
prescriptions nearly doubled from 2 billion to 3.9 billion (Tong, Peake, & Braund, 2011).
In addition, most households contain over-the-counter (OTC) prescription drugs, such as
nonsteroidal anti-inflammatory drugs (NSAIDs), the most widely used drug class, which
includes aspirin and ibuprofen. These drugs have the potential to cause kidney damage;
kidney failure has been observed in animals exposed to NSAIDs in water (Ortner &
McCullough, 2010). Tetracycline, a common antibiotic, was one of the first drugs
discovered in water (Zhang, Zhang, & Fang, 2009). Significantly, the growth of
tetracycline-resistant bacteria has been reported ever since. Hundreds of antibiotic
resistant genes (ARGs) associated with resistance to a wide range of antibiotics have
been detected in wastewaters, wastewater treatment plants, surface water, ground water,
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and drinking water (Fatta-Kassinos et al., 2011). All carry the potential to be transferred
to humans through direct and indirect contact.
For decades, recommendations by researchers and international and U.S. health
organizations for disposing of unused or expired medications were guided by concerns
about inadvertent or intentional poisoning. Flushing them down the toilet or rinsing them
down the drain was considered the safest and simplest way to dispose of unwanted drugs
(McCullagh, Schim, & Ortner, 2012; Ortner & McCullagh, 2010). Given increasing
awareness of the consequences of pollution from pharmaceuticals on the environment
and its potential effects on human health, numerous international and government bodies
recommend adopting strategies to minimize the amount of pharmaceuticals that enter the
natural environment (WHO, 2011). Unfortunately, these recommendations have left the
timeline for implementing the policies and the funding for providing consumers with safe
disposal options to the respective governments. These strategies include drug take-back
programs, guidelines and regulations, increased public awareness, and consumer
education aimed at promoting the proper disposal of unused, unwanted, and expired
medications. All take-back programs in the United States are administered by the Drug
Enforcement Administration (DEA), which provides the destruction of the drugs through
incineration.
According to Nisbet and Gick (2008), who envisioned a key role for health
psychology in environmental protection, people generally desire a “safe, healthy
environment” (p. 296). However, the concept of a safe, healthy environment is fairly
abstract and, as a result, many people do not comprehend or do not link the issue of
problems in the environment with the potential impact on human health. Moreover, even
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public-awareness campaigns designed to educate consumers about the impact of their
behavior on the environment do not necessarily result in behavior change. A long history
of public health campaigns has failed to produce the desired results, especially in
changing behaviors that are deeply entrenched. Most consumers are so accustomed to
disposing of drugs in the sink or toilet that they may not question their behavior, despite
health and environmental concerns. Even nurses, pharmacists, and other health care staff
who are highly aware of proper and improper disposal practices dispose of unused
pharmaceuticals in the toilet or drain (Abahussain, Waheedi, & Koshy, 2012; McCullagh
et al., 2012; U.S. Environmental Protection Agency [EPA], 2010).
A critical flaw in many public health and awareness campaigns is that they
underestimate the complex array of factors that underlie human behavior (Nisbet & Gick,
2008). It has become a cliché in health and behavioral psychology that education is
essential but not sufficient to effectively change people’s behavior. In 2008, the White
House Office of National Drug Control Policy (ONDCP) presented the first federal
guidelines for the disposal of prescription drugs by consumers and health professionals
(McCullagh et al., 2012). Initially, regulations governing transportation of controlled
substances posed an obstacle to the return of consumer drugs for proper disposal. In
2009, the DEA conducted a public-opinion survey to get input on developing a safe
disposal policy, which led to the Secure and Responsible Drug Disposal Act of 2010 and
the Safe Drug Disposal Act of 2010, paving the way for drug take-back programs that
allow for the return of controlled and uncontrolled substances (Fass, 2011).
In February 2016, Walgreens launched the first national initiative to promote
proper drug disposal by a pharmacy retail chain by installing safe medication disposal
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kiosks in more than 500 locations, mostly in stores, open 24 hours daily (Walgreens,
2017). This pioneering effort, which began in California, encompassed drugstores in 39
states and the District of Columbia and was scheduled to be completed by end of 2016.
As of September 2017, Walgreen has installed disposal kiosks in more than 600
pharmacies across 45 states.
The purpose of this quantitative cross-sectional study was to examine knowledge
and behavior regarding drug disposal practices in a sample of residents in the northeast
United States. Specifically, I examined people’s disposal practices, local availability of
disposal options, awareness of proper disposal practices, and the potential correlations
between people’s actual disposal practices and their knowledge of the impact that
disposal practices may have on the environment and human health.
I started Chapter 1 with a high-level overview of the issue around drug disposal,
and why it is a relevant and important topic to be studied within the realm of public
health; I also introduce the research gaps, the conceptual framework, research questions
and hypotheses, study design and sampling approach, data analysis plan, overview of the
literature, and limitations of the study.
The scholarly literature has a glaring gap regarding the pharmaceutical disposal
practices of the general population. Although drug take-back programs date back to the
mid-2000s when they were recommended by the federal government, they inspired few
empirical studies. The program “Safe Medication for ME” was implemented in the State
of Maine in response to excessively high rates of deaths from prescription drug
overdoses, and has been hailed as a model program for drug disposal (Ruhoy & Kaye,
2010). This unique program, which initially ran in conjunction with DEA take-back
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events, allowed people to anonymously return controlled and uncontrolled substances
free of charge, through the mail. The program is currently under the direction of the
University of Maine Center on Aging; consumers can obtain prepaid, tamper-resistant
envelopes from community distributors, including pharmacies, medical offices,
community organizations, police departments, hospice, and other sites located throughout
the state. Each envelope includes explicit instructions for safely packaging and mailing
pharmaceuticals of various types.
Although advocates of the Maine program often point to the ease of returning
drugs through the mail as its defining characteristic, according to Ruhoy and Kaye
(2010), the most notable feature is that the program systematically gathers data in a
database on the returned medications. The first published study of the Maine Prescription
Monitoring Program focused on detailed information on the types and amounts of drugs
returned through six DEA take-back events (Stewart et al., 2015). However, the Ruhoy
and Kaye study did not provide information on participants’ attitudes toward the
program, or their motivations to take part in it. Only two studies of take-back events
surveyed participants, one covering 11 take-back events in the rural Appalachian region
of northeast Tennessee and southwest Virginia (Gray & Hagemeier, 2012), and one
involving 11 take-back events in Hawaii (Ma, Batz, Juarez, & Ladeo, 2014).
As drug take-back programs become more prevalent, it is likely more studies will
query feedback to help improve such programs. However, research is still limited in
disclosing relationships between consumers’ knowledge, attitudes, and behaviors, in that
such knowledge involves only those individuals who have actively made the decision to
avail themselves of safe medication disposal options. A dearth of research explores the
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drug disposal habits of the general public; in fact, studies of pharmaceutical disposal
practices tend to focus on nurses (McCullagh et al., 2012), pharmacists (Abahussain et
al., 2012), or Veterans Affairs (VA) hospital outpatients (Seehusen & Edwards, 2006;
Trovato & Tuttle, 2014). In view of this gap in the literature, it was necessary to
extrapolate from the research on recycling to gain insight on consumer knowledge,
attitudes, and behaviors related to environmental protection (Best & Mayerl, 2013;
Culiberg, 2014; Nigbur, Lyons, & Uzzell, 2010; Pearson, Dawson, & Breitkopf, 2012;
Seacat & Northup, 2010; White, Smith, Terry, Greenslade, & McKimmie, 2009).
The framework selected to guide this study comprised two models: the health
belief model (HBM) and the theory of planned behavior (TPB). Despite parallels between
health and environmental behavior, the fields of health promotion and health behavior
change are rarely applied to environmental issues (Nisbet & Gick, 2008). Environmental
behavior is multifactorial, and consequently, I considered more than one model to address
the complexity of this environment–human health-related issue. By surveying members
of the general public on their attitudes and behaviors related to disposal of
pharmaceuticals, I was able to address the knowledge gap on this significant public health
and environmental issue.
Problem Statement
Guided by recommendations from poison-control centers, or only by
convenience, health professionals and consumers alike have customarily disposed of
unused pharmaceuticals into the public water system by flushing them down the toilet or
rinsing them down the drain (McCullagh et al., 2012; Ortner & McCullagh, 2010). This
practice was standard until the discovery of measurable amounts of pharmaceutical
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chemicals in water triggered alarm about the consequences of pharmaceutical pollution in
the environment, and its potential effects on human health (Blair, Crago, Hedman, &
Klaper, 2013; Fatta-Kassinos et al., 2011; Kotchen, Kallaos, Wheeler, Wong, & Zahller,
2009; A. Kumar, Chang, & Xagoraraki, 2010; Musson, Townsend, Seaburg, & Mousa,
2007; Nikoalaou, Meric, & Fatta, 2007; WHO, 2011). In the United States, this situation
is magnified by the sheer number of prescriptions given to consumers, coupled with poor
medication adherence, which increases the amount of unused and expired drugs in the
home (Daughton & Ruhoy, 2013).
The first federal guidelines for prescription-drug disposal were issued in 2007,
providing consumers with a list of options for disposing of medications (Ortner &
McCullagh, 2010; Ruhoy & Daughton, 2008). In 2010, the ONDCP announced that the
guidelines for individual medication disposal had been replaced by official take-back
days. At the same time, challenges existed in the widespread implementation and
availability of take-back programs (Fain & Alexander, 2014). Of the options cited in the
original guidelines, the U.S. Food and Drug Administration (FDA) continues to
recommend consumers to mix unused drugs with unpalatable substances and place the
mixture in sealed containers as a safe disposal technique (FDA, 2011); this process
renders the drugs unusable to those for whom they were not prescribed, but the impact
that these mixtures could have on the environment when placed in a landfill is unknown.
The guidelines explicitly state that drugs should not be flushed down the toilet unless the
instructions specifically say to do so, which the FDA recommends for a small number of
drugs that could be “especially harmful and, in some cases, fatal with just one dose if
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they are used by someone other than the person for whom the medicine was prescribed,
as, for example, fentanyl patches for pain” (FDA, 2017, para 11).
The few studies of drug take-back events suggest they are well-received by
community members (Gray & Hagemeier, 2012; Ma et al., 2014). However, no recent
studies explored the knowledge of community members on human health as the
consequence of pharmaceutical disposal in the environment, general disposal practices,
and the potential relationship that may exist between people’s knowledge of the disposal
options and their actual disposal practices. I designed my study to help address that gap.
Purpose of the Study
The purpose of this quantitative cross-sectional study was to investigate consumer
knowledge of the environmental and human-health impact of pharmaceutical disposal,
knowledge of recommended disposal practices, and actual practices for disposing of
unwanted, unused, and expired drugs. According to research using the HBM across
numerous studies and types of behaviors, perceived barriers are the decisive factor in
adopting health-related behaviors (Strecher & Rosenstock, 1997). In view of this
predisposition, I also examined the relationship of locally available disposal options to
consumers’ actual disposal practices.
The sample for this study consisted of adults (aged 18 years or older) who were
residents of the northeast United States and had taken a prescription drug in the past 2
years. A questionnaire designed for this study was administered via the Internet. The U.S.
Census Bureau (n.d.) defined the northeast region as comprising nine states: Connecticut,
Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York,
and Pennsylvania. As of 2013, the estimated size of this population was approximately 56
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million residents. Findings from this study intend to provide insights on the hypothesized
associations between disposal practices and knowledge, attitudes, and disposal options.
This study contributes to increasing overall knowledge on pharmaceutical product
disposal processes and helps identify key factors that may promote or inhibit safe
disposal practices in the target population. The results of the study may create momentum
for the future development of strategies that will promote positive social change and
additional research opportunities. A change of behavior in disposal practices will
translate into a reduction of the toxic substances released into the environment,
minimizing the negative impact on human health.
Significance of the Study
Compelling evidence suggests that pharmaceutical substances often accumulate in
one’s home due to various disposal habits. For example, some patients may stop the full
course of their medication regimen because they experience changes in symptoms or
dosage requirements, or they may begin to feel better. In aggregate, these behaviors
become a threat to the environment and ultimately impact public health. Research
detecting the presence of pharmaceuticals in waters began in the 1970s, gaining
momentum during the next 3 decades (WHO, 2011). The most widely cited work in the
scholarly literature on the presence of drugs in surface water involves a study conducted
by the U.S. Geological Survey in 1999 and 2000 that discovered more than 50
pharmaceuticals in 139 streams across 30 U.S. states. An alarming 80% of the streams
explored yielded at least one contaminant, with an average of seven contaminants per
stream (Ortner & McCullagh, 2010). Nearly a decade later, a 2008 report entitled
PharmaWater I described the findings of an Associated Press (AP) Investigative Team,
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disclosing that at least 41 million Americans are served by water supplies with evidence
of pharmaceuticals including anticonvulsants, antibiotics, mood stabilizers, and hormones
(Ortner & McCullagh, 2010).
Studies conducted in Europe produced comparable results. In Germany, for
example, a research synthesis documented the presence of cholesterol medications,
analgesics, and anticonvulsants in groundwater and surface water (Ortner & McCullagh,
2010). Researchers from the United States and the United Kingdom reported that
treatment plants were not completely effective in removing active pharmaceutical agents
from treated water. In fact, a major concern is that conventional treatment plants are not
equipped to completely remove micropollutants such as pharmaceuticals from
wastewaters (de Cazes et al., 2014; Fatta-Kassinos et al., 2011; Milic et al., 2013; Uslu,
Jasim, Arval, Bewta, & Biswas, 2013; WHO, 2011). Moreover, even the most advanced
and expensive treatment techniques leave detectable traces of pharmaceuticals (Li, Shi,
Lik, Zhang, & Gan, 2014).
The United States lags behind many other developed countries in establishing
formal guidelines and policies for the safe disposal of pharmaceuticals. Countries such as
Australia, France, Sweden, Portugal, Spain, New Zealand, and the United Kingdom have
had formal programs for collecting unused medications for quite some time (Ruhoy &
Daughton, 2008). A study conducted by Health Canada (2009) compared the status of the
recommended disposal practices across the European Union and member states to
establish a benchmark against which to compare those established in Canada. For
example, the report illustrated that Sweden has one of the most successful programs for
the proper disposal of pharmaceuticals (Health Canada, 2009). Apoteket B is the
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Swedish, government-owned pharmacy chain that oversees an environmental program
driven by targeted public-awareness campaigns to educate the public about the harmful
effects of flushing drugs down the drain or throwing them into the trash. In response,
more than 70% of Swedish consumers return unused drugs to the pharmacy (Health
Canada, 2009). Another reported example is in Spain, where the Spain Integrated Waste
Management System also conducts intensive public-awareness campaigns, successfully
generating large volumes of returned medications (Health Canada, 2009). From a
broader, global perspective, it is important to acknowledge that global awareness of the
issue of drug disposal has increased. For example, Pfizer, one of the largest
pharmaceutical companies, has addressed the issue of proper drug disposal (Pfizer, 2017),
and Asian countries, such as Japan (Nagaizumi Town, 2014) and India (Udupa,
Muragundi, Nagappa, & Janodia, 2013), have either implemented or are in the process of
finalizing drug disposal recommendations and the infrastructure to support them.
It seems evident that national policies and programs facilitate successful drug
return programs; in the case of Sweden, through a unique retail-pharmacy system
organized into a single government-owned chain (Health Canada, 2009). In contrast,
disposing of unused drugs in the United States has historically been complicated by
contradictory regulations from various agencies and legal regulations on controlled
substances that, even with DEA involvement, continue to result in conflict with state laws
(Ortner & McCullagh, 2010; Ruhoy & Kaye, 2010). The federal government has
advocated for drug take-back programs as the gold standard for safe drug disposal since
2010, but these programs often take the form of occasional one-day or weekend events.
Thus far, only the Maine Prescription Monitoring Program has produced evidence of a
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successful, ongoing statewide effort to encourage consumers to return unused and expired
drugs (Stewart et al., 2015).
After years of disposing of pharmaceuticals into the drain or toilet, which may
seem the most convenient method of disposing of unused drugs, gathering unused or
expired drugs and taking them to a designated location for proper disposal, or even
mixing the drugs with unappetizing substances (e.g., coffee grounds or cat litter as the
FDA [2011] recommended), represents a radical change of behavior. Frameworks such as
the HBM and the TPB have been applied to understand what motivates or inhibits healthrelated behavior change (Nisbet & Gick, 2008) in drug disposal practices. Pharmaceutical
disposal differs from changing behaviors related to health issues that may present an
immediate threat to the individual, such as obesity or cardiovascular risk. However,
empirical research into recycling behavior demonstrates that behavior-change models can
be effectively applied to environmental protection. Improper disposal of pharmaceuticals
threatens the environment and human health (Fatta-Kassinos et al., 2011).
A review of the literature has shown a lack of research in exploring the
knowledge, attitudes, and behavior of the general public toward the proper disposal of
pharmaceuticals. Given this gap, limited evidence exists on the success of campaigns to
promote proper disposal and, thus, no empirical foundation exists to design successful
public-awareness and education campaigns or improve those that exist. Findings from
this study provide valuable insight into disposal practices, and the factors that motivate
individuals to properly dispose of unused and expired medications or, alternatively, what
inhibits them from doing so. The ultimate goal of this study is to create momentum for
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the future development of strategies that will promote social change, reducing the impact
on human health from toxic substances that are released in the environment.
With the advent of programs such as Walgreens’ (2016) initiative to provide local
disposal kiosks available 24 hours a day, residents in communities across most of the
United States will have greater access to a convenient disposal option. However, a large
body of health-psychology research demonstrates that subjective perceptions, rather than
structural barriers or knowledge per se, play a pivotal role in changing health-related
behavior, especially when it is deeply ingrained (Nisbet & Gick, 2008). Findings from
this study are significant for public health officials and health professionals who advocate
the safe and proper disposal of pharmaceuticals. In particular, this information should be
useful to health professionals (e.g., nurses, pharmacists) who are at the forefront of
patient education on the safe administration, storage, and disposal of pharmaceutical
products. Above all, these findings may guide the development of strategies that improve
public awareness (e.g., public health promotion campaigns and local community
programs to educate consumers on proper disposal of pharmaceuticals) as well as the
availability of flexible and convenient options for disposing of pharmaceutical products.
Theoretical Framework
Environmental behavior is multifactorial; consequently, I considered two
conceptual models for behavior change: the HBM and the TPB. I deemed the TPB most
relevant to the issue of proper pharmaceutical disposal from the perspective of the
motivation that results into the intention to perform an action or behavior. Will
motivation be triggered by the consumers’ knowledge or perceptions of disposal practices
and their impact on human health? Will motivation be triggered by the information
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received, if any, on disposal recommended practices? Will both factors motivate
consumers and to what degree? The key aim of this study was to examine these research
objectives.
The HBM aligns with studies that involve recycling and environmental
protection. Strecher and Rosenstock (1997) discussed how perceived barriers were the
decisive factor in adopting health-related behaviors. Consequently, one objective of this
study was to examine the degree to which the availability and convenience to reach and
use locally available disposal options may impact consumers’ actual disposal practices.
Despite extensive interest by the public in protecting the environment and
improving personal health, many public health campaigns fail to generate changes in
peoples’ behavior. A critical reason for this perennial problem is that program designers
and policymakers fail to recognize marked discrepancies among attitudes toward health,
the environment, and related behavior (Nisbet & Gick, 2008). Virtually all guidelines,
reports, policy and position papers, and standards issued by government agencies,
international bodies, and professional associations stress the importance of consumer and
patient education in the safe use and disposal of medications. Education is an essential
prerequisite; however, information, per se, is notoriously ineffective in altering human
behavior, especially when it is deeply entrenched.
Campaigns designed to inspire healthy and proenvironmental behavior are
typically “information-intensive” on the assumption “that once people are informed they
will act differently” (Nisbet & Gick, 2008, p. 297). The failure of a myriad of public
health programs to produce the desired effects underscores the misguided nature of that
approach. Indeed, the development of the HBM in the 1950s arose from the poor
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response to public health campaigns to promote disease screening (Strecher &
Rosenstock, 1997).
Building on detailed analyses of probability samples of adults in cities that offered
tuberculosis screening, Hochbaum identified the beliefs that underpin the HBM:
perceived susceptibility and perceived benefits of action (Strecher & Rosenstock, 1997).
Hochbaum also recognized the role of intrinsic and extrinsic cues or triggers in
motivating people to act. Decades later, the HBM has been refined and expanded and has
a firm empirical base (Strecher & Rosenstock, 1997). The model includes several
essential components. Perceived susceptibility refers to an individual’s subjective
perception of experiencing a health or medical condition. This dimension encompasses
susceptibility to illness in general in addition to vulnerability to a specific condition.
Perceived severity is a related factor, denoting the seriousness of experiencing the
condition or allowing it to remain untreated or unaddressed. This aspect includes medical
consequences (pain, disability, and death) and social consequences (such as the impact of
the condition on work and social relationships). In conjunction, perceived susceptibility
and perceived severity produce perceived threat.
Although acceptance of a perceived personal threat is a prerequisite for taking
action, the specific course of action an individual chooses to take rests on the perceived
benefits of the available options (Strecher & Rosenstock, 1997). Bringing unused and
expired drugs to a take-back event or disposal center neutralizes the potential hazard to
people and pets and does not contribute to environmental pollution. Beyond the practical
benefit, this action might produce the intrinsic reward of believing one has done the right
thing. A drug take-back event can offer an opportunity for socializing with friends or
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neighbors or meeting others in the local community. For young people in particular, peer
pressure to engage in environmentally friendly behavior might influence drug disposal
practices.
Despite awareness of the potential benefits of a given health behavior or
behaviors, perceived barriers serve as obstacles to the recommended course of action. In
a comprehensive research review of the HBM, perceived barriers emerged as the single
most important factor in health behaviors across all studies and behaviors (Strecher &
Rosenstock, 1997). For preventive behaviors, perceived susceptibility and perceived
barriers are the best predictors of behavior, whereas for behavior related to a current
health problem (such as adhering to medication), perceived severity and perceived
barriers are most significant (Nisbet & Gick, 2008). Notably, poor medication adherence
is a key contributor to pharmaceutical pollution (Daughton & Ruhoy, 2013). Although it
is not the focus of this study, it is possible that efforts to promote the proper disposal of
pharmaceuticals may have the additional benefit of improving consumers’ adherence to
their prescribed medications.
The TPB is an extension of Ajzen and Fishbein’s theory of reasoned action (TRA)
(Ajzen & Madden, 1986). The TPB and TRA models hinge on intention; that is, the
immediate antecedent of any action is the person’s intention to perform it. According to
the TRA, two key determinants of intention are attitude toward the behavior and
subjective norm, representing an individual and a social factor, respectively. The TRA
also addresses the antecedents of these two factors. Behavioral beliefs are presumed to
influence attitudes toward a behavior, whereas normative beliefs underpin subjective
norms. Cote, Gagnon, Houme, Ben Abdeljelil, and Gagnon (2012) included moral norms
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in their research model, and they identified this attribute in nurse intentions when
performing their duties in caring for patients; in their study, these researchers identified
moral norms as the strongest predictive factor in drug disposal behavior. This finding
may be valuable in explaining nurse decisions to dispose of unused medications. Moral
and ethical perspectives may be especially useful for examining behavior related to
environmental protection.
Researchers have also used the TPB model to examine behavior in organizations.
Sanchez-Medina, Romero-Quintero, and Sosa-Cabrera (2014) applied the TPB to the
study of environmental measures taken by managers of small and midsized firms. Waste
disposal was one of the practices they investigated.
Studies by Culiberg (2014), Nigbur et al. (2010), White et al. (2009), and
Sanchez-Medina et al. (2014) added to a small but growing body of research using the
TPB as a framework to investigate behaviors related to environmental protection. Most
studies in this line of research focus on recycling behavior (Nisbet & Gick, 2008). In their
review of this research, Nisbet and Gick (2008) found that, on the whole, intentions to
recycle arise from positive attitudes toward recycling and that “people feel their own
contribution is important” (p. 298).
Cues to action are important factors in health behaviors but have not been
systematically investigated (Strecher & Rosenstock, 1997). In general, it is difficult to
quantify cues because they are often subtle. In addition, they rest markedly on individual
perceptions.
The HBM has been applied to a wide range of health behaviors, including cancer
screening, sunscreen use, dental hygiene, medication adherence, and HIV risk behaviors
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(Nisbet & Gick, 2008). Nisbet and Gick (2008) found only one published study in which
the HBM was applied to behaviors related to environmental protection, specifically
recycling. Given that improper disposal of pharmaceuticals may adversely affect personal
health as well as the natural environment, the HBM was useful in helping understand the
connection between the more abstract threat (environmental pollution) and the more
proximal threat (personal health) in consumers’ adherence to recommendations for proper
disposal of medications. The TPB model complemented the HBM by providing a broader
perspective on attitude toward the behavior and subjective and moral norms, which were
useful in exploring the possible rationale for why people do what the accepted social
norms indicate, such as bringing unused drugs to a take-back event or disposal site.
Background of the Study
It seems ironic that the same substances that have been helping people live longer
and healthier lives are polluting our natural environment and posing a threat to the future
of human health. Virtually all classes of drugs have been detected in the environment.
Abundant evidence shows that medications containing estrogens, such as contraceptives
and hormone-replacement therapy, antidepressants, and antibiotics, all link to
abnormalities in aquatic life (Corcoran et al., 2010; Ortner & McCullagh, 2010). The
phenomenon now known as endocrine disruption was first identified in the 1970s, when
zoologist and former pharmacist Theo Colbern presented evidence derived from hundreds
of studies examining how pollution impacted wildlife in the Great Lakes (Ortner &
McCullagh, 2010). The detrimental effects of estrogens on fish populations are probably
the most heavily documented consequences of pharmaceutical pollution (Corcoran et al.,
2010; Ortner & McCullagh, 2010). These numerous adverse effects include changes in
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mitochondrial activity, energy metabolism, and cell-cycle regulation, as well as the
feminization of male fish and the development of genital abnormalities. In some cases,
entire fish colonies have collapsed due to reproductive failure (Ortner & McCullagh,
2010).
Anti-infectives refer to several bioactive compounds with the ability to inhibit the
growth or survival of microorganisms without harming the host (Segura, François,
Gagnon, & Sauvé, 2009). This category includes some antifungal agents and synthetic
drugs, as well as antibiotics, which have become a key focus in the literature on
pharmaceutical pollution due to the presence of ARGs found in water supplies, soils, and
sediments, and their potentially harmful impact on human health (Fatta-Kassinos et al.,
2011; Marti, Jofre, & Balcazar, 2013; Milic et al., 2013; Uslu et al., 2013; Zhang et al.,
2009). ARGs can be transferred to humans from the environment through direct and
indirect contact, and miniscule levels of antibiotics may act as “signaling agents in
microbial environments” (Fatta-Kassinos et al., 2011, p. 228) to various plants equipped
with receptors for antibiotics and disinfectants.
Adding to the prospective threat presented by ARGs in the environment, these
microorganisms are also resistant to wastewater treatment (de Cazes et al., 2014; Milic et
al., 2013; Zhang et al., 2009). Technological advances have enabled researchers to detect
increasingly smaller traces of pharmaceuticals in the natural environment, but the
techniques for removing them have not kept up and are inadequate. As Segura et al.
(2009) observed, “Anti-infectives, the miracle drugs of the 20th century have become
environmental contaminants of emerging concern in the 21st century” (p. 682).
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Pharmaceuticals enter the environment through various pathways. Manufacturing
and agriculture unquestionably play a prominent role. Through individual drug
consumers, household pharmaceuticals enter the environment in three ways. The first is
through natural excretion, as only a fraction of medication, whether ingested, injected, or
infused, is metabolized by the body (Daughton & Ruhoy, 2013; Harvard Health, 2011;
Ortner & McCullagh, 2010; Rodriguez-Mozaz & Weinberg, 2010; Ruhoy & Daughton,
2008). The unmetabolized compound and its metabolites are excreted in urine and feces,
and to a lesser extent, perspiration. A second pathway is the removal of topical products
while bathing. The third pathway, which is the focus of this research project, is the
disposal of unused, unwanted, and expired medications.
At the same time, the three routes of environmental pollution are interrelated. The
terms upstream and downstream have been used to describe two approaches to reducing
the amount of presence of pharmaceuticals in the environment (Daughton, 2014a). The
upstream approach concentrates on minimizing the amount and toxicity that a given
pharmaceutical product would release when discarded in the environment. Also called
“green pharmacy” or “eco-friendly pharmacy,” this approach starts by designing drugs
with maximum absorption potential, such that smaller traces are excreted. For drugs
currently on the market, an upstream approach involves limiting overprescribing,
curtailing aggressive drug marketing, and improving patient adherence to the prescribed
drug regimen (Daughton & Ruhoy, 2013; Ruhoy & Daughton, 2008; Ruhoy & Kaye,
2010). Diligent monitoring of drugs released in the environment is another element of the
upstream approach (Daughton, 2014b; Ruhoy, 2009).
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The downstream approach focuses on promoting the safe and proper disposal of
unused, unwanted, and expired medications (Ruhoy & Daughton, 2008). This approach is
exemplified by drug take-back programs that allow consumers to bring unused
pharmaceuticals to a designated site where the drugs are collected and transported to be
destroyed. According to preliminary findings, drug take-back events are successfully
attracting people and collecting millions of tons of pharmaceutical waste for safe disposal
(Fain & Alexander, 2014; Fass, 2011; Gray & Hagemeier, 2012; Lubick, 2010; Ma et al.,
2014; Stewart et al., 2015; Tucker, 2011). However, many drug take-back programs are
no more than annual events. For drug return strategies to effectively reduce the massive
amount of pharmaceutical chemicals systematically entering the natural environment,
consumers need return sites that are readily accessible and available daily.
Pharmacies are considered the ideal venue for returning unused medications
(Abahussain et al., 2012; Fain & Alexander, 2014; Fass, 2011; Zimmermann, Wengler, &
Popowski, 2011). Pharmacies are also excellent places to educate the public about proper
medication management and disposal. However, challenges exist to the widespread
adoption of pharmacy returns. Although providing consumers with access to receptacles
is typically recommended and likely to be popular with the public, some pharmacies have
raised concerns about the burdens and costs of requisite measures as well as potential
legal liability. The effectiveness of this strategy depends on the voluntary participation of
pharmacies, as well as adequate funding to offset the costs involved in adhering to DEA
requirements (Fain & Alexander, 2014). With Walgreens in the lead, other large
pharmacy chains may adopt similar programs, thereby greatly expanding the access of
local communities to safe and convenient drug disposal options.
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Upstream approaches may be preferable theoretically, but they do not address the
drugs that already proliferate in household medicine cabinets. Medication take-back
programs appear to be promising. Ultimately, their success depends on the active
participation of stakeholders, including local pharmacies or other sites, and above all, the
everyday consumers of prescription and OTC drugs.
Research Questions
This cross-sectional, quantitative study is driven by the following research
questions:
RQ1: Is there an association between knowledge of the environmental and the
human-health impact of pharmaceutical disposal and actual disposal
practices?
RQ2: Is there an association between knowledge of recommended disposal
practices and actual disposal practices?
RQ3: Is there an association between available disposal options and actual
disposal practices?
RQ4: To what degree can actual disposal practices (the dependent variable) be
explained by the combined and differential contribution of the three
independent variables: knowledge of the environmental and human-health
impact, knowledge of recommended disposal practices, and locally available
disposal options?
RQ5: Do differences exist among RQ1, RQ2, and RQ3 across demographic
groups?
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Research Hypotheses
The following hypotheses derived from the research questions:
H01: No significant association exists between knowledge of the environmental
and the human-health impact of pharmaceutical disposal and actual disposal
practices.
H11: A significant association exists between knowledge of the environmental and
the human-health impact of pharmaceutical disposal and actual disposal
practices.
H02: No association exists between knowledge of recommended disposal
practices and actual disposal practices.
H12: An association exists between knowledge of recommended disposal
practices and actual disposal practices.
H03: No association exists between available disposal options and actual disposal
practices.
H13: An association exists between available disposal options and actual disposal
practices.
H04: Actual disposal practices cannot be explained to a significant degree by the
combined and differential contribution of knowledge of the environmental and
the human-health impact, knowledge of recommended disposal practices, and
locally available disposal options.
H14: Actual disposal practices can be explained to a significant degree by the
combined and differential contribution of knowledge of the environmental and
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the human-health impact, knowledge of recommended disposal practices, and
locally available disposal options.
H05: No significant demographic differences exist in the relationships of
knowledge of the environmental and the human-health impact, knowledge of
recommended disposal practices, and locally available disposal options to
actual disposal practices.
H15: Significant demographic differences exist in the relationships of knowledge
of the environmental and the human-health impact, knowledge of
recommended disposal practices, and locally available disposal options to
actual disposal practices, when controlling by demographic variables (e.g.,
age, race, education level).
Nature of the Study and Study Design
Research Design
The research design for this study was quantitative and cross-sectional. When a
researcher’s goal is to examine associations between quantifiable and objectively
measurable concepts, a quantitative method is appropriate (Howell, 2010). The main
objective of this study was to investigate the hypothesized association between
consumers’ actual disposal practices (outcome of interest/dependent variable) and the
factors (independent variables) that may influence them. Because the variables under
investigation are quantifiable and objectively measurable, a quantitative method was
appropriate. Specifically, I selected a cross-sectional design because my aim was to
examine associations between variables measured at a single point in time.
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Typical disadvantages of using a cross-sectional design include the challenges
associated with establishing causal inferences, and the notion that the findings represent
the phenomenon in a specific single time and place (Pine, Pitts, & Nugent, 1997). To
inspire social change, results from this study can be applied toward the design of healthpromotion programs that encourage optimal drug disposal practices, encourage the
simplification of disposal options, improve patient drug compliance, and generate
momentum for the development of drugs that are less toxic to the environment. In
aggregate, if adopted, the aforementioned approaches could reduce the posed risks to
human health by improper disposal of pharmaceutical products in the environment.
Dependent and Independent Variables
Actual disposal practices was the outcome (dependent) variable. As suggested by
the reviewed literature, this study used the following key independent variables: (a)
knowledge of environmental and human-health impacts, (b) knowledge of recommended
disposal practices, and (c) availability of disposal options. Data on the outcome variable
and the independent variables were collected using a questionnaire.
Survey Instrument
The contents of the survey instrument for this study were adapted from items used
by Seehusen and Edwards (2006). Approval for the use and adaptation of the
questionnaire was given by Dr. Seehusen and can be found in Appendix A. The final
draft version of the questionnaire was pilot tested after Institutional Review Board (IRB)
review and approval, following the process recommended by Radhakrishna, Francisco,
and Baggett (2003).
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The questionnaire consists of content questions used to measure the constructs of
interest as well as demographic questions. The survey questionnaire was administered via
the Internet by SurveyMonkey, an online survey service provider, using web-based,
electronic forms for data input. Cottrell and McKenzie (2010) argued that researchers
cannot assume that most U.S. residents would be sufficiently computer literate and have
Internet access to complete a survey online. Within the last few years, however, Internet
access and broadband have become so widely available that large government programs,
such as the Affordable Care Act (U.S. Department of Health and Human Services [HHS],
n.d.), are administered via the Internet. On the basis of these considerations, I deemed the
online approach to be a practical and efficient medium for the administration of the
survey questionnaire.
The questionnaire consists of content questions used to measure the constructs of
interest, as well as demographic questions. The first question of the survey asks, “What is
your most used method for disposing of unused or expired medications?” Participants
answered this question by selecting one of eight possible response options that included
“I flush them down the toilet” and “I follow the disposal instructions that accompany the
medicine,” among others. This question was used to measure the dependent variable:
actual disposal practices.
The next questions on the survey were, “In your area, is there a designated
collection location where you can dispose of your unused or expired medication?” and
“How convenient is it for you to reach the designated disposal location?” These questions
represented the independent variable: available disposal options. Next, participants were
asked, “Do you believe that improper disposal of medications in the environment could
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have negative consequences on human health?” Participants responded to this question
on an ordinal scale and their responses represented the independent variable: knowledge
of environmental and the human-health impact. Participants were also asked four
questions, which were answered on categorical and ordinal scales that assessed the
participants’ knowledge of disposal practices. These questions were used to represent the
independent variable: knowledge of recommended disposal practices. Finally,
participants were asked to provide basic demographic information. Specifically, they
were asked to report their gender, year of birth, race, highest level of education
completed, and their state of residence.
Questions related to knowledge and awareness were scored using a coded ordinal
scale, as suggested by Monnin and Perneger (2002). In contrast, data from the dependent
variable, actual disposal practices, were categorical. A dichotomous Yes/No outcome
was used to assess and code the dependent variable.
Population and Sample
The sampling approach for this study was convenience sampling. A conveniencesampling method is appropriate when a true random sample is not feasible to obtain.
Because I was unable to randomly sample all possible residents in the northeast United
States, a convenience sample was appropriate. Participants in this study had to meet the
following three inclusion criteria: (a) resident of the northeast United States, (b) aged 18
or older, and (c) having used a prescription drug in the prior 2 years. The U.S. Census
Bureau (n.d.) defined the northeast region as comprising nine states: Connecticut, Maine,
Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, and
Pennsylvania. As of 2013, the estimated size of this population was approximately 56
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million residents. Participants who met these criteria were recruited online from
SurveyMonkey’s participant pool. The appropriate sample size was calculated using as
input in the algorithm the following parameters: (a) population size = 55,943,073,
corresponding to the entire northeast region (U.S. Census Bureau, n.d.), (b) confidence
level = 95%, and (c) margin of error = 5%. The resulting sample size was 385
(SurveyMonkey, 2016).
Data Collection
After obtaining IRB approval to conduct the study, I used SurveyMonkey to
recruit participants who met the eligibility criteria of the study. The study consisted of an
online survey hosted by SurveyMonkey. Cottrell and McKenzie (2010) argued that
researchers could not assume that most U.S. residents would be sufficiently computer
literate and have Internet access to complete a survey online. In recent years, however,
Internet access and broadband have become so widely available that even large
government programs, such as the Affordable Care Act (HHS, n.d.), are administered
through the Internet. On the basis of these considerations, I deemed the online medium to
be practical and efficient to administer the survey questionnaire.
Aligned with Walden University’s IRB policy regarding participation in online
surveys, given that participants had the option to take or ignore the survey, I had no need
to include a separate consent form; however, the survey included a section that described
the participants’ rights and provided contact information for Walden’s IRB and me.
Individuals who agreed to participate after indicating they met the three inclusion criteria
were directed to the survey. The survey was intended to be open to potential participants
for up to 3 weeks; however, the target sample size was achieved in a much shorter time.
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Participants received no compensation for participation in the study. At the end of the
recruitment period, SurveyMonkey provided me with two data files on their secure server
for download: one Excel and one SPSS-formatted file. I stored the survey data files on a
password-protected personal computer that is only accessible to me. The data are also
backed up on a password-protected storage medium, stored safely and securely.
Data Analyses
I performed all data analyses using SPSS. Prior to the analyses, and upon
collection, I cleaned the data to ensure all records had sufficient and accurate data for
analysis. I accomplished the data cleaning by running frequency distributions for each
variable, ensuring the data were within the acceptable range of values. Given that the data
were collected electronically using a web-based form that only accepts predefined input
values, there were no values entered outside the acceptable range; however, there were
several cases in which the survey participants had skipped some questions, and this
resulted in fields with missing data. In addition to descriptive statistics, the key statistical
procedures to address the research questions and test the stated hypotheses were binary
logistic regression and analysis of variance.
Definition of Key Terms
The following terms are defined for the purpose of this study:
Downstream approach: Approach to reducing the amount of pharmaceutical
substances in the environment by promoting the safe and proper disposal of unused,
unwanted, and expired drugs (Ruhoy & Daughton, 2008).
Drug take-back programs: Under the auspices of the DEA, drug take-back
programs allow consumers to return unused OTC and prescription human and pet
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medications to specific locations equipped with receptacles for their safe disposal (Fain &
Alexander, 2014).
Endocrine-disrupting chemicals: Chemicals that can interfere with endocrine
functioning to cause damage to the developmental, reproductive, neurological, and
immune systems of human and animal life (Ortner & McCullagh, 2010).
Green pharmacy or ecofriendly pharmacy: A key component of the upstream
approach focuses on designing drugs with highly specific drug action and the capacity for
maximal absorption by the body so smaller trace amounts are excreted (Daughton &
Ruhoy, 2008).
Nonsteroidal anti-inflammatory drugs (NSAIDs). The most widely used class of
drugs including acetylsalicylic acid (aspirin), ibuprofen, and diclofenac; NSAIDs have
the potential to cause kidney damage, which has been observed in animals exposed to
NSAIDs in water (Ortner & McCullagh, 2010).
Pharmaceuticals: Compounds manufactured for medicinal purposes,
pharmaceuticals are distinguished from other environmental pollutants because they are
made to be biologically active (Fatta-Kassinos et al., 2011).
Upstream approach: A proactive approach to reducing the amount of
pharmaceutical substances in the environment by minimizing the amount and toxicity of
drugs with the potential to contaminate the environment, and for drugs already on the
market, curbing overprescription, ensuring patients are prescribed the most effective
drugs in precise doses, and improving patient medication adherence (Ruhoy & Daughton,
2008).
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Brief Review of the Literature
Disposal Practices Among Nurses
Nurses counsel and educate patients; thus, they are ideally positioned to inform
patients about proper medication disposal procedures. However, few studies examined
practices among nurses. McCullagh et al. (2012) examined the medication disposal
practices and attitudes toward medication disposal of home hospice nurses. Educating
patients and caregivers regarding how to store, manage, and dispose of medications is a
key aspect of the professional role of nurses. Upon a patient’s death, however, the nurse
is often entrusted with discarding unused medications. A total of 138 home hospice
nurses completed an online survey. Almost half of the nurses (44%) reported disposing of
11 or more medication doses upon a patient’s death. Although close to two-thirds (64%)
of the nurses reported always or often mixing the drugs with unpalatable substances, as
recommended, more than half discarded them in the toilet or drain with the same
frequency.
The vast majority of nurses considered mixing medications with an unpleasant
substance as acceptable (94%) and safe (91%). Striking about the study was the notable
discrepancy between the almost unanimous endorsement of the safety and acceptability
of mixing drugs with an undesirable substance, and the number of participants who
regularly disposed of drugs in that manner (McCullagh et al., 2012). The nurses gave
high priority to ensuring that drugs were not diverted, which could help to explain why
they were inclined to dispose of medication to sewage. Nevertheless, it was clear that
their actions were not consistent with their beliefs about how drugs should be discarded.
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Most nurses drew their information on safe medication disposal from their own reading
rather than from formal training in nursing school or on the job.
Disposal Practices Among Patients
In a unique study on the handling, storage, and disposal practices of patients
taking anticancer drugs at home, Trovato and Tuttle (2014) surveyed 42 patients (95%
male) being treated at a VA hospital. In the course of a year, the use of oral
chemotherapy by outpatients increased substantially. Patients received education from
medical, nursing, and pharmacy staff, but had no standardized practices.
Overall, storage practices among patients conformed to recommended guidelines
(Trovato & Tuttle, 2014). All kept their medication away from children and pets, most
kept the drugs free of extreme temperatures or humidity, and those who did not keep the
drugs in the original container made use of a pill sorter to simplify adherence to the
prescribed regimen. Few participants had unused drugs.
The gaps between recommended practices for the safe handling and disposal of
anticancer drugs were attributed to lack of patient education (Trovato & Tuttle, 2014).
Close to half of the patients (45%) had not received information on safe handling and
storage practices. Those who were informed had acquired their information from nurses
and pharmacists, and to a lesser extent, physicians. Health professionals who counsel
cancer patients on medication often focus primarily on administration and potential side
effects (Trovato & Tuttle, 2014). With limited time, health professionals are likely to give
precedence to these critical issues. However, a definite need exists for better patient
education on the storage, handling, and disposal of anticancer drugs. The pharmacist
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authors altered their practices in response to the survey to ensure the safe management
and disposal of the powerful chemotherapy drugs.
Drug Take-Back Programs
Gray and Hagemeier (2012) examined the characteristics of rural residents who
participated in 11 take-back events held between 2009 and 2011, and the medicines they
brought. A total of 752 individuals returned 16,956 containers of medications prescribed
for 1,210 patients. Participants were mostly White, on average about 40 years old, and
women accounted for more than half of the group (57%). In descending order, the
dominant reasons for participating were a desire to clean out their medicine cabinets
(68%), environmental concerns associated with disposing of drugs and other waste
materials (45%), and concerns about accidental poisoning (14%). The surveyed
participants were those who participated in the take-back events and were therefore
already motivated to comply with the proper disposal of expired or unused drugs. Most
participants lived within 10 miles of the take-back site, leading to the conclusion that
geographic distance is a consideration in people’s attendance at take-back events (Gray &
Hagemeier, 2012). For urban and suburban residents, other issues such as time concerns
may emerge as more relevant perceived barriers.
Ma et al. (2014) presented the results of 11 drug take-back events held in Hawaii.
These events were advertised in the media (television, radio, and newspapers), through
brochures and flyers in pharmacies and medical offices, and by word of mouth.
Participants at the 2011 Good Life Senior Expo were surveyed regarding prior
experiences with unused or expired drugs. Most discovered the event through newspaper
or TV advertisements. Before the take-back events, the predominant methods for
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managing unused medications were throwing them in the trash (34%), keeping them at
home (32%), or flushing them down the toilet (24%). Only 10% had returned
medications to a pharmacy or medical office. Two-thirds of the participants kept unused
medications at home for a year or longer. All participants (> 99%) wanted the take-back
events to continue.
The 11 events yielded 8,011 pounds of medication, primarily pills or tablets (Ma
et al., 2014). The largest proportion was categorized as “Other” or miscellaneous.
Antihypertensives were the next largest drug class, similar to the prevalence of
cardiovascular drugs in the Maine take-backs (Stewart et al., 2015). Other drugs returned
in large quantities were gastrointestinal drugs and analgesics. The most common OTC
drugs fell into this last category: aspirin, naproxen, and ibuprofen. A substantial amount
of pseudoephedrine was returned, used in the manufacture of methamphetamine, and one
of the most common OTC drugs returned. Controlled substances accounted for 10% of
the drugs. This occurrence seemed to be fairly consistent, as similar proportions of
controlled substances were returned in Maine (Stewart et al., 2015) and Appalachia (Gray
& Hagemeier, 2012).
Ma et al. (2014) did not collect participant information as did Gray and
Hagemeier (2012). However, both studies generated enthusiastic responses. As staunch
advocates of drug take-back programs, Ma et al. called for efforts to identify prospective
process champions and stakeholders, including consumers, government organizations,
and “all parties involved in the medication chain of manufacturing, ordering, prescribing,
dispensing, administering, and monitoring” pharmaceuticals (2014, p. 30).
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Assumptions
The main assumption guiding this study was that the participants would respond
to the questionnaire honestly and accurately. Participation was entirely voluntary, the
survey was completed anonymously, and participants were assured of complete
confidentiality. The anonymity of this online survey is assumed to have facilitated
truthfulness and has reduced the potential for responses based on social desirability.
Limitations
Participation in this study was limited to adults residing in the northeast United
States. This region is known for its diverse demographic composition (U.S. Census
Bureau, n.d.). According to the 2010 U.S. Census (recounted in the U.S. Census, 2011),
the socioeconomics characteristics of the northeast region of the United States include the
following:
•

Median household income = $53,283, compared to the Midwest = $48,445,
the South = $45,492, and the West = $53,142.

•

Percent in poverty level = 11.8, compared to the Midwest = 13.3, South =
15.7, and the West = 14.8

•

Number of people without health insurance coverage = 11.8, compared to the
Midwest = 12.7, the South = 19.2, and the West = 17.7

These data illustrate how the northeast appears to have socioeconomic
characteristics more favorable than those of other regions. Consequently, the
generalization of the results of this study to the general U.S. population can be drawn
with caution. In fact, socioeconomic characteristics such as income, employment status,
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and health insurance coverage have been associated with health care use and interaction
with health care professionals (Blackwell, Martinez, Gentleman, Sanmartin, & Berthelot,
2009), and, by inference, these factors may have influenced the likelihood of receiving
drug disposal information.
Given the emphasis on prescription drugs in the national strategy to reduce the
amount of pharmaceuticals in the environment, this study was restricted only to
individuals who have used at least one prescription. However, OTC drugs, especially
NSAIDs, are widely used, and like prescription drugs, have the potential to pollute the
environment and present a threat to human health. Thus, this study had intrinsic
limitations by excluding a sizable proportion of consumers of common pharmaceuticals,
who may be less likely than those with prescription drugs to have accurate knowledge of
recommended disposal practices.
The use of the Internet may have also excluded those people who are unfamiliar
or uncomfortable with this technology. In spite of optimistic figures of large diffusion of
the use of the Internet, groups of people, due to age or financial condition, may not have
had the opportunity to be part of the population sample. The survey was only in the
English language; therefore, people who were not fluent in English may not have
completed it. Consequently it is unknown what disposal practices are being used by that
population group.
This chapter began with an introduction to the problem area, significance of the
study, theoretical frameworks, research questions, and study design. In Chapter 2, I
present a review of the literature on the theoretical framework, types of drugs and their
effects, and the evolution of policy. In Chapter 3, I provide the research design,
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methodology of the study, and the data analysis plan. In Chapter 4, I present the results of
the study, and Chapter 5 includes conclusions and recommendations for social change
and future research and practices.
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Chapter 2: Literature Review
For decades, poison-control centers in the United States recommended disposing
of unused or expired medications by flushing them down the toilet or rinsing them down
the drain to prevent inadvertent or intentional poisoning (McCullagh et al., 2012; Ortner
& McCullagh, 2010). Health professionals believed they were acting responsibly by
disposing of drugs in the safest possible way, and few consumers would reject such a
simple and convenient mode of disposal. However, detection of measurable amounts of
pharmaceutical substances in water raised alarm about the consequences of pollution
from pharmaceuticals on the environment and its potential effects on human health (Blair
et al., 2013; Fatta-Kassinos et al., 2011; Kotchen et al., 2009; A. Kumar et al., 2010;
Musson et al., 2007; Nikoalaou et al., 2007; WHO, 2011).
The presence of pharmaceuticals and personal-care products as traces of
environmental pollutants first gained attention in the 1980s (Daughton, 2003a).
Developments in analytical techniques have allowed scientists to detect, quantify, and
document trace amounts of pharmaceutical substances in wastewaters, sediments,
groundwater, surface water, and even drinking water (Bound & Voulvoulis, 2005;
Daughton, 2014b; de Cazes et al., 2014; Fatta-Kassinos et al., 2011; A. Kumar et al.,
2010; Larsson, 2014; Nikoalaou et al., 2007; Orton & McCullagh, 2010; RodriguezMozaz & Weinberg, 2010; Segura et al., 2009; Uslu et al., 2013; WHO, 2011; Zhang et
al., 2009). Pharmaceuticals are unique among environmental pollutants in that they are
designed to be bioactive. Numerous studies of water samples have detected antibiotics,
anticonvulsants, analgesics, mood stabilizers, hormones, and chemotherapy agents
(Bound & Voulvoulis, 2005; Corcoran et al., 2010; Harvard Health, 2011; McCullagh et
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al., 2012; Ortner & McCullagh, 2010; Uslu et al., 2013). These substances have been
linked with disruptions to aquatic life, such as genital abnormalities in fish, foot
detachment in frogs, and, in some cases, the collapse of entire fish populations.
In 2009, the WHO (2011) formed a working group composed of experts in the
fields of pharmacology, toxicology, water chemistry, water quality and health, water
treatment, and water regulation and policy. The group conducted an exhaustive and
detailed review of the existing literature and called in additional experts to consult and
further review scientific evidence. According to the WHO experts, trace concentrations
of pharmaceutical substances in drinking water are low enough that they are unlikely to
present risks to human health. At the same time, the same experts acknowledged that
limited understanding exists of potential health risks associated with long-term exposure
to low levels of pharmaceutical substances in drinking water or of the combined effects
of mixtures of pharmaceutical compounds.
Other experts raise the question of the potential effects of pharmaceutical
exposure on sensitive populations such as pregnant women, children, elders, and
individuals with compromised immune systems (A. Kumar et al., 2010). The discovery of
ARGs in treated wastewater also raises the issue of whether that resistance might transfer
to microbes capable of affecting human health (Lubick, 2011; Marti et al., 2013; Sahoo,
Tamhankar, Johansson, & Lundborg, 2010; Segura et al., 2009; Zhang et al., 2009).
WHO (2011) is one of many international and government bodies that
recommend adopting strategies to minimize exposure to pharmaceuticals in water, such
as take-back programs, guidelines and regulations, public-awareness campaigns, and
consumer education to promote the proper disposal of unused, unwanted, and expired
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medications and reduce the amount of pharmaceuticals that enter the environment. In
2008, the White House ONDCP formulated the first federal guidelines for the disposal of
prescription drugs by consumers and health professionals (McCullagh et al., 2012).
However, regulations governing the transport of controlled substances presented a barrier
to the return of consumer drugs for proper disposal. In 2009, the DEA solicited public
opinion on the issue of disposing of controlled substance dispensed to individual patients
to develop a safe disposal policy (Fass, 2011). This led to the enactment of the Secure
and Responsible Drug Disposal Act of 2010 and the Safe Drug Disposal Act of 2010,
thereby paving the way for drug take-back programs that allow for the return of
controlled and uncontrolled substance. The ONDCP (2011) emphasized the importance
of proper medication disposal to protect human health and the natural environment.
The purpose of this quantitative cross-sectional study was to examine the disposal
practices and disposal attitudes of a sample population in the northeast United States.
This study was guided by five research questions:
1. Is there an association between knowledge of the environmental and the
human-health impact of pharmaceutical disposal and actual disposal
practices?
2. Is there an association between knowledge of recommended disposal practices
and actual disposal practices?
3. Is there an association between locally available disposal options and actual
disposal practices?
4. To what degree can people’s actual disposal practices be explained by the
combined and unique contributions of knowledge of environmental and
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human-health impact, knowledge of recommended practices, and locally
available disposal options?
5. Do differences exist among RQ1, RQ2, and RQ3 across demographic groups?
Numerous theories and models have evolved in health psychology to explain
health-related attitudes, beliefs, and motivations and their influence on individual
behavior (Bandura, 1997; Nisbet & Gick, 2008; Strecher & Rosenstock, 1997).
Environmental behavior is multifactorial; consequently, I found it important to consider
more than one model as the theoretical framework for behavior change: the HBM and the
TPB.
Search Strategy
The literature presented in this review drew primarily from PubMed/MEDLINE
and the following EBSCO databases: Academic Search Premier, MasterFILE Premier,
Business Source Premier, PsycINFO, and PsycARTICLES. I did not restrict the searches
to peer-reviewed scholarly articles, as I deemed reports and guidelines from government
agencies as well as international bodies such as the WHO to be important sources of
information on the topic. In the initial searches, keywords, used either individually or in
conjunction, included pharmaceuticals, drugs, medication, disposal, waste, pollution,
contamination, contaminants, toxins, environment, and health. This strategy produced a
large number of research studies. Many were from the biochemistry and environmentalscience literature. These articles provided compelling evidence of what is happening to
the physical environment as a result of massive amounts of pharmaceuticals entering the
environment. A review of these articles generated additional searches including the
following keyword searches: antibiotics, antibiotic resistance, analgesics,
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antidepressants, hormones, endocrine disrupting chemicals, measurement, evaluation,
water treatment, water treatment facilities, wastewater, drinking water, soils, sediments,
and removal.
Environmental studies also confirmed the role of human actions in the
accumulation of pharmaceutical pollutants. Many studies in this line of research advocate
strategies such as drug take-back programs to reduce the amount of pharmaceutical
compounds entering the natural environment. However, they do not directly relate to the
behavioral aspects of drug disposal by consumers or health care professionals who handle
unused or expired drugs. Thus, I needed to conduct additional searches. The keywords
drug disposal programs, drug take-back programs, and take-back events produced a
number of articles on the topic. Although take-back programs date to the mid-2000s
when they were recommended by the federal government as a strategy for safe
medication disposal, they generated few empirical studies. The new generation of takeback programs under the auspices of the DEA is a recent phenomenon. Highlighting the
relative newness of the DEA programs, the first study of the Maine Prescription
Monitoring Program (the most publicized program) appeared in the January 2015 issue of
the American Journal of Public Health (Stewart et al., 2015).
The theoretical frameworks selected for this study were the TPB and the HBM.
These models, as well as the keywords health, health psychology, public health,
knowledge, awareness, beliefs, education, information, attitudes, behavior, and
environment, produced several studies, although more research appeared to focus on the
attitudes and practices of health professionals than the general public. I added the terms
patients and consumers to the search criteria. Theory of planned behavior and health
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belief model and environment revealed several studies involving recycling behavior and
other environmental-protection activities, and they are included in this chapter.
The articles that I selected for this review span the years 2003 to 2015, with the
exception of theoretical material. Numerous scientific studies were published during the
1990s documenting the presence of pharmaceutical substances in water. Not until the
early to mid-2000s, however, did this knowledge spur calls to take action to address the
burgeoning problem. The selected dates cover the time frame from which pharmaceutical
waste captured global attention as an important environmental and public health concern,
from warnings by environmentalists of polluted waterways—including drinking water
supplies—to government recognition of the potential public threat. Calls ensued to
educate the general public about proper medication disposal and to encourage this
behavior through patient education, public-awareness campaigns, medication take-back
events, and the provision of disposal sites at pharmacy chains and health care facilities.
The literature reveals glaring gaps in knowledge of the potential effects of
pharmaceuticals in the environment on human health due to weaknesses in the existing
research, as well as a dearth of empirical studies examining the medication disposal
practices of consumers and the effectiveness of programs and strategies to encourage
proper disposal.
Organization of the Literature Review
This chapter began with an introduction to the problem of pharmaceutical
pollution in the environment, its potential impact on human health, and steps being taken
to address the problem. I followed with a brief statement of the purpose and research
questions of this study, the organization of the literature review, the theoretical
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framework guiding the study, the presence of pharmaceuticals in the environment, the
evolution of policies and programs, knowledge, attitudes, and disposal practices of health
professionals and consumers, medication take-back groups, recycling attitudes, and
behavior, and a brief summary and conclusion.
Theoretical Framework
According to Nisbet and Gick (2008), despite parallels between health and
environmental behavior, the fields of health promotion and health-behavior change are
not often applied to environmental issues. Environmental behavior is multifactorial;
consequently, I decided to consider more than one model as the theoretical framework of
behavior change: the HBM and the TPB. I deemed the TPB most relevant to the issue of
proper pharmaceutical disposal, whereas the HBM aligned with studies that involved
recycling and environmental protection.
Theory of Planned Behavior
The TPB is an extension of Ajzen and Fishbein’s TRA (Ajzen & Madden, 1986).
Both models hinge on intention; that is, the immediate antecedent of any action is the
person’s intention to perform it. According to the TRA, people have two key
determinants of intention: attitude toward the behavior and subjective norm, representing
an individual and a social factor, respectively. The theory also addresses the antecedents
of these two factors. Behavioral beliefs are presumed to influence attitudes toward the
behavior, while normative beliefs underpin subjective norms.
Missing from the original model, according to Ajzen and Madden (1986), was the
issue of behavioral control, and the extent to which an individual has the control to
achieve the behavioral goal. Given that numerous factors can interfere with the actual
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control one has over carrying out a given behavior, behavioral control was
conceptualized as perceived control, “the person’s belief as to how easy or difficult
performance of the behavior is likely to be” (Ajzen & Madden, 1986, p. 457). The more
internal and external resources and opportunities people perceive they have and the fewer
obstacles they anticipate, the stronger their sense of perceived control over performing
the target behavior. Attitudes, subjective norms, and perceived behavioral control all have
distinct effects on behavior (Ajzen & Madden, 1986).
Ajzen and Madden (1986) tested two versions of the TPB in two experiments.
Both experiments confirmed that the TPB was superior to its predecessor. Consistent
with expectations, the addition of perceived behavioral control greatly enhanced the
ability of the theory to predict intentions and subsequent achievement of behavioral
goals.
Since its inception, researchers have used the TPB extensively in examining
health-related behaviors such as smoking cessation, health screening, and dental flossing
(Nisbet & Gick, 2008), as well as the behavior of health care professionals (Cote et al.,
2012; Ward, 2013). Ajzen recognized that subsequent research was likely to disclose
additional factors that influence intention and outcomes (Ward, 2013). Furthermore,
Ajzen and Fishbein (as cited in Ajzen & Madden, 1986) acknowledged that social norms
did not necessarily represent a unitary construct. Rather, descriptive norms, denoting
perceptions of others’ behavior, and injunctive norms, denoting perceived expectations
for how one should act, may have independent effects on intentions (Nigbur et al., 2010;
White et al., 2009). Nigbur et al. (2010) and White et al. (2009) explored the respective
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influences of descriptive and injunctive norms, as well as aspects of social identity in
their application of the TPB to household recycling behavior.
Culiberg (2014) added moral perspectives, applying the TPB to recycling
behavior. Also expanding the TPB in this direction, Cote et al. (2012) included moral
norms in research exploring nurse intentions to incorporate research evidence into
clinical decision making. In fact, moral norms emerged as the strongest predictive factor.
This finding may be valuable for explaining nurse decisions in disposing of unused
medications. Moral and ethical perspectives may be especially useful in examining
behavior related to environmental protection.
Researchers also used the TPB to examine behavior in organizations. SanchezMedina et al. (2014) applied the TPB to the study of environmental measures taken by
managers of small and midsized firms. Waste disposal was one of the practices
investigated. For health care facilities, proper pharmaceutical disposal must be managed
at the organizational as well as the individual level (EPA, 2008, 2010).
Studies by Culiberg (2014), Nigbur et al. (2010), White et al. (2009), and
Sanchez-Medina et al. (2014) added to a small but growing body of research using the
TPB as a framework to investigate behaviors related to environmental protection. Most
studies in this line of research focused on recycling behavior (Nisbet & Gick, 2008). In
their review of this research, Nisbet and Gick (2008) found that intentions to recycle
arose from positive attitudes toward recycling and perceived behavioral control, provided
that “people feel their own contribution is important” (p. 298). The influence of
subjective norms on recycling was less consistent. Nigbur et al. and White et al.
deliberately chose to focus on the influence of subjective norms on recycling.
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In summary, the behaviors that trigger the disposal of unused or expired
pharmaceutical products are multifactorial and can therefore be best explained by using
two theoretical frameworks: the TPB and the HBM. The TPB model (Ajzen & Madden,
1986) hinges on the concept of intention to perform an action, given that the individual
has the perception of having behavioral control. In the context of this study, the TPB has
provided clues on the need for individuals to have feasible (and available) disposal
options. Culiberg (2014), Nigbur et al. (2010), White et al. (2009), and Sanchez-Medina
et al. (2014) used the TPB to investigate behaviors related to environmental protection,
whereas Nisbet and Gick (2008) used the TPB to explore behaviors related to recycling.
Health-Belief Model
Hochbaum developed the HBM in the 1950s in response to the poor success of
public health campaigns to promote disease screening (Strecher & Rosenstock, 1997).
Based on detailed analyses of probability samples of adults in cities that offered
tuberculosis screening, Hochbaum identified the beliefs that form the basis of the model:
perceived susceptibility and perceived benefits of action. Hochbaum also recognized the
role of intrinsic and extrinsic cues or triggers in motivating people to take action,
although never empirically investigating that feature of the model (Strecher &
Rosenstock, 1997).
Decades later, the HBM has been refined and expanded, and has a strong
empirical foundation (Strecher & Rosenstock, 1997). The model has several essential
components. Perceived susceptibility denotes the person’s subjective perception of
experiencing a health or medical condition. This dimension encompasses susceptibility to
illness in general, as well as vulnerability to a specific condition. A related factor is
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perceived severity, referencing the seriousness of experiencing the condition or allowing
it to remain untreated. This component includes medical consequences (pain, disability,
and death) and social consequences (for example, the impact of the condition on work
and social relationships). Taken together, perceived susceptibility and perceived severity
produce perceived threat.
Although acceptance of a perceived personal threat is a prerequisite for taking
action, the specific course of action the person chooses to take depends on the perceived
benefits of the available options (Strecher & Rosenstock, 1997). Bringing unused and
expired medications to a take-back event or disposal center neutralizes the potential threat
those drugs might present to people and pets, and does not contribute to environmental
pollution. The action might carry the intrinsic reward of feeling one has done the right
thing. A drug take-back event might offer an opportunity for socializing. For young
people in particular, peer pressure to engage in environmentally friendly actions might
influence drug disposal behavior.
Despite awareness of the potential benefits of a given health behavior or
behaviors, perceived barriers can arise as obstacles to the recommended course of action.
A comprehensive research review of the HBM found perceived barriers to be the single
most important factor in health behaviors across all studies and behaviors (Strecher &
Rosenstock, 1997). For preventive behaviors, perceived susceptibility and perceived
barriers are the best predictors of behavior, whereas for behavior related to a current
health problem (such as adhering to medication), perceived severity and perceived
barriers are most important (Nisbet & Gick, 2008).
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Cues to action are recognized as important factors in health behaviors, but have
not been systematically examined (Strecher & Rosenstock, 1997). In fact, it is difficult to
quantify cues because they are often subtle and highly individual. For example, people
who love nature or are aware of the toxic impact of improperly disposing of medications
in the environment might be more likely to change behavior and implement a proper
disposal practice. The HBM has been applied to a wide variety of health behaviors. A
short list includes cancer screening, wearing sunscreen, dental hygiene, medication
adherence, and HIV risk behavior (Nisbet & Gick, 2008). To date, the HBM has been
used in only one published study related to the environment: recycling behavior. In a
1997 study by Lindsay and Strathman, individuals who viewed the consequences of not
recycling as more of a serious threat were more inclined to comply. Self-efficacy and
greater perception of benefits (or lower perceived costs) also aligned with recycling. Selfefficacy has been applied to a myriad of health behaviors. The more confident people feel
in executing a course of action and accomplishing the desired results, the more likely
they are to undertake the behavior and persist through challenges to achieve their goals
(Bandura, 1997).
According to Nisbet and Gick (2008), health psychology is a model with an
important role in the realm of environmental protection. In Canada, the environment has
supplanted health as the Canadians’ top concern, although health still ranks high on the
list. In Canada, as in the United States, the majority of consumers continue to dispose of a
large proportion of unused and expired medications in the toilet and drain (Health
Canada, 2009). In a fashion similar to the United States, Canada has a federal structure
whereby programs that encourage the proper disposal of pharmaceuticals are being
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enacted at the provincial level, with a substantial degree of variation between provinces.
In the United States and Canada, results have been promising, but many people are
unaware of the options for safe disposal of drugs, and barriers do exist. Barriers to the
return of medications to pharmacies and other disposal sites include lack of locally
available facilities and limited hours for return, as well as lack of awareness.
Nisbet and Gick (2008) pointed out that, in general, people desire a “safe, healthy
environment” (p. 296). However, the concept of a safe, healthy environment is relatively
abstract, and many people do not understand the potential and actual consequences of
environmental problems such as climate change, habitat destruction, and pollution impact
on human health. Despite widespread interest by the public in protecting the environment
and improving personal health, many public health campaigns fail to elicit changes in
people’s behavior. A key reason for this persistent problem is that program designers and
policymakers fail to recognize inconsistencies between attitudes toward health and the
environment and related behavior. Virtually all guidelines, reports, position papers, and
standards issued by government agencies, international bodies, and professional
associations emphasize the importance of consumer and patient education on the safe use
and disposal of medications. Education is an essential prerequisite for behavior change,
but information per se is notoriously ineffective for changing human behavior.
Nisbet and Gick (2008) observed, “Attempts to inspire healthy and proenvironmental behavior often rely on information-intensive messages, assuming that once
people are informed they will act differently” (p. 297). A plethora of public health
programs that have failed to produce the intended effects that rely on that assumption.
However, the problem is that the complexity of factors affecting behavior is
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underestimated (Nisbet & Gick, 2008). External factors such as lack of transportation,
lack of recycling or drug disposal centers, and low socioeconomic status are impediments
to proenvironmental and health behavior. Proximity is an important concern in
encouraging rural residents to participate in medication take-back events (Gray &
Hagemeier, 2012).
Furthermore, many health and environmental behaviors are deeply entrenched.
Most consumers are so used to disposing of medications in the sink or toilet that they
may not give a second thought to their behavior, despite health and environmental
concerns. Even nurses, pharmacists, and other health care staff who are aware of proper
and improper disposal practices dispose of unused pharmaceuticals in the drain or toilet
(Abahussain et al., 2012; McCullagh et al., 2012; EPA, 2010).
Another reason that inhibits behavior change is the belief that the risk (to the
environment or to one’s health) is low (Nisbet & Gick, 2008). The use of prescription
drugs in the United States has been labeled an epidemic (Maxwell, 2011; ONDCP, 2011).
Publicity for medication take-back programs emphasizes the dangers of keeping unused
and expired medications in the home. If the perception is that it is more hazardous to
keep medication at home than to discard it to sewage (a more immediate versus a more
distant risk) in the absence of a conveniently accessed disposal program, the messages
may inadvertently reinforce the continued use of improper disposal practices. Threats to
personal health from subtle changes to the environment may be perceived as not
happening in one’s lifetime. People with young children may be most receptive to
messages about the human-health threat of discarding drugs to sewage.
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Nisbet and Gick (2008) also pointed out that people are prone to unrealistic
optimism regarding health and environmental risks that have not yet happened and are
thought to be unlikely. Even if individuals are convinced of the seriousness of a health or
environmental threat, their optimism may lead them to believe they are less vulnerable
than others, and thus would be less likely to take action to change their behavior. Other
individual attributes such as a sense of responsibility toward nature and the environment
are likely to influence behavior related to environmental protection and health.
In conclusion, the HBM hinges on a strong empirical foundation (Strecher &
Rosenstock, 1997), whereby an individual’s perceived susceptibility and perceived
severity of a threat are at the core of its conceptual framework. For example, the results
of the study by Nisbet and Gick (2008) suggested that the more people were concerned
about the threat (consequences) of missing a dose of their prescribed medication, the
more likely they were to comply with their medication intake. Certain behaviors, such as
that of disposing of pharmaceutical drugs in the drain or toilet, are deeply entrenched;
therefore suggesting that the perceived threat to one’s health from a polluted environment
is either too low to be worth considering, or nonexistent.
Toward Managing Pharmaceutical Disposal
Daughton and Ruhoy (2013) referenced the increasing presence of
pharmaceuticals in the environment as a side effect of medication prescribing. The same
substances that have been helping people in contemporary society to live longer, healthier
lives are polluting the natural environment. Pharmaceuticals enter the environment
through various routes. The manufacturing process certainly plays a key role in the way it
impacts the environment; for example, in a region of India that serves as a manufacturing
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hub for the global production of pharmaceuticals, the wastewater has registered levels of
some pharmaceuticals that surpass the amount in the blood of patients on that medication
(Larsson, 2014). Agricultural practices also contribute to pharmaceutical pollution; for
example, antibiotics are dispersed in the environment through the excretion of antibiotics
by animals which are provided antibiotics with their feed to promote growth (K. Kumar,
Gupta, Baidoo, Chander, & Rosen, 2005).
However, for household pharmaceuticals, pharmaceuticals enter the environment
in three pathways. The first is through natural excretion: the body metabolizes only a
fraction of medication ingested, injected, or infused (Daughton & Ruhoy, 2013; Harvard
Health, 2011; Ortner & McCullagh, 2010; Rodriguez-Mozaz & Weinberg, 2010; Ruhoy
& Daughton, 2008). The unmetabolized compound and its metabolites are excreted in
urine and feces and to a lesser degree, sweat. A second pathway is the removal of topical
medications while bathing. The third pathway, which is the focus of this study, is the
disposal of unused, unwanted, and expired medications.
However, the three pathways interrelate and contribute to the overall impact on
the environment. Daughton (2014a) used the terms upstream and downstream to denote
two approaches to reducing the amount of pharmaceutical substances in the environment.
The upstream approach focuses on minimizing the amount and toxicity of substances that
have the potential to contaminate the environment. This approach can also be called
green pharmacy or ecofriendly pharmacy (Daughton, 2003a, 2003b; Daughton & Ruhoy,
2008). The upstream approach begins with the design of drugs with maximum potential
to be absorbed by the body so smaller trace amounts are excreted. Drugs in this category
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are designed to increase the specificity of drug action at the target cells, and can be
prescribed in lower dosages.
For drugs that are already on the market, an upstream approach involves curbing
the overprescribing of medications, limiting aggressive marketing that encourages
patients to request medications that may not be necessary and leaves household medicine
cabinets with samples of numerous drugs that go unused. Improving diagnostic
procedures for such drugs allows patients to be prescribed the most effective drugs and
precise dosages, thereby improving patient adherence to the prescribed medication
regimen; poor medication adherence is a major contributor to the unused drugs that find
their way into the waterways (Daughton, 2003a, 2003b; Daughton & Ruhoy, 2013;
Ruhoy & Daughton, 2008; Ruhoy & Kaye, 2010).
Diligent monitoring is another aspect of the upstream approach (Daughton,
2014b; Ruhoy, 2009). Gathering inventory data from coroner’s offices provides a novel
and effective mechanism to identify precisely how much of a particular pharmaceutical
ingredient has been disposed of in a given geographic region and the frequency with
which the substance is disclosed in the disposal inventories. Researchers investigating the
unusual variability in pharmaceutical concentrations in water surrounding a college town
found that variations in the chemical composition aligned with changes in the average
age of the population when students were on vacation or on campus (Ottmar, Colosi, &
Smith, 2013). Specifically, the effect they observed was due to higher and lower levels of
oral contraceptives. When students were absent, more evidence accrued of cardiovascular
drugs. Researchers were able to track the prescribing and use volume of tamiflu during
real or anticipated flu epidemics by analyzing their concentrations in the environment
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(Singer et al., 2008, 2014). Knowledge of where drugs accumulate and the factors leading
to that accumulation provide a foundation to curb the accumulation of pharmaceutical
waste.
The downstream approach involves promoting the safe and proper disposal of the
unused, unwanted, and expired medications that accumulate in most households (Ruhoy
& Daughton, 2008). This approach is exemplified by drug take-back programs that allow
consumers to bring unused pharmaceuticals to a specific site where the drugs are
collected and transported to be destroyed. These programs have been carried out since
2010 under the direction of the DEA so that controlled substances can be returned and
transported (Fain & Alexander, 2014). Preliminary data indicate that drug take-back
events across the United States effectively draw people and collect millions of tons of
pharmaceutical waste, nationally, for safe disposal (Fain & Alexander, 2014; Fass, 2011;
Gray & Hagemeier, 2012; Lubick, 2010; Ma et al., 2014; Stewart et al., 2015; Tucker,
2011). Participants at a take-back event in Honolulu were virtually unanimous in wanting
to see the event repeated (Ma et al., 2014). However, annual take-back events remain
sporadic, and for drug return strategies to effectively reduce the huge amount of
pharmaceutical substances that enter the environment, consumers should be able to
access return sites whenever they have a need.
Pharmacies are routinely hailed as the ideal venue for returning unused
medications (Abahussain et al., 2012; Fain & Alexander, 2014; Fass, 2011; Zimmermann
et al., 2011). Pharmacies are also excellent sites to educate the public about proper
medication management and disposal. However, the widespread adoption of pharmacy
returns has marked challenges. Medication-return programs existed before the DEA
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became involved to allow the return of controlled substances (Musson et al., 2007;
Thompson, 2007). In September 2014, the DEA issued a regulation requiring pharmacies
to follow specific guidelines to implement take-back programs (Fain & Alexander, 2014).
The regulation stipulates specific ways patients are allowed to return unused and expired
drugs, such as through collection boxes at registered pharmacies. Indeed, providing
consumers with access to receptacles is often recommended and likely to be popular with
the general public. However, some pharmacies have raised concerns about the burdens
and costs of requisite measures, as well as potential legal liability.
The effectiveness of this strategy also rests on the voluntary participation of
pharmacies and adequate funding, especially to offset additional costs due to DEA
requirements (Fain & Alexander, 2014). Many pharmacies have enthusiastically
participated in drug take-back events and are interested in continuing. Upstream
approaches may be preferable in theory, but they do not address the drugs that are already
in medicine cabinets. Medication take-back programs have shown a good deal of
promise, but their success depends on the active involvement of stakeholders.
Environmental Impact: Empirical Evidence
Pharmaceutical compounds have been steadily entering the natural environment
since their introduction into human and veterinary medicine more than a century ago (de
Cazes et al., 2014). The first studies documenting the presence of drugs in environmental
waters date back to the 1970s, when researchers in the United States detected evidence of
analgesics, heart medications, and contraceptive drugs in wastewater (WHO, 2011). This
line of research gathered momentum in the 1980s and 1990s. The most extensively cited
work in the peer-reviewed literature of the presence of drugs in surface water is an
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investigation conducted by the U.S. Geological Survey in 1999 and 2000, revealing more
than 50 pharmaceuticals in 139 streams across 30 U.S. states. Of the streams examined,
80% contained at least one contaminant, with an average of seven contaminants per
stream (Ortner & McCullagh, 2010).
Similar studies conducted in Europe showed comparable results. A research
synthesis published in 1997 reported the presence of cholesterol medications, analgesics,
and anticonvulsants in surface waters and groundwater in Germany (Ortner &
McCullagh, 2010). In March 2008, the AP released a report entitled PharmaWater I,
detailing the findings of an AP investigative team. The report revealed that at least 41
million Americans were served by water supplies with evidence of pharmaceuticals,
including anticonvulsants, antibiotics, mood stabilizers, and hormones (Ortner &
McCullagh, 2010). The team found drugs in the water supplies of 24 major metropolitan
areas across the United States. Studies from the United States and the United Kingdom
disclosed treatment plants were not completely effective in removing active
pharmaceutical ingredients from treated water.
Indeed, a key concern is that conventional treatment plants are not equipped to
fully remove micropollutants such as pharmaceuticals from wastewaters (de Cazes et al.,
2014; Fatta-Kassinos et al., 2011; Milic et al., 2013; Uslu et al., 2013; WHO, 2011).
Advanced treatment techniques such as ozonation, advanced oxidation, activated carbon,
and membrane are capable of removal rates exceeding 99% for specially-targeted
pharmaceutical compounds (WHO, 2011). However, even the most advanced and
expensive treatment techniques leave detectable levels of pharmaceuticals. Prevalence of
advanced treatment plants across the United States was estimated as 18.3% of the total
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budgeted needs for clean watersheds, aligned with the EPA survey conducted in 2012
(EPA, 2016).
For conventional methods, the effective removal of pharmaceuticals ranges
substantially, from more than 90% to less than 20%. To an extent, this variation depends
on the nature of the wastewater treatment plant and treatment techniques employed; in
fact, the EPA (2016) listed several categories of treatment that have distinct functions, for
example secondary, advanced, and storm-water management. Even more significant, the
pharmaceuticals currently produced represent more than 4,000 molecules with varying
properties related to absorption, bioactivity, and biodegradability (de Cazes et al., 2014).
ARGs have been discovered in treated wastewater, raising concern as to whether
that resistance might transfer to microorganisms capable of affecting human health
(Lubick, 2011; Marti et al., 2013; Sahoo et al., 2010; Segura et al., 2009; Zhang et al.,
2009). Wastewater-treatment plants reduce the total amount of bacteria in water, but are
not effective enough to remove ARGs (Marti et al., 2013; Milic et al., 2013; Zhang et al.,
2009). Furthermore, beyond being inefficient in removing ARGs from wastewater,
treatment plants may facilitate the “horizontal transfer of resistance determinants” among
an array of microorganisms, thus treatment plants may actually “contribute to the
occurrence, spread and persistence of both antibiotic-resistant bacteria and antibiotic
resistant determinants in the environment” (Marti et al., 2013, p. 2).
Pharmaceuticals are distinguished from other environmental pollutants because
they are made to be biologically active. Unique characteristics of pharmaceuticals include
their highly complex chemical structure, polymorphism (the ability of a molecule to
crystallize into more than one crystalline form), and their ability to be ionized and have
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multiple ionization sites dispersed throughout the molecule (Fatta-Kassinos et al., 2011).
To strengthen their intended action, pharmaceuticals are created to be resistant to
biodegradability, and many drugs are extremely powerful. The complex nature of
compounds that are typical of pharmaceutical products is a challenge, even to more
advanced treatment plants and technology.
An additional distinction is that pharmaceuticals often enter the environment after
being metabolized by human or veterinary patients. In addition, drugs also enter the
environment in an unmetabolized form, by direct disposal to sewage. Sales of
pharmaceuticals have been increasing annually at about 5% to 7% (Corcoran et al.,
2010). In the United States, hospitals, care facilities, and pharmacies discard an estimated
$1 billion of unused drugs each year, exceeding the amount of drugs discarded by
consumers.
Because pharmaceuticals have been detected in a wide range of environmental
sources with concentrations typically ranging from traces to even smaller concentrations
in the order of parts per billion has led to some speculation that pharmaceuticals are not
likely to have a harmful impact on the environment (Fatta-Kassinos et al., 2011; WHO,
2011). However, Fatta-Kassinos et al. (2011) are among a number of sources that are
skeptical of that assumption, citing weaknesses in the existing research, ambiguous
findings, and glaring knowledge gaps (de Cazes et al., 2014; Daughton, 2014b; A. Kumar
et al., 2010; Ortner & McCullagh, 2010; Rahman et al., 2010; Rodriguez-Mozaz &
Weinberg, 2010). Ortner and McCullagh (2010) pointed out that, “Active pharmaceutical
ingredients have been found in the ambient environment that not long ago were
considered infinitesimally low” (p. 18). Even these very low concentrations have been
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implicated in abnormalities found in fish populations (Corcoran et al., 2010; Ortner &
McCullagh, 2010). In addition to the adverse effects on fish, ecotoxicity studies have
shown that pharmaceutical pollutants are capable of affecting the growth, reproduction,
and behavior of birds, invertebrates, plants, and bacteria, even at very low levels (e.g., a
few nanograms per liter; de Cazes et al., 2014). According to de Cazes et al. (2014), trace
concentrations in soils, which directly link with food and drinking water, present a hazard
to human health. Notably, concentrations of pharmaceuticals in soils and sediments tend
to be higher than levels detected in water (Fatta-Kassinos et al., 2011).
Analytical and Research Techniques
The discovery of very low concentrations of pharmaceuticals in the environment
is due primarily to the development of increasingly sensitive, sophisticated, and accurate
detection equipment and analytical techniques (Fatta-Kassinos et al., 2011; WHO, 2011).
Gas chromatography with mass spectrometry or tandem mass spectrometry and liquid
chromatography with mass spectrometry or tandem mass spectrometry are capable of
discerning target compounds near a nanogram per liter. Technicians routinely use these
advanced techniques to detect pharmaceuticals in water and wastewater. The precise
choice of method depends on the chemical and physical properties of the target
compound. Similarly, the inherent degree of variability increases the challenge of
understanding the potential effects of pharmaceuticals on the environment and human
health. Specifically, the absence of standardized methods or protocols for sampling and
analyzing the presence of pharmaceuticals in water, soils, sediments, or other
environmental features precludes the ability to ensure “the comparability and quality of
the data generated” (WHO, 2011, p. 2).
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Daughton (2014b) raised a particularly interesting and significant criticism of the
existing research on pharmaceutical pollution. According to Daughton, risk-assessment
studies on pharmaceutical pollution were governed by the “Matthew Effect.” That is,
monitoring surveys tend to focus on active pharmaceutical ingredients (APIs) that have
already been the subject of previous research, ignoring the vast majority of
pharmaceuticals discharged into the environment and resulting in research findings that
are redundant and incomplete. For example, a review of research on the presence of 203
common APIs in 41 countries found that most monitoring efforts focused on only 14
APIs, representing a scant 7% of the drugs.
Daughton (2014b) referenced chemicals marked by a dearth of research as
“Matthew Effect Orphaned Chemicals” (MEOCs). In a case study of more than 200 drugs
designed to discern the scope of MEOCs, Daughton found 73 MEOCs, with 33 having no
published data, 20 with minimal published data (one or two published reports), and 20
with limited published data (a maximum of three to six studies reporting positive
findings). Daughton noted that these 73 APIs had been previously described as highvolume pharmaceuticals that had not been captured in research, but were “estimated to be
persistent and/or bioaccumulative” (Howard & Muir, 2011, as cited in Daughton, 2014b,
p. 319). Notably, Daughton pointed to the lack of occurrence data on 14 APIs still
classified as MEOCs as early as 2001. These still unmonitored but widely prescribed
drugs include alendronate, amiodarone, benazepril, chlorthalidone, clonazepam,
cyclobenzaprine, doxazosin, glipizide, guaifenesin, pramipexole, quinapril, ropinirole,
spironolactone, and terazosin. With respect to half-life of pharmaceutical products, a
large spectrum of variability exists across compounds, even in the same category of
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products. For example, a study conducted by Halling-Sorensen, Lutzhoft Holten,
Andersen, and Ingerslev (2000) to assess biodegradability compared three types of
antibiotics: mecillinam, ciprofloxacin, and trimethoprim. Study results indicated that
mecillinam and ciprofloxacin were readily biodegradable whereas trimethoprim was not.
These findings pose an additional challenge to the overall strategy for water treatment;
however, they also provide hope that it may be possible to engineer pharmaceutical
compounds that are environment friendly.
Daughton (2014b) acknowledged that the absence of data on some APIs may be
due to presumed pharmacokinetic properties, for example based on the properties of a
parent drug that is “extensively metabolized” (p. 322). However, Daughton (2014b)
argued that the pharmacokinetics of many drugs is poorly understood. In addition, this
approach ignores the fact that regardless of pharmacokinetic properties, these drugs will
enter the sewage system directly when people dispose of their unused medications in the
sink or toilet. Inadherence is a major reason to discard medications, often due to a drug’s
toxic side effects. If not completely removed by wastewater treatment, virtually all APIs
are capable of interacting with other drugs. Daughton (2014b) also noted that seven of the
73 MEOPs are highly active topical medications released through bathing or sweat.
Transdermal and transmucosal devices retain significant amounts of their original
content, even after several days of use (Ortner & McCullagh, 2010). Thus, these devices,
when discarded without being used, are likely to be heavily bioactive.
Two main approaches can manage APIs in the environment (Daughton, 2014b).
The first is monitoring a more extensive number of APIs, which should lead to greater
detection of previously ignored, potentially hazardous pharmaceuticals. A second,
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highlighting the upstream approach, is that knowledge of the relative impact of specific
APIs could lead to prescribing those drugs that intrinsically provide minimal toxic risk
and impact on the environment. Daughton’s ongoing extensive research highlights
numerous knowledge gaps that have persisted for more than a decade (Daughton, 2003a,
2003b, 2014a, 2014b; Daughton & Ruhoy, 2008; Ruhoy & Daughton, 2008).
The most prevalent and powerful criticism of the existing research is that most
studies focus on the short-term effects of individual agents, whereas little is known about
the cumulative and synergistic effects of the plethora of bioactive chemicals discharged
into the environment on a daily (and increasing) basis (Corcoran et al., 2010; Daughton,
2014b; de Cazes et al., 2014; Fatta-Kassinos et al., 2011; A. Kumar et al., 2010; Ortner &
McCullagh, 2010; Rahman et al., 2010; Rodriguez-Mozaz & Weinberg, 2010; WHO,
2011). Among the pharmacokinetic properties of APIs is their interaction with other
drugs (Daughton, 2014b). The effects of drug interactions in the human body are not
necessarily well understood. The current trend in research examining single APIs in
geographic isolation as well as isolation from other substances precludes greater
understanding of the potential synergistic effects of drug interactions in the natural
environment. A. Kumar et al. (2010) could find no studies investigating the effects of
mixtures of pharmaceuticals. They described this lack of knowledge of pharmaceutical
interactions as an “important uncertainty” (p. 3946). In fact, the uncertainty attached to
long-term persistent exposure to bioactive chemicals in water, soil, and sediments, even
at low concentrations, is a pervasive theme in the literature.
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Types of Drugs and Effects
Virtually all classes of drugs have been detected in the environment. Estrogens,
antidepressants, and antibiotics have all aligned with abnormalities in aquatic life
(Corcoran et al., 2010; Ortner & McCullagh, 2010). The term endocrine disrupting
chemical entered the lexicon in 1991 at a conference organized by Colbern, a zoologist
and former pharmacist who first called attention to the phenomenon of endocrine
disruption in the 1970s after reviewing hundreds of studies investigating the impact of the
contamination of wildlife in the Great Lakes (Ortner & McCullagh, 2010). A study
conducted to assess the status of the water quality of Lake Huron, the second-largest of
the Great Lakes, revealed the presence of atrazine, fluoxetine, and carbamazepine at trace
concentrations (> 58 ng/L) in at least four samples, and ibuprofen and atorvastatin in one
sample (Rahman et al., 2010). Although not widely prescribed, carbamazepine emerged
in numerous samples, due to its low biodegradability (Corcoran et al., 2010). According
to Rahman et al. (2010), the presence of atrazine in Lake Huron has particular health
implications because it has the potential to contaminate drinking water in downstream
regions. The researchers acknowledged that “the occurrence of these compounds … does
not necessarily confirm health risk” but “neither does non-detection guarantee safety”
(p. 227). This statement highlights the uncertainty that runs through the literature.
No uncertainty exists, however, on the impact of endocrine-disrupting chemicals
on the aquatic environment. The adverse effects of estrogens on fish populations are
probably the most documented consequences of pharmaceutical pollution (Corcoran et
al., 2010; Ortner & McCullagh, 2010). These effects include alterations in mitochondrial
activity, energy metabolism, and cell-cycle regulation, as well as the feminization of male
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fish and the development of genital abnormalities, in some cases leading to the collapse
of fish colonies due to reproductive failure.
NSAIDs are the most widely used class of drugs (Ortner & McCullagh, 2010).
NSAIDs reduce inflammation by inhibiting the synthesis and release of prostaglandins.
Examples of NSAIDs include acetylsalicylic acid (aspirin), ibuprofen, and diclofenac.
These drugs have the potential to damage the kidneys, an effect documented by kidney
failure in animals exposed to NSAIDs in water. One striking study reported the deaths of
vultures in India and Pakistan due to kidney failure from feeding on the carcasses of
livestock treated with diclofenac (Rahman et al., 2010; Rodriguez-Mozaz & Weinberg,
2010). The vulture population declined dramatically in the course of 3 years.
The term anti-infectives encompasses several bioactive compounds with the
capacity to inhibit the growth or survival of microorganisms without harming the host
(Segura et al., 2009). This category includes some antifungal agents and synthetic drugs,
but in particular, antibiotics, which have become a major focus of attention in the
literature on pharmaceutical pollution due to the presence of ARGs found in water
supplies, soils, and sediments and their potential negative impact on human health (FattaKassinos et al., 2011; Marti et al., 2013; Milic et al., 2013; Uslu et al., 2013; Zhang et al.,
2009). Tetracycline was one of the first drugs detected in the environment, and the
growth of tetracycline-resistant bacteria has been reported ever since (Zhang et al., 2009).
In fact, hundreds of ARGs linked with resistance to a wide variety of antibiotics have
been discovered in wastewaters, wastewater treatment facilities, surface water, ground
water, and drinking water. These microorganisms have the potential to be transferred to
humans from the environment through direct and indirect contact. Even at very low
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levels, antibiotics may act as “signaling agents in microbial environments” to various
plants that have receptors for antibiotics and disinfectants (Fatta-Kassinos et al., 2011,
p. 228).
Adding to the prospective threat posed by ARGs in the environment, ARGs are
also resistant to wastewater treatment and advanced treatment techniques (de Cazes et al.,
2014; Milic et al., 2013; Zhang et al., 2009). Advances in removing pharmaceuticals from
the environment have not kept up with the ability to detect them. Segura et al. (2009)
stated that: “Anti-infectives, the miracle drugs of the 20th century have become
environmental contaminants of emerging concern in the 21st century” (p. 682). Upstream
and downstream approaches are needed to address the problem of the increasing pollution
of the environment by pharmaceutical compounds. Green pharmacy is still in a fledgling
state, but consumers, pharmacists, nurses, and other health professionals, as well as
concerned businesses, have the power to reverse the increasing dispersal of
pharmaceuticals into the environment by proper disposal of unused and expired
medications.
Evolution of Medication Disposal Policy and Practice
A number of countries, including Australia, France, Sweden, Portugal, Spain, the
United Kingdom, and New Zealand, have had formal programs to collect unused drugs
for some time (Ruhoy & Daughton, 2008). European Union directives require member
states to have suitable collection systems in place for the return of unused and expired
drugs (Health Canada, 2009). Australia’s Return Unwanted Medicines Project is financed
by the federal government. Sweden has an unusual retail-pharmacy system organized into
a single government-owned chain called Apoteket B. Apoteket B operates an
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environmental program driven by targeted public-awareness campaigns to educate the
public about the adverse effects of flushing medications down the drain or throwing them
into the trash. The focus on public awareness seems to be working: more than 70% of
consumers with leftover drugs return them to the pharmacy. The Spain Integrated Waste
Management System also carries out intensive campaigns to raise public awareness,
successfully producing large volumes of returned medications. In contrast, in Poland,
environmental awareness is low, and consumers have few places to return unused drugs,
resulting in improper medication disposal (Zimmermann et al., 2011).
Disposing of unused drugs in the United States has long been complicated by
contradictory regulations from various agencies, and legal regulations on controlled
substances that even with DEA involvement still clash with state laws. The first federal
guidelines for the disposal of prescription drugs were issued in 2007 (Ortner &
McCullagh, 2010; Ruhoy & Kaye, 2010). Consumers were provided a list of options for
disposing of medications:
● Take advantage of community take-back programs that allow the public to
bring unused pharmaceuticals to a designated location for proper disposal.
● Remove unused prescription drugs from their original containers and throw
the loose medications in the trash.
● Mix prescription medications with an unappetizing substance such as coffee
grounds or cat litter and put them in impermeable, nondescript containers to
ensure they are not diverted.
● If the patient information specifically instructs, flush prescription medications
down the toilet.
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The guidelines were issued with the dual goals of preventing prescription drugs
from being diverted and protecting the environment (Thompson, 2007). Although these
guidelines represented an important step forward, they became a source of derision for
the inclusion of cat litter as a disposal option (Knopf, 2013). In 2010, the White House
announced that the guidelines for individual medication disposal had been replaced by
official take-back days. However, the FDA (2011) still recommends mixing unused drugs
with unpalatable substances and putting the mixture into sealed containers. The recent
federal guidelines do not recommend throwing loose medications in the trash, and are
quite explicit about taking advantage of take-back programs and properly disposing of
drugs. The guidelines also state to not flush medications down the toilet unless the
instructions specifically say to do so. The FDA recommends flushing 26 drugs because of
the high risk associated with keeping these drugs in the house, such as fentanyl patches
for pain. The FDA estimated that in 2009, about 5,000 children had accidental exposure
to drugs in the house, and about 100 died (Mitka, 2009).
In the 1990s, people saw a proliferation of numerous studies documenting the
presence of pharmaceuticals in the environment and effects on aquatic life. In the early to
mid-2000s, a few studies emerged in the United States and other countries examining
consumers’ medication disposal knowledge and attitudes. At the time, the outpatient
pharmacy at Madigan Army Medical Center at Fort Lewis in Washington State had a
policy that allowed patients to return unused or expired medication, which would be
disposed of as medical waste (Seehusen & Edwards, 2006). Controlled substances were
excluded from the program. Information about the policy was clearly stated on the
instruction sheets that patients received when they received medication, specifying that
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this was the preferred mode of medication disposal. In addition, patients also had the
option to return unused or expired drugs to a provider.
In another study, the researchers’ goal was to gain insight into hospital patient
practices for disposing of medication and their beliefs about medication disposal
techniques. A total of 301 patients completed the survey, most taking no more than five
medications or having more than five medications at home (Seehusen & Edwards, 2006).
Less than 20% of participants had received any guidance from a health professional about
proper disposal of medication. Given the time of the study and lack of professional
advice, it is unsurprising that more than half the participants kept unused or expired drugs
at home, and a similar proportion flushed drugs down the toilet. Slightly more than onethird rinsed drugs down the drain. Only 14% returned unused drugs to a health care
provider, and 23% returned drugs to a pharmacy.
A marked contrast arose between participants’ beliefs about drug disposal and
their behavior (Seehusen & Edwards, 2006). The portions of individuals who deemed it
acceptable to return drugs to a pharmacist or health care provider far surpassed the
proportion of those who actually did so, whereas the reverse was true for disposing of
drugs in the toilet or sink. In other words, people were disposing of drugs in ways they
did not really consider acceptable. Their behavior might have been dictated by habit or by
lack of awareness of alternative options.
Notably, having been educated about safe disposal practices strongly linked with
returning drugs to a pharmacy or to a health care provider. Patterns between frequent
pharmacy visits, being prescribed more drugs, and returning unused drugs, suggested
patients were given advice on drug disposal when they returned for new medications
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(Seehusen & Edwards, 2006). Seehusen and Edwards (2006) strongly advocated patient
education. They proposed that health professionals and pharmacy staff could discuss drug
disposal with patients, and that patients could be provided written information when
receiving medications or medication labels or pill bottles could display information about
disposal. This last suggestion is admirable but misguided. Patients routinely do not read
the label or simply ignore instructions (Bound & Voulvoulis, 2005).
Seehusen and Edwards (2006) asserted that persuading patients to believe it is
desirable to return drugs to a health professional or pharmacy is a prerequisite for getting
them to actually carry out the behavior. However, their own findings revealed a gap
between beliefs and behaviors. Even pharmacists (Abahussain et al., 2012) and nurses
(McCullagh et al., 2012) do not always act in accordance with their knowledge of proper
drug disposal. Models of behavior change rest on recognition that education is a requisite,
but not sufficient to change behavior (Bandura, 1997; Nisbet & Gick, 2008; Strecher &
Rosenstock, 1997).
In the United Kingdom, Bound and Voulvoulis (2005) examined household
practices in disposing of unused and expired medication in a general population survey of
400 respondents in southeastern England. They broke down disposal practices by drug
type. Virtually all respondents had some medications at home. Most households had a
combination of prescription and OTC drugs (60.2%), and close to one-third had only
OTC drugs. Most respondents reported using all the painkillers they purchased or were
prescribed (80%). However, the figure for antibiotics was striking: only 16% of
respondents consumed all the antibiotics they had acquired. Many people stop taking
antibiotics as soon as their symptoms disappear, even though they are told to finish the
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supply. Antibiotics are also notoriously overprescribed (Daughton & Ruhoy, 2013;
Ruhoy & Daughton, 2008). Overprescribing and poor adherence to antibiotics contributes
to the presence of antibiotics in the environment and drives concerns about antibiotic
resistance (Lubick, 2011; Marti et al., 2013; Sahoo et al., 2010).
Most UK respondents disposed of drugs with household trash (Bound &
Voulvoulis, 2005). Only a small fraction (11.5%) disposed of drugs in the sink or toilet,
and no respondents who took hormone medications disposed of their medication in that
manner; all returned unused medications. That effect might have been due to awareness
of the effects of hormones on the aquatic environment.
The most striking finding was the comparison by Bound and Voulvoulis (2005) of
their findings with data from the United States. In the British sample, 21.8% returned
their medication to the pharmacy compared to a scant 1.4% in the United States. In
contrast, 11.5% of the UK respondents flushed medication down the toilet or sink versus
35.4% in the United States. The researchers speculated this result might have reflected
different regulations and advice in the two countries. In fact, U.S. residents were
instructed to dispense of medications in the sink or toilet, and at the time of the survey,
few available locations existed for returning unused medicines.
The presence of leftover prescription drugs beyond antibiotics suggested that
many respondents were not adhering to their medication as prescribed. Bound and
Voulvoulis (2005) concluded that a substantial amount of pharmaceuticals were finding
their way into the environment. The United Kingdom has since adopted a formal
medication-return program (Health Canada, 2009). At the same time, deeply ingrained
practices can be difficult for people to change.
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It is important to recognize that in the United States in particular, changes to
federal guidelines and regulations and the implementation of the DEA program are driven
primarily by dangers posed by rampant prescription-drug abuse (ONDCP, 2011).
Replacing flushing medications with returning them reflects recognition of the harmful
effects of pharmaceuticals on the natural environment and their potentially harmful
effects on human life, but the emphasis in awareness campaigns is on the hazards of
keeping unused medications in the home. That may actually be advantageous to changing
behavior in that it emphasizes the more immediate threat (poisoning) over the more
distant threat (pollution). At the same time, environmental protection is a powerful
motivator for many participants at take-back events (Gray & Hagemeier, 2012). For
health care facilities that have large quantities of unused pharmaceuticals, protecting the
environment is a major issue.
Attitudes and Behavior of Health Professionals and Patient Health Care Facilities
In response to compelling evidence of detectable levels of various pharmaceutical
compounds in waterways across the United States, the EPA (2008, 2010) embarked on
research investigating the pharmaceutical disposal practices of health care facilities. The
study was driven by the assumption that health care facilities continue to discard large
quantities of unused pharmaceuticals to sewers, to the detriment of the environment and
public health. For the most part, federal, state, and local regulations governing the
disposal of medical waste were the main influence on disposal practices. However, size,
ease, and access of disposal, and financial cost also impacted unused pharmaceutical
disposal. Due to differences in regulations governing hospitals and long-term care
facilities, long-term care facilities had more constraints on returning unused medications.
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The investigators concluded that the widespread adoption of best management practices
could have a substantial impact on the amount of unused pharmaceuticals entering the
aquatic environment (EPA, 2008, 2010).
To encourage proper disposal, the EPA (2010) developed a list of best-practice
guidelines for health care facilities. The first step in the process entails conducting an
inventory of pharmaceuticals used at the institution, and identifying the unused
pharmaceuticals, the reasons for waste, and the practices currently used for management
and disposal (EPA, 2010). Taking inventories and maintaining a comprehensive database
is essential to the practice of green pharmacy (Daughton, 2003a, 2003b).
The initiation of a waste-management program includes a set of diverse
techniques for waste segregation to meet all relevant regulations and potentially minimize
costs (EPA, 2010). An essential component of a good waste-management program is staff
training for pharmacists, nurses, and other personnel involved in managing unused
pharmaceuticals. The EPA recommends that staff members are trained to recognize when
unused medications should be returned to the pharmacy or when they should be
discarded, and in what manner. Training should be ongoing with refresher sessions to
keep staff members current, and their feedback should be solicited for continuous quality
improvement. Other strategies include prominent signs and posters to remind staff
members of the disposal policy, and waste-management audits conducted at the time of
pharmaceutical stocktaking. Sapkota, Gupta, and Mainali (2014) presented the case study
of a hospital in Nepal that radically transformed poor waste-management practices with
the implementation of a program reflecting the EPA best-practice guidelines.
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Intervention
Sapkota et al. (2014) presented the first study from Nepal to examine the impact
of a training intervention on the health care waste-management practices of hospital staff.
Prior to the intervention, the government hospital in Katmandu had no formal policy or
protocols for handling health care waste. Under the leadership of the hospital’s executive
director, a health care waste-management committee was organized, with the director
assuming responsibility for all the committee’s activities. Representatives from all
hospital units and departments served on the committee, which drew up a policy and
standard operating procedures aligned with national waste-management and
environmental regulations. Participants in the training program were nurses, doctors, and
waste handlers from the hospital’s obstetrics, gynecology, pediatrics, medicine, and
orthopedic wards. Based on safe health care waste-management practices recommended
by WHO, the program included orientation to health care waste management, standard
operating protocols, and legal provisions for safe waste management, segregation,
collection, and handling techniques for different types of hospital waste, along with safe
occupational health and safety issues and safe injection practices.
A nurse from each ward was entrusted to counsel and record activities related to
waste management (Sapkota et al., 2014). As each new patient was admitted, the nurse
would give caregivers a brochure developed by the committee, containing comprehensive
information on the hospital’s waste-management protocol. The committee enacted
detailed procedures for handling, collecting, storing, and transporting hazardous and
nonhazardous waste.
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Pre- and postinformation on the waste-management practices, before the study
and 8 months later, was compared using the Individualized Rapid Assessment Tool
created by the United Nations Development Program Global Environment Project
(Sapkota et al., 2014). The preintervention assessment revealed highly inadequate wastemanagement practices. Prior to the study, the hospital tended to work on the principle of
reduce, reuse, and recycle, which could be dangerous in a hospital setting. Procedures
changed dramatically after the intervention. Procedures were carried out meticulously.
Improvements were captured in postintervention Individualized Rapid Assessment Tool
scores, which soared from a dismal 26% to 86% (Sapkota et al., 2014).
Several positive features contributed to the success of the project: a dedicated
waste-management team, effective leadership, diligent planning, sound organization,
sufficient funding, and the enthusiastic involvement of trained staff (Sapkota et al., 2014).
These attributes are valuable, if not indispensable, for any change-management initiative.
In addition to standardizing and improving waste management in health care settings, the
same type of leadership, teamwork, planning, and organization could transfer to
community programs for encouraging safe and environmentally friendly disposal of
pharmaceutical waste.
Nurses
Given the holistic and caring orientation of nursing, the nursing literature is
replete with calls to adopt safe practices that protect the environment (McKown &
Pawloski, 2013; Ortner & McCullagh, 2010; Shaner-McRae, McRae, & Jas, 2007).
Nurses counsel and educate patients, which provides them with excellent opportunities to
inform and educate patients about safe medication disposal. At the same time, it is
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unclear if nurses follow best practices in disposing of pharmaceuticals. In particular,
nurses who work in home care are not governed by the stringent regulations for disposing
of hospital waste.
McCullagh et al. (2012) explored the medication disposal practices and attitudes
toward medication disposal of home hospice nurses. Home hospice nurses provide
holistic palliative care to terminally ill patients and their families. Educating patients and
caregivers regarding how to safely store, manage, and dispose of medications is an
essential part of their professional role. Upon a patient’s death, however, the nurse is
often entrusted with the responsibility of discarding unused medications.
McCullagh et al. (2012) developed their survey based on items drawn from a
previous study. The researchers pretested the items with a group of five home hospice
nurses, and revised based on their feedback. McCullagh et al. designed two parallel
measures to capture drug disposal practices among nurses and related attitudes and
beliefs among nurses. A total of 138 home hospice nurses completed the online survey.
As a group, participants were experienced health care professionals and close to twothirds (64%) had been working in hospice care for more than 5 years. Almost half the
nurses (44%) reported disposing of 11 or more medication doses upon a patient’s death.
Although roughly two-thirds (64%) of the nurses reported always or often mixing the
drugs with undesirable substances, as recommended, more than half reported discarding
them in the toilet or drain with the same frequency.
The nurses overwhelmingly endorsed the practice of mixing medications with an
unpleasant substance as acceptable (94%) and safe (91%). Most deemed it unacceptable
to return the drugs to the hospice (79%) as unsafe or extremely unsafe (61%). The nurses’
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rejection of returning drugs to the hospice aligned with legal restrictions on nurses
transporting controlled substances (McCullagh et al., 2012).
Nurses obtained their information on medication disposal mainly from the hospice
manual, regulations, other documents, or in-service training (McCullagh et al., 2012). A
substantial proportion of nurses, close to one-third, acknowledged they were unfamiliar
or only minimally familiar with the Centers for Medicare & Medicaid Services Hospice
Conditions of Participation rules for disposing of medications. Most of the group
expressed concern about legal and environmental issues, but considered the prospect of
drug diversion as the foremost issue.
McCullagh et al. (2012) noted that gap between nurses’ regular practices in
disposing of medication and federal guidelines for disposing of drugs in home hospice
care. A marked gap emerged between the almost unanimous endorsement of the safety
and acceptability of mixing drugs with an unpleasant substance and the number of
participants who regularly disposed of drugs in that manner. Nurses placed high priority
on ensuring drugs were not diverted, which could help explain why they were inclined to
dispose of medication in the toilet or drain. In fact, McCullagh et al. attributed their
strong concern for drug security to a sociopolitical environment where the “war on
drugs” is heavily publicized, and health care professionals are acutely aware of their role
in ensuring drug security: lax drug disposal practices could jeopardize their professional
license. At the same time, the guidelines for supplanting sewage disposal with the mixing
technique come from federal agencies.
In-service training was one source of information on proper medication disposal,
although it did not appear to be prevalent, as most nurses acquired information though
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reading materials. Only 16% of nurses had learned about safe medication disposal in
nursing-education programs. However, McCullagh et al. (2012) acknowledged that this
could be due to the emphasis on direct patient care in undergraduate nursing education,
with medication management perceived as the pharmacist’s role. Another reason may be
that respondents had completed their education before environmental issues were
recognized as a public health concern.
The proposed explanation of McCullagh et al. (2012) that nurses’ continued
disposal of medications to sewage might be due to the high priority they place on drug
security is consistent with the finding of Cote et al. (2012) that nurses are motivated by
strong moral norms. In their research, Cote et al. used the TPB to explore the intentions
of nurses at a Quebec hospital to integrate research evidence into their clinical decision
making. The researchers noted that since the 1990s, a powerful drive has taken place to
implement evidence-based practice in health care. Nurses not only represent the largest
group of health professionals but are considered uniquely important due to their closeness
to individual patients, sensitivity to community needs, and involvement in virtually all
aspects of health care, including health promotion, disease prevention, and clinical care.
Nurses are entrusted with educating patients and caregivers on safe medication storage
and disposal (McCullagh et al., 2012). Theoretically, nurses’ integration of best-practice
guidelines for proper medication disposal into their daily decision making constitutes
evidence-based nursing practice.
In addition to expanding the TPB to include moral norms, Cote et al. (2012) also
explored the influence of past behavior. Together, moral norms, normative beliefs,
perceived behavioral control, and past behavior accounted for 70% of the variation in
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nurse intentions to integrate research evidence into their practice. Past behavior may be
especially salient to understanding medication disposal, because disposing of drugs to
sewage was the accepted practice for so many years (McCullagh et al., 2012; Ortner &
McCullagh, 2010). Findings by McCullagh et al. (2012) and Cote et al. suggested nurses
should be educated on why and how current guidelines for medication disposal represent
clinical best practices.
Pharmacists
Abahussain et al. (2012) examined the attitudes and practices of pharmacists in
Kuwait toward returning unused pharmaceuticals for disposals. The Kuwaiti Ministry of
Health established guidelines for the disposal of medical waste by hospitals and other
health care facilities, but with no parallel measures guiding the disposal of medications
returned by the general public, nor does Kuwait have take-back programs for unused
medications. Abahussain et al. believed pharmacists are ideally positioned to influence
the medication disposal practices of consumers. A previous study disclosed that 54% of
Kuwaiti pharmacists deemed it appropriate for consumers to return unused medications.
Abahussain et al. addressed the question of whether pharmacists actually received unused
medications from the public and how they managed their disposal, along with their
knowledge of environmental knowledge and opinions of medication disposal.
The sample consisted of 144 pharmacists from six large government hospitals and
12 specialized clinics (Abahussain et al., 2012). Close to three-quarters of the participants
(72%) had received unused medications and disposed of them (71%) at their workplace.
Most participants (73%) simply threw the materials in the trash. Only 16% followed the
Ministry of Health guidelines for disposing of medical waste.
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At the same time, the overwhelming majority of pharmacists agreed that
environmental damage results from disposing of medications in the trash (83%) or in the
sink or toilet (83%). Virtually all (97%) agreed that protecting the environment is one of
their personal responsibilities (Abahussain et al., 2012). Most pharmacists viewed their
workplace as a good venue for disposing of unused medications (86% from clinics, 88%
of the hospital pharmacists). Other venues suggested were private pharmacies (67%) and
supermarkets (70%).
Abahussain et al. (2012) noted that the disposal practices of pharmacists—
throwing unused drugs in the trash or in the sink or toilet—were the same practices used
by the general public in Kuwait. Therefore, carrying out an effective drug take-back
program would entail developing guidelines to dispose of returned medications. An
obvious dichotomy emerged between pharmacist recognition that their disposal practices
were detrimental to the environment and their sense of responsibility for environmental
protection. The absence of a formal policy and system for managing unused
pharmaceuticals that are not classified as medical waste seemed to be the main barrier to
proper disposal.
According to Abahussain et al. (2012), pharmacy students “have a golden
opportunity to participate in promoting awareness and establishing a national drug takeback program” (p. 199). Pharmacy students represent the future of the profession and
have the potential to draw effective guidelines and promote their implementation. The
authors envisioned a central role for pharmacists in conducting patient and community
education and raising awareness and understanding of the damaging consequences of
accumulating unused pharmaceuticals and improperly disposing of them.
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Abahussain et al. (2012) cited a study from the United States documenting a
successful collaboration between pharmacy students and local officials and businesses in
providing safe and appropriate medication disposal for the community. Pharmacy
students often play a central role in drug take-back events in the United States. Ma et al.
(2014) described the Drug Take-Back events that arose from partnership between the
Hawaii Narcotics Enforcement Division and the University of Hawaii at Hilo Daniel K.
Inouye College of Pharmacy. In Broward County’s Operation Medicine Cabinet events,
pharmacy students and pharmacists count, identify, separate, and document all
uncontrolled medications, which greatly aids the data-collection process (Fass, 2011). In
addition, pharmacists and pharmacy students disseminate medication-safety information
and answer questions raised by consumers, consistent with the role Abahussain et al.
envisioned.
Participation by pharmacy students in the United States also reflects the vision of
pharmacy students as the future direction of the profession. Fourth-year students
participate in drug take-back events as part of their advanced pharmacy-practice druginformation rotation (Fass, 2011). Before participating in drug take-back events, students
are educated on all relevant issues, including prescription-drug abuse, national and
statewide trends, pharmacology, drug disposal laws and regulations, drug information
resources, and the role of pharmacists in preventing prescription drug abuse. Students
must be equipped with requisite knowledge and skills to counsel consumers. The training
they receive in preparation for drug take-back events is equally applicable to their future
careers and professional roles when interacting with consumers and educating them about

83
medication use and disposal. Pharmacy students and pharmacists also educate lawenforcement officials about drugs being returned (Fass, 2011).
Patients
The use of oral anticancer medications has increased tremendously since the early
2000s (Lester, 2012). According to an analysis of insurance claims in Massachusetts,
16.1% of patients being treated with chemotherapy received oral chemotherapy, and that
figure is expected to reach 25% as new drugs are continually being developed in response
to consumer demand (Neuss et al., 2013). Oral medications offer many advantages to
patients, including the convenience and comfort of being able to administer the drugs at
home, fewer side effects, less disruption to daily activities, enhanced quality of life,
sustained exposure to medication, decreased reliance on health care resources, and
satisfactory outcomes (Lester, 2012; Trovato & Tuttle, 2014). An additional psychosocial
benefit of taking medication at home is a shift in perspective that views cancer as a
chronic condition conducive to self-management.
However, despite the benefits, the new cancer agents have raised concerns
regarding safe storage and disposal. If not stored properly, the drugs can become
degraded or contaminated, compromising safety and efficacy. Indoors, the drugs can pose
a risk to other people and pets, and if disposed of improperly, they can be hazardous to
the environment.
Lester (2012) declared, “Information about safe handling and disposal practices
should be incorporated into professional, patient, and family education” (p. e192). In
addition, institutions should have standard operating protocols to educate patients and
family members about safety. In many facilities, however, patient education is not

84
standardized (Trovato & Tuttle, 2014). Standard guidelines exist for the preparation,
handling, and administration of parenteral chemotherapy in the health care setting, but
lack parallel guidelines for handling and disposing of oral chemotherapy medications at
home.
Various recommendations address the handling of oral anticancer medications
derived from expert opinion, published recommendations, and policies adopted at the
government or hospital level (Trovato & Tuttle, 2014). Recommendations for patients
and caregivers include following written instructions for storing a medication, wearing
gloves to administer a drug, washing hands after medication administration, limiting
others’ access to the medication, and returning unused medication to the pharmacy,
doctor’s office, or hospital. Also included in recommendations are practices to avoid,
such as exposing the drug to direct sunlight or moisture, leaving medication where
children or pets can reach it, crushing or breaking pills, and disposing of medication in
the garbage or toilet.
The Oncology Nursing Society and the American Society of Clinical Oncology
jointly developed national standards for the safe administration of oral chemotherapy,
revised, updated, and expanded in 2012 (Neuss et al., 2013; Trovato & Tuttle, 2014). The
most recent guidelines, which expound on issues raised by the growing reliance on oral
chemotherapy, include a detailed section on patient consent and education (Neuss et al.,
2013). Information on the storage, handling, preparation, administration, and disposal of
oral chemotherapy is an essential component of patient education.
Adherence is an important issue with a prescribed drug regimen, as inadherence
adversely affects the ability of the medication to control or eliminate the cancer (Lester,
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2012). Adherence to anticancer drugs has also become a greater challenge due to the
increased amount of drugs, drugs that are taken in combination, the longer duration of
therapy, and the increasing age of patients with cancer. Broadly, all these factors involve
the increasing presence of pharmaceuticals in the environment (Daughton, 2003a, 2003b;
Ruhoy & Daughton, 2008; Ruhoy & Kaye, 2010).
In a rare study on the handling, storage, and disposal practices of patients taking
anticancer drugs at home, Trovato and Tuttle (2014) surveyed 42 patients (95% male)
under treatment at a VA hospital. The use of oral chemotherapy at the hospital outpatient
chemotherapy clinic escalated in the course of a year. Patients were receiving education
from medical, nursing, and pharmacy staff, but without standardized practices, yielding
information that was unreliable.
Of participants who did have unused medication, six returned any leftover drugs
to the pharmacy (Trovato & Tuttle, 2014). However, another six threw extra medication
in the garbage. Two participants were uncertain of what they should do with the extra
medication. Close to half the patients (45%) had not received information on safe
handling and storage practices. Those who were informed received their information
from nurses and pharmacists and, to a lesser extent, from physicians.
Most patients (79%) felt their oral chemotherapy drugs were safe from the
perspective that the side effects were tolerable (Trovato & Tuttle, 2014). However,
several raised concerns related to storage, handling, and disposal. Health professionals
who counsel patients about anticancer drugs often concentrate primarily on
administration and potential side effects (Trovato & Tuttle, 2014). Time may be a factor,
so the issues viewed as the most important from the perspective of health professionals
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are given top priority. The responses clearly revealed a need for better patient education
on the topic of storage, handling, and disposal of anticancer agents. Notably, the
pharmacist authors changed their practices following the survey. The pharmacist provides
patient education immediately after the patient and physician have completed the consent
process, and the new patient-education guidelines include standard criteria for proper
drug storage, handling, and disposal that could be adopted by all health care
professionals. As an additional safeguard, the pharmacist provides a follow-up phone call
to the patient to reinforce safe-handling procedures, as well as to monitor the patient for
adverse effects.
Drug Take-Back Programs
In 2010, the DEA held the first national Take-Back Days, which produced more
than 4.1 million pounds of medications in little more than a week (Fain & Alexander,
2014). However, Fain and Alexander pointed out that although that figure may seem
impressive, it represents only a small fraction of the medications stored in U.S. homes.
Fain and Alexander (2014) put forth that retail pharmacies are the ideal venue for
returning unused medications. More than 70% of people across the United States live
within 5 miles of a pharmacy chain and make frequent trips to the pharmacies not only to
fill prescriptions, but to purchase items on a regular basis. In addition to the convenience
to consumers, pharmacies are well-equipped to develop and implement take-back
programs, given that they already have systems in place to manage and dispose of unused
drugs from their inventory.
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Pre-DEA Involvement in Take-Back Programs
Pharmacy programs to promote the safe disposal of unused medication predate
DEA sponsorship. A program involving seven clinic-associated Group Health
Cooperative pharmacies in Washington State began operations in fall 2006 (Thompson,
2007). Each pharmacy has a medication disposal bin in their public area. The Washington
State Board of Pharmacy and Department of Ecology were both involved in the pilot
program (Thompson, 2007). Pharmaceuticals From Households: A Return Mechanism
tested two return-and-disposal program models. One model, which works with clinics
and pharmacies, was designed for consumers, school districts, childcare centers, hospice
patients’ families, and hotels. The second model was developed for nursing home
residents. Both models dispose of unused pharmaceuticals through incineration.
Other programs emerged in other parts of the country. Good Samaritan Hospital
in San Jose, CA, held a Safe Drug Drop at its pharmacy during National Patient Safety
Week (Thompson, 2007). The city’s major newspaper provided publicity for the event.
Plastic storage bags were provided for people to empty the drugs they brought, and a
pharmacy technician poured the contents into pharmaceutical waste bins. After eight
hours, the drug drop produced 144 gallons of medication, including one supply that had
been purchased when Ronald Reagan was president. The pharmacy locked the bins and
sent them to a firm that incinerates pharmaceuticals. After the 1-day event, the pharmacy
began keeping a locked disposal box outside so people could simply discard their unused
pharmaceuticals without help. This practice is now recommended to make it easy for
people to return unused drugs (Fain & Alexander, 2014).
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Musson et al. (2007) initiated a self-serve pilot project in Florida, introduced to
enable people to properly dispose of prescription and nonprescription medications. In an
area that includes small communities and the city of Gainesville, the researchers chose
sites to reach the largest number of people. Participants deposited their medications
directly into a collection container containing tap water or an aqueous acidic solution that
rendered the medication unrecognizable and unusable. An extensive advertising
campaign to inform local residents of the program accompanied the inception of the
program. The campaign made use of newspapers, local cable television, and the Internet.
Challenges encountered in developing the program highlighted how much drug
disposal programs have progressed in the last decade (Musson et al., 2007). Despite
multiple attempts to gain their participation, major pharmacy chains declined to
participate, due to possible public perceptions that pharmacies would reuse the returned
medications, legal implications of accepting drugs dispensed by another pharmacy,
concerns that patient confidentiality would be compromised, concerns over the security
of controlled substances, and lease provisions that prohibited the acceptance and storage
of returned merchandise. In spite of the obstacles, Florida residents did have access to a
simple and convenient way to dispose of medications. Recent take-back programs
addressed some of the concerns expressed by pharmacies, and with the involvement of
the DEA, returning controlled substances is not a barrier. Some pharmacies have raised
issues about cost due to new DEA regulations (Fain & Alexander, 2014). Now, as when
Musson et al. (2007) began the self-serve pilot project, consumers are attracted to an
option to dispose of drugs that is simple and available.
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Post-DEA Involvement Take-Back Programs
Gray and Hagemeier (2012) investigated characteristics of individuals who
participated in medication take-backs, and the medicines they disposed of in the rural
Appalachian area of northeast Tennessee and southwest Virginia. The study covered 11
events held between 2009 and 2011. During that time, 752 individuals donated 16,956
containers of medications prescribed for 1,210 patients. Donors were overwhelmingly
White, averaged 40 years old, and women comprised more than half of the group (57%).
In descending order, the main reasons for participating were a desire to clean out their
medicine cabinets (68%), environmental concerns related to disposing of drugs and other
waste materials (45%), and concerns about accidental poisoning (14%).
Safe Medicine Disposal for the State of Maine (ME) has been hailed as a model
program for medication disposal (Ruhoy & Kaye, 2010). The unique program allows
people to anonymously mail controlled and uncontrolled drugs free of charge through the
postal service. High rates of deaths from prescription drug overdose throughout the state
drove the Maine initiatives (Stewart et al., 2015). In 2009, prescription overdose
surpassed all other causes of death among Maine residents, and in 2012, the Centers for
Disease Control and Prevention reported that of all states, Maine has the highest rate of
prescriptions for high-dose opioid pain relievers.
The mail-in program accompanied DEA take-back events until 2013 (Stewart et
al., 2015) and currently runs under the direction of the University of Maine Center on
Aging. Consumers obtain prepaid tamper-resistant envelopes from roughly 150
community distributors, including pharmacies, medical offices, community
organizations, police departments, hospice, and other sites located throughout the state
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(Ruhoy & Kaye, 2010). Each envelope has clear, explicit instructions for safely
packaging and mailing pharmaceuticals in various forms. Although program advocates
often cite the ease of returning drugs through the postal services as its defining
characteristic, Ruhoy and Kaye (2010) viewed its outstanding feature as that the program
systematically collected data on the returned medications and the people participating in
the program. Ruhoy and Daughton (2008) consistently called for a comprehensive
database on returned medications (Daughton, 2003a, 2003b; Ruhoy, 2009; Ruhoy &
Daughton, 2008).
According to the collected data, each returned envelope contained roughly seven
ounces of drugs and an average of four medications (Ruhoy & Kaye, 2010). Controlled
substances constituted nearly 14% of the returned drugs. Painkillers, antianxiety drugs,
antidepressants, and cardiovascular drugs comprised about 25%. Accompanying surveys
provided valuable information. Nearly half of participants reported they would have
flushed the drugs down the toilet without the simple option of the mail-back program,
and one-third would have discarded them in the trash. The survey data also revealed
numerous reasons for accumulating drugs in the home, including discontinuation due to
allergies or side effects, death of the patient, explicit instructions by the doctor to
discontinue the medication, feeling better, and not wanting to take the drug as it was
prescribed.
Ruhoy and Kaye (2010) attributed much of the program’s success to collaboration
across multiple agencies. Furthermore, the process is simple and user friendly, has
numerous quality and safety checks built into the design, minimizes the number and cost
of intermediary staff, and demands minimal effort on the part of the participants. Safe
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Medicine Disposal for ME was initially funded by the Aging Initiative to serve Maine’s
aging population. The program also sponsors a cadre of older adults who provide
presentations on medication disposal to community groups. These volunteers are the
cornerstone of the program’s outreach and education initiative. They offer community
members opportunities to discuss various issues relevant to their communities.
Safe Medication Disposal for ME is a model program for several reasons (Ruhoy
& Kaye, 2010). First and foremost, the program prevents the damaging environmental
impacts and health hazards of disposing of drugs by flushing or throwing them in
household trash. Second, the process is easy, convenient, and anonymous. Third, the
program takes advantage of the security protocols of the postal service. Fourth, Maine
has a large rural population, and the program is easily accessible to individuals residing
in rural areas with no take-back events or drug disposal sites. Moreover, the program also
appeals to individuals who might not be able to take advantage of events, such as those
who are ill or infirm. Finally, the program is able to accept controlled substances because
the drugs are mailed directly to the Maine Drug Enforcement Agency.
The program builds on a unique collaborative partnership between environmental,
drug enforcement, and health care officials at the federal, state, and local levels (Ruhoy &
Kaye, 2010). From a social perspective, the program addresses the concerns of multiple
stakeholders because it has the capacity to reduce the number of drug-related crimes and
opportunities for drug abuse. It is also cost efficient because it provides consumers with a
safe alternative to keeping drugs at home. As information about Safe Medication
Disposal for ME has been disseminated, it has become a model for shaping state and
national public policy, medical prescribing practices, and health-education outreach
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tactics. Reflecting the green pharmacy or upstream approach to reducing medical waste
in the environment (and opportunities for drug abuse), in 2009, Maine began limiting
first-time prescriptions to 15 days for certain drugs prescribed for Medicaid recipients.
Subsequently, the state has added more drugs to that list.
The Maine Prescription Monitoring Program database acts as a tracking and
monitoring system for the prescription and distribution of controlled substances.
However, at the time of their study, only about half the state’s prescribers were registered
with the program (Stewart et al., 2015). Despite widespread publicity on prescriptiondrug misuse nationwide, researchers noted remarkably little knowledge attests to
prescription waste in communities across the country. Stewart et al. (2015) analyzed data
on unused medications collected in 11 Maine cities from 2011 to 2013, covering six DEA
take-back events. The researchers had two major goals: to provide information to health
care providers and public health officials about the amount and types of prescription-drug
waste, and to raise awareness of medication waste in local communities and its potential
consequences in poisoning, abuse, misuse, and diversion of prescription drugs.
Doctor of pharmacy candidate volunteers carried out the project, supervised by
licensed pharmacists, with direct oversight from local law-enforcement officials (Stewart
et al., 2015). The take-back events generated 13,599 medications of all types returned by
1,049 participants. Controlled substances represented 9.1% of the drugs collected,
virtually identical to the proportion reported in the Appalachia study (Gray & Hagemeier,
2012). Uncontrolled prescription drugs accounted for 56.4% of the medications collected
(Stewart et al., 2015). Cardiovascular drugs consistently formed the largest proportion of
drugs returned. Beyond medication disposal programs, “medication education is an
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essential component of the overall solution” to the escalating public health problem of
prescription drug overuse (Stewart et al., 2015, p. e69). The ONDCP (2011) report
contained a large section on education. The report pointed out that antidrug campaigns
have such great emphasis on illicit drugs that people are unaware of the dangers of
prescription drugs. Education covers health care providers as well as consumers (with
special attention to parents and youth), and is an important strategy to reduce
overprescribing. Safe medication disposal is an essential component of education for
health professionals and the general public. One strategy in the ONDCP (2011) report
involves working with private-sector groups to create an evidence-based media campaign
on prescription-drug abuse tailored to parents, to inform them of the risks and importance
of storing drugs securely and disposing of them properly.
Ma et al. (2014) presented the results of 11 drug take-back events in which the
University of Hawaii, College of Pharmacy collaborated with the Narcotics Enforcement
Division. The events took place in 2011 and 2012. The Good Life Senior Expo in
Honolulu, an annual 3-day exposition, hosted two of the largest events. Several Kaiser
Permanente clinics hosted the remaining nine events. Both events were advertised in the
media (television, radio, and newspapers), through brochures and flyers in pharmacies
and doctors’ offices, and by word of mouth. All returned medications were recorded with
their generic name, drug class, dose, quantity, and dosage format. Narcotics Enforcement
Division agents and students and faculty of the pharmacy college counted, identified, and
documented the drugs. As with all drug take-back events, law-enforcement officials were
present at all times, and were responsible for the destruction of the drugs.
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Ma et al. (2014) surveyed participants at the 2011 Good Life Senior Expo
regarding their prior experiences with unused or expired medications. Most participants
learned about the event through newspaper or TV advertisements. Before the take-back
events, the most common methods for managing unused drugs were throwing them in the
trash (34%), keeping them at home (32%), or flushing them down the toilet (24%). Only
10% had returned medications to a pharmacy or medical office. Two-thirds of
participants kept unused medications at home for a year or more. Virtually all participants
(> 99%) wanted the take-back events to continue.
The 11 events produced a total of 8,011 pounds of medication, with most drugs
taking the form of pills or tablets (Ma et al., 2014). Participants returned few liquids,
intravenous drugs, dermal patches, lotions, creams, or suppositories. The largest quantity
fell into the category of “Other” or miscellaneous. Antihypertensives were the next
largest drug class, consistent with the overriding presence of cardiovascular drugs in the
Maine take-backs (Stewart et al., 2015). Other drugs returned in large quantities were
gastrointestinal drugs and analgesics. The most prevalent OTC drugs were in this last
category: aspirin, naproxen, and ibuprofen. In addition, participants returned a substantial
amount of pseudoephedrine. Pseudoephedrine is used in the manufacture of
methamphetamine and is one of the most common OTC drugs returned.
Controlled substances comprised 10% of the drugs returned (Ma et al., 2014).
Similar proportions seem to be relatively consistent with other take-back programs (Gray
& Hagemeier, 2012; Stewart et al., 2015). Although consumers returned most of the
drugs, clinics and other facilities also returned drugs such as long-term-care facilities and
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clinical trials. The researchers did not collect demographic information about
participants.
Ma et al. (2014) are staunch advocates for continuing and expanding medication
take-back programs. Clearly, the results of their survey confirmed the popularity of takeback for the Hawaiian public. Following the example of Alameda County, California, the
researchers called for efforts to identify potential champions and stakeholders including
consumers, government organizations, and “all parties involved in the medication chain
of manufacturing, ordering, prescribing, dispensing, administering, and monitoring”
pharmaceuticals (Ma et al., 2014, p. 30). Soliciting involvement from all entities would
greatly expand the number and type of facilities to which consumers could return
medications. To facilitate ease and convenience and make disposal immediately
accessible, Ma et al. recommended strategies such as installing take-back lock boxes in
pharmacies and law-enforcement offices, regularly scheduled medication take-back
events in accessible venues, and the distribution of prepaid return envelopes with all
medications dispensed.
Kotchen et al. (2009) queried respondents on their willingness to pay for a
medication disposal program in their survey of medication disposal preferences and
practices. One problem with surveys of medication disposal is that most are based on
small convenience samples. Kotchen et al. gathered data from respondents to the annual
Central Coast Survey covering 1,005 California households. In addition to questions
regarding general awareness of pharmaceutical pollution, disposal practices, and
willingness to participate in a disposal program, the authors added the question of paying
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to establish a drug disposal program. The cost would be a surcharge added to
prescriptions.
The effect derived from their analysis was that starting with a mean bid of $1.07,
every increase of $.10 decreases the likelihood of an affirmative response by 0.01.
Overall, however, Kotchen et al. (2009) found that a substantial proportion of
respondents were willing to pay. Less than half the respondents (43%) were aware that
pharmaceutical substances had been found in their wastewater. For disposal practices, the
findings were largely consistent with most studies, with disposal in the trash as most
prevalent (45%), followed by disposal in the sink or toilet (25%). Only 5% returned their
unused drugs to a pharmacy or a hazardous-waste site; 12% of the sample kept
medications at home. Knowledge proved to be an important predictor of behavior.
Respondents who were aware of environmental pollution were less likely to dispose of
medications to trash or sewage, and three times more likely to return them to a pharmacy
or bring them to a hazardous waste site. Older respondents were more than twice as likely
to return drugs to a pharmacy than were younger adults, possibly because they used more
prescriptions and thus had more pharmacy visits.
Recycling and Environmental Protection
Pearson et al. (2012) examined attitudes and behavior regarding recycling among
low-income Latina women attending a clinic in southeast Texas. The influence of
sociocultural factors, including acculturation, was a key focus of study. According to
Pearson et al., the women held two contrasting viewpoints on the environmental attitudes
of individuals born in developing countries. From one perspective, participants thought
they were less likely to engage in behavior to protect the environment as a result of more
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immediate concerns about economic security. However, that viewpoint would seem to be
more of a matter of socioeconomic status than cultural influence, and might be equally
applicable to low-income individuals regardless of heritage. According to the contrasting
perspective, individuals from developing countries might be more sensitive to
environmental issues due to environmental damage in their home countries. The literature
on pharmaceuticals and the environment suggested the problem draws extreme concern
in developing countries due to the latter reason, and a lack of government regulations on
medication disposal (Abahussain et al., 2012; A. Kumar et al., 2010; Sahoo et al., 2010;
Sapkota et al., 2014).
Participants were 1,512 Latinas, with 37% born in the United States and the
remaining participants born in Mexico, Puerto Rico, and various Central American and
South American countries (Pearson et al., 2012). An acculturation scale accompanied a
survey designed to assess knowledge, beliefs, behavior, and the type of recycling services
offered in their locale. Highlighting the importance of having convenient, accessible
facilities, women residing in areas where recycling facilities included both curbside
services and drop-off facilities were more likely to recycle than those living in areas with
no recycling facilities or only one of the two services.
Knowledge and convenience positively linked with recycling, whereas lack of
knowledge and inconvenience were major barriers to recycling (Pearson et al., 2012).
Acculturation inversely linked with recycling, and income was not a factor, possibly due
to the relatively small variation in income among participants. As a group, the women
who were less predisposed to recycle were not aware that recycling saves landfill space,
and considered it too time-consuming. Less than half the women recycled or lived with
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someone who recycled. These findings are congruent with the HBM (Nisbet & Gick,
2008; Strecher & Rosenstock, 1997). It seems probable that similar patterns would
emerge in returning medications to a disposal site. The difference is that recycling
facilities are far more prevalent in most communities. The Pearson et al. assertion that
education would overcome lack of awareness of the importance of recycling runs
throughout the literature on medication disposal.
Focus groups can serve as excellent vehicles to solicit input from prospective
participants on what community programs may need to be successful in managing
hazardous substances. Smolenske and Kaufman (2007) aimed to guide the design of a
community-education program to raise awareness of hazardous substances in the home
and promote safe storage and disposal practices. The project began with a pilot survey
based on data analyzed from calls to a poison-control center in Genesee County,
Michigan. The researchers selected a total of 10 substances that presented the greatest
hazard to children. Smolenske and Kaufman gave prescription medications the highest
hazard rating of substances, which also included ibuprofen, acetaminophen, bleach,
cosmetics, birth-control pills, silica gel packets, vitamins with iron, hydrogen peroxide,
and mercury thermometers. Notably, more than half the hazardous substances are
pharmaceuticals.
Smolenske and Kaufman (2007) chose 13 residents for the focus group and used
their input to refine the survey (Smolenske & Kaufman, 2007). The survey covered four
broad areas: (a) room location and storage elevation, (b) awareness of the Poison Control
Center, (c) sources of information about hazardous household materials, and
(d) residents’ participation in activities such as recycling and pickup programs for
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hazardous household materials. The survey proved to be an effective assessment tool to
understand consumers’ perceptions of poisoning risk. The level of awareness was low,
confirming the need for an education campaign. Others can use a similar strategy to
create an educational campaign to raise people’s awareness of the risk of storing
medication at home and of proper disposal practices. Focusing the campaign at the
community level also provides an opportunity to solicit opinions and preferences related
to drug take-back programs and other options to dispose of unused pharmaceuticals.
Summary and Conclusions
During the 1990s, a proliferation of scientific studies documented the presence of
trace amounts of pharmaceuticals in the aquatic environment. Pharmaceutical pollution of
the environment is a global problem (WHO, 2011). In the United States, previous advice
to consumers and health care professionals alike had been to dispose of unused
medication by flushing it down the toilet or rinsing it down the sink drain (McCullagh et
al., 2012; Ortner & McCullagh, 2010). Pharmaceutical compounds remain in treated
sewage and have even been found in drinking water. Thus, improper disposal of
medication is a threat to the natural environment and to public health.
With collaboration from the DEA and laws that include the disposal of controlled
substances, drug take-back programs are the best mode for disposing of unused and
unwanted medications. Current data is preliminary, but programs have brought in
millions of pounds of pharmaceuticals and have been greeted favorably by participants
(Fain & Alexander, 2014; Gray & Hagemeier, 2012; Ma et al., 2014). Participants who
attended take-back events expressed a desire for ongoing programs. Availability and
convenience emerged as key factors in participation. Providing consumers with a locked
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disposal bin that they can access at all times may be critical to promoting widespread
participation.
Education is another important concern in raising awareness of drug take-back
programs, but also of proper (and improper) medication disposal practices and the
dangers of keeping unused or expired medications in the home. Similarly, numerous
studies by health psychologists demonstrate that knowledge per se is inadequate to
change behavior (Nisbet & Gick, 2008). Even nurses and pharmacists displayed a gap
between what they consider best practices in medication disposal, and their actual
behavior (Abahussain et al., 2012; McCullagh et al., 2012). Based on the limited research
on medication take-back programs and studies involving recycling behavior, removing
barriers and easing access to drug return sites may be the most effective way to
encourage proper disposal practices. Maine’s mail-back program requires minimal effort
by consumers and is successful (Ruhoy & Kaye, 2010). Stakeholders have hailed the
program as a model program, and other states and communities are learning from the
features that contribute to its success.
This study examined the associations of knowledge of the environmental and
human-health impacts of medication disposal, knowledge of proper medication disposal
practices, and the availability and convenience of disposal sites in a sample of residents
in the northeast United States. In Chapter 3, I describe the methodology that I used to
conduct and analyze the data from this study.
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Chapter 3: Research Method
Introduction
The purpose of this quantitative cross-sectional study was to investigate
consumers’ practices in disposing of unwanted, unused, and expired pharmaceutical
prescriptions drugs. In addition, I provide insights as to whether disposal practices are
influenced by consumers’ knowledge of the impact of pharmaceutical disposal on the
environment and human health, and awareness of the recommended disposal options. An
analysis of the most applicable theoretical frameworks in the context of pharmaceutical
disposal has provided important insights, identifying key dependent and independent
variables used in this study.
According to Nisbet and Gick (2008), despite parallels between health and
environmental behavior, the fields of health promotion and health behavior change are
rarely applied to environmental issues. Environmental behavior is multifactorial;
consequently, I considered two theoretical frameworks for behavior change: the HBM
and the TPB.
The TPB was most relevant to the issue of proper pharmaceutical disposal from
the perspective of the motivation that results in the intention to perform an action or
behavior. The aim was to discern whether consumers’ knowledge or perceptions of
disposal practices and their impact on human health precipitated motivation. In addition, I
aimed to determine whether information received, if any, on disposal recommended
practices motivated consumers. Finally, I evaluated whether both factors influenced
consumer action and to what degree.
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In the literature, the HBM aligned with studies that involved recycling and
environmental protection. Strecher and Rosenstock (1997) discussed how perceived
barriers were the decisive factor in the adoption of health-related behaviors.
Consequently, one objective of this study was to examine the degree to which the
availability and convenience to reach and use locally available disposal options impacted
consumers’ actual disposal practices.
This chapter contains a discussion of the research design and the methodology of
the study. In the next section, I discuss the rationale for the research design, followed by
discussions of the population, the sample, data collection, and instrumentation. I describe
the data-analysis plan, followed by discussions of validity and ethical issues of the study.
Finally, I conclude this chapter with a brief summary.
Research Design and Rationale
Actual disposal practices was the outcome (dependent) variable in this study. As
suggested by the reviewed literature, this study used the following key independent
variables: (a) knowledge of environmental and human-health impact, (b) knowledge of
recommended disposal practices, and (c) availability of disposal options. Data on the
outcome variable and the independent variables were collected using a questionnaire.
The research design was quantitative and cross-sectional. A quantitative method
is appropriate when the researcher’s goal is to examine associations between quantifiable
and objectively measurable concepts (Howell, 2010). My main objective in this study
was to investigate the hypothesized association between consumers’ actual disposal
practices (outcome of interest/dependent variable) and the factors (independent variables)
that may have influenced them. Because the variables under investigation are quantifiable
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and objectively measurable, a quantitative method was appropriate. Specifically, I
selected a cross-sectional design because my aim was to examine the associations
between variables measured at a single point in time. Typical disadvantages of using a
cross-sectional design include the challenges associated with establishing causal
inferences, and the notion that the findings represent the phenomenon in a single time and
place (Pine et al., 1997). To inspire social change, results from this study provide the
basis for recommendations that include the design of health-promotion programs that
encourage optimal drug disposal practices, encourage the simplification of disposal
options, improve patient drug compliance, and generate momentum for the development
of drugs that are less toxic to the environment. In aggregate, if adopted, the
aforementioned approaches could mitigate the risks to human health posed by
pharmaceutical contaminants in the environment.
Methodology
Population
The population of this study was a sample of residents of the northeast United
States. The U.S. Census Bureau (n.d.) defined the northeast region as comprising nine
states: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont,
New Jersey, New York, and Pennsylvania. As of 2013, the estimated size of this
population was approximately 56 million residents.
Sampling and Sampling Procedures
The sampling approach for this study was convenience sampling. A convenience
sampling method is appropriate when a true random sample is not feasible to obtain.
Because I was unable to survey all possible residents in the northeast United States, a
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convenience sample approach was appropriate. The participant sample for this study
consisted of residents of the northeast region of the United States who were aged 18 years
or older and had used a prescription drug in the prior two years. I recruited participants
who met these criteria using SurveyMonkey’s online participant pool. I calculated the
appropriate sample size using the SurveyMonkey sample-size tool, using the following
parameters: (a) population size = 55,943,073, corresponding to the entire northeast region
(U.S. Census Bureau, n.d.), (b) confidence level = 95%, and (c) margin of error = 5%.
The resulting sample size was 385 (SurveyMonkey, 2016)
Procedures for Recruitment, Participation, and Data Collection
After obtaining IRB approval to conduct the study, I employed SurveyMonkey’s
online survey platform to recruit participants for this study. Cottrell and McKenzie
(2010) argued that researchers could not assume that most U.S. residents would be
sufficiently computer literate and have Internet access to complete a survey online. In the
last few years, however, Internet access and broadband have become so widely available
that even large and popular government programs, such as the Affordable Care Act
(HHS, n.d.), are administered through the Internet. In addition, according to the U.S.
Census Bureau, the northeast United States has one of the highest rates of Internet access
in the country (File, 2013). Thus, I deemed the online medium to be practical and
efficient for the administration of the survey questionnaire. The survey was anonymous,
compliant with the data-privacy rule (HHS, 1996), and administered electronically
through the Internet using a secure (encrypted) line. Potential participants were people
who had used SurveyMonkey’s Audience services in the past, and had participated in
other surveys. SurveyMonkey sent an invitation to these potential responders to
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participate in the survey; for each completed survey, SurveyMonkey made a donation to a
charitable institution; participants did not receive any monetary incentive from
participating except that completion of the survey would result in a donation to charity.
Aligned with Walden University’s IRB policy regarding participation in surveys
in which the participants have the option to take or decline to take a survey, I had no need
for a separate consent form; however, I informed potential participants of their rights and
provided them with contact information for the Walden University IRB and me, in case
they had any questions. Individuals who agreed to participate and met the inclusion
criteria were directed to the survey that contained the study instrument. I planned the
survey to be open to potential participants for 3 weeks; however, the target sample size
was reached and exceeded in a shorter period of time. At the end of the survey
recruitment period, SurveyMonkey made available for download from their secure server
two files with all the data: one Excel and one SPSS-formatted file. I stored the data files
on a password-protected personal computer to which I was the only one with access. In
addition, all data were backed up onto a password-protected external storage medium,
stored safely in a location different from that of the personal computer.
Instrumentation and Operationalization of Constructs
The contents of the survey instrument for this study were adapted from items used
by Seehusen and Edwards (2006). I received approval for the use and adaptation of the
questionnaire from the main author, and the approval letter can be found in Appendix A.
The final draft version of the questionnaire was pilot tested after IRB review and
approval, following the process recommended by Radhakrishna et al. (2003) and
Bolarinwa (2015). The process for pilot testing consisted of providing the questionnaire
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to a convenient subsample, separate and in addition to the final target sample (N = 385).
The subsample was originally planned to be 10% of the final target sample, and thus to
include 39 participants; however, the final number of the subsample consisted of a larger
number of participants, thanks to an efficient recruitment by SurveyMonkey’s service. As
part of the pilot testing, subsample participants evaluated each question of the
questionnaire for clarity, legibility, and comprehensiveness. Seehusen, author of a
published study on medication disposal, reviewed the content and provided favorable
feedback. I archived Seehusen’s feedback and e-mail exchanges (see Appendix A).
The survey (see Appendix B) consisted of content questions used to measure the
constructs of interest, as well as demographic questions. The first question of the survey
was intended to measure the dependent variable—actual disposal practices—and asked
survey participants, “What is your most used method for disposing of unused or expired
medications?” Participants answered this question by selecting one of eight possible
response options that included “I flush them down the toilet, “ and “I follow the disposal
instructions that accompany the medicine,” among others.
The next questions on the survey were, “In your area, is there a designated
collection location where you can dispose of your unused or expired medication?” and
“How convenient is it for you to reach the designated disposal location?” I used these
questions to represent the independent variable: available disposal options. Next,
participants answered the question, “Do you believe that improper disposal of
medications in the environment could have negative consequences on human health?”
Participants responded to this question on an ordinal scale, and I used their responses to
represent the independent variable: knowledge of environmental and human health

107
impact. I also asked participants four questions using categorical and ordinal response
scales to assess knowledge of disposal practices. I used these questions to represent the
independent variable: knowledge of recommended disposal practices. Finally, I asked
participants to provide basic demographic information. Specifically, I asked them to
report their gender, year of birth, race, highest level of education completed, and state of
residence.
I scored questions related to knowledge and awareness using a coded ordinal
scale, as suggested by Monnin and Perneger (2002). In contrast, data from the dependent
variable, actual disposal practices, were categorical. A dichotomous, Yes/No outcome
was used to assess and code the dependent variable.
Data-Analysis Plan
I conducted all data analyses using SPSS (IBM, 2016). SPSS is a software
package used to perform statistical analysis. In 2009, IBM acquired SPSS Inc., and since
then, its official name has become IBM SPSS Statistics. Although originally intended to
be used in the realm of social sciences, this software is used in a variety of fields, such as
data mining, market research, government, and education. The latest version of SPSS
Statistics v 24.0 was released on March 15, 2016.
Upon completion of the data collection, I reviewed and cleaned the data to ensure
all the records had sufficient and accurate data for analysis. I accomplished this process
by running frequency distributions for each variable, ensuring the data were within the
acceptable range. Given that the data were collected electronically, using a web-based
form that only accepts predefined input values, there were no out-of-range data values;
however, there were records with missing data. In Chapter 4, I describe the specific
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information regarding missing data and the records that had to be removed from the
analyses due to incomplete data inputs.
In addition to descriptive statistics, binary logistic regression was the key
statistical procedure employed to address and explore the following research questions
and hypotheses:
RQ1: Is there an association between knowledge of the environmental and the
human-health impact of pharmaceutical disposal and actual disposal
practices?
H01: No significant association exists between knowledge of the environmental
and the human-health impact of pharmaceutical disposal and actual disposal
practices.
RQ2: Is there an association between knowledge of recommended disposal
practices and actual disposal practices?
H02: No association exists between knowledge of recommended disposal
practices and actual disposal practices.
RQ3: Is there an association between available disposal options and actual
disposal practices?
H03: No association exists between available disposal options and actual disposal
practices.
RQ4: To what degree can actual disposal practices (the dependent variable) be
explained by the combined and differential contribution of the three
independent variables, specifically, knowledge of the environmental and
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human health impact, knowledge of recommended disposal practices, and
locally available disposal options?
H04: Actual disposal practices cannot be explained to a significant degree by the
combined and differential contribution of knowledge of the environmental and
the human-health impact, knowledge of recommended disposal practices, and
locally available disposal options.
RQ5: Do differences exist among RQ1, RQ2, and RQ3 across demographic
groups?
H05: No significant demographic differences exist in the relationships of
knowledge of the environmental and the human-health impact, knowledge of
recommended disposal practices, and locally available disposal options to
actual disposal practices.
Binary logistic regression is an appropriate statistical-analysis procedure when the
researcher’s aim is to determine whether significant associations exist between multiple
independent variables and a single dichotomous dependent variable. In this analysis, the
dependent variable was actual disposal practices. I coded actual disposal practices as a
dichotomous variable where 0 = unrecommended disposal practice, and 1 =
recommended disposal practice, based on participants’ responses to the question, “What
is your most used method for disposing of unused or expired medications?” The
independent variables were the survey questions pertaining to knowledge of
environmental and human-health impacts, knowledge of recommended disposal
practices, and availability of disposal options. I assessed the significance of the overall
model using the chi-square fit statistic at a significance level of .05. I calculated
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McFadden’s R2 to assess model fit, where values of .2 or greater indicated good model fit
(Louviere, Hensher, & Swait, 2000). The plan was that if the overall model was
significant, I would explore individual model coefficients to determine which
independent variables were significantly associated with the dependent variable.
Given that logistic regression is heavily influenced by multicollinearity, I used
SPSS to run collinearity diagnostics to measure the degree to which the independent
variables related to each other. Ideally, independent variables strongly relate to the
dependent variable and do not strongly relate to each other. To this end, I assessed
multicollinearity using the variance inflation factors (VIF). According to Menard (2009),
VIF values greater than 10 indicate a multicollinearity problem. The plan was that if I
detected multicollinearity, I would remove the predictors with the highest VIF values.
After conducting a binary logistic regression that included the key independent
variables (i.e., knowledge of environmental and human health impact, knowledge of
recommended disposal practices, and availability of disposal options), I conducted a
second binary logistic regression with the demographic variables included as predictors. I
conducted this second regression model to address Research Question 5. I evaluated this
regression in the same manner as the first regression, then compared the second
regression model to the initial model to determine the influence of the demographic
variables.
Threats to Validity
External validity is the extent to which the results of the study may be generalized
to other populations or contexts. Because the population under investigation included
only residents of the northeast United States, the results of this study may not be
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generalizable to other regions of the United States or to other countries. As indicated in
the 2010 U.S. Census (U.S. Census Bureau, 2011), the socioeconomics characteristics of
the northeast region of the United States include the following:
•

Median household income ($53,283), compared to the Midwest = $48,445,
the South = $45,492, and the West = $53,142.

•

Percent in poverty level (11.8), compared to the Midwest = 13.3, South =
15.7, and the West = 14.8

•

Number of people without health insurance coverage (11.8), compared to the
Midwest = 12.7, the South = 19.2, and the West = 17.7

These data illustrate that the northeast has socioeconomic characteristics more
favorable than those of other regions. Consequently, the generalization of the results of
this study to the general U.S. population had to be considered with caution. In fact,
socioeconomic characteristics such as income, employment status, and health insurance
coverage have aligned with health care use and interactions with health care professionals
(Blackwell et al., 2009), and, by inference, may have impacted the likelihood of
consumers receiving drug disposal information.
Additionally, results from this study may not apply to the disposal of
nonprescription drugs or other substances. Given the emphasis on prescription drugs in
the national strategy to reduce the amount of pharmaceuticals in the environment, this
study was restricted only to individuals who have used at least one prescription drug.
However, OTC drugs, especially NSAIDs, are widely used, and, like prescription drugs,
have the potential to pollute the environment and present a threat to human health. Thus,
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this study is limited by excluding a sizable proportion of consumers of common
pharmaceuticals who may be less likely than those with prescription drugs to have
accurate knowledge of recommended disposal practices.
The use of the Internet may also have excluded those people who are unfamiliar
or uncomfortable with this technology. In spite of optimistic figures of a large diffusion
of Internet use, groups of people, due to age or financial condition, may not have had the
opportunity to be part of the population sample. The survey was in English only;
therefore the chance exists that people who are not fluent in English did not complete it,
and consequently it may not be known what disposal practices that population group
uses.
Internal validity is the extent to which the results of the study are attributable to
the independent variables, and that the study survey measured the variables that it
intended to measure. To increase internal validity, I pilot tested (N=65) the survey
instrument prior to conducting the main study. Additionally, to help ensure participants
provided honest and accurate responses, I assured participants that their responses would
be anonymous and kept confidential. Finally, statistical-conclusion validity is the extent
to which the results of the data analysis are statistically valid. To ensure statisticalconclusion validity, I performed an a priori sample-size calculation to determine the
minimum number of participants needed to obtain statistically valid results.
Ethical Procedures
I conducted this study in accordance with the ethical procedures required by the
Walden University IRB. I obtained IRB approval prior to collecting any data (approval
number 03-07-17-0129575). To protect participants’ rights, I informed each participant
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that input in the study was completely voluntary, and that participants had the right to
stop taking the survey at any point in time without consequence. I also informed
participants that their responses would remain anonymous and kept confidential. In
addition, I assured participants I am the only one with access to the data, and the data will
be stored on my password-protected computer and backed up on a secure medium.
Aligned with Walden University IRB procedures, the survey included information on
participants’ rights and contact information for the IRB and me.
Summary
The key objective of this cross-sectional retrospective study was to attempt to
close a knowledge gap about the disposal practices of pharmaceutical products in the
general population. The data accrued from a convenient sample of the population residing
in the northeast region of the United States. The key research questions explored the
hypothesized relationship between actual disposal practices and people’s knowledge of
appropriate disposal practices, the potential impact these practices could have on human
health, and the availability of convenient disposal options. Although a retrospective
cross-sectional study is, by definition, unable to establish a causal relationship, the results
of the statistical analyses provided important insights and clues to the development of
social-change strategies. The ultimate goal of this study was to learn how to improve
drug disposal practices, and thus reduce the likelihood that improperly disposed
pharmaceutical products in the environment will negatively impact human health.
In Chapter 4, I am providing an in-depth description of the statistical analyses that
were performed, and the interpretation of the study findings with respect to the stated
research questions and hypotheses.
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Chapter 4: Results
Purpose of Study
The purpose of this study was to assess the prescription drug disposal practices of
adults living in the northeast United States, and how an individual’s knowledge of
environmental and human health impact, knowledge of appropriate disposal practices,
and locally available disposal options influence one’s disposal practices. My aim in this
study was to identify the key factors that may influence compliance with the
recommended disposal practices (e.g., returning unused pharmaceuticals to a pharmacy),
so that future work can take steps to promote safe disposal practices, in turn protecting
the environment and human health. The Walden University IRB reviewed and approved
this study design and its survey tool on March 7, 2017.
This chapter begins by reviewing the five research questions of interest and the
hypotheses for each. Subsequently, I present and discuss the results of the pilot study (n =
62), and those of the main study (n = 485).
Research Questions and Hypotheses
Research Question 1. Is there an association between knowledge of the
environmental and the human-health impact of pharmaceutical disposal and actual
disposal practices?
H01: No significant association exists between knowledge of the environmental
and the human-health impact of pharmaceutical disposal and actual disposal
practices.

115
H11: A significant association exists between knowledge of the environmental and
the human-health impact of pharmaceutical disposal and actual disposal
practices.
Research Question 2. Is there an association between knowledge of recommended
disposal practices and actual disposal practices?
H02: No association exists between knowledge of recommended disposal
practices and actual disposal practices.
H12: An association exists between knowledge of recommended disposal
practices and actual disposal practices.
Research Question 3. Is there an association between available disposal options
and actual disposal practices?
H03: No association exists between available disposal options and actual disposal
practices.
H13: An association exists between available disposal options and actual disposal
practices.
Research Question 4. To what degree can actual disposal practices (the
dependent variable) be explained by the combined and differential contribution of the
three independent variables, specifically, knowledge of the environmental and human
health impact, knowledge of recommended disposal practices, and locally available
disposal options?
H04: Actual disposal practices cannot be explained to a significant degree by the
combined and differential contribution of knowledge of the environmental and
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the human-health impact, knowledge of recommended disposal practices, and
locally available disposal options.
H14: Actual disposal practices can be explained to a significant degree by the
combined and differential contribution of knowledge of the environmental and
the human-health impact, knowledge of recommended disposal practices, and
locally available disposal options.
Research Question 5. Do differences exist among RQ1, RQ2, and RQ3 across
demographic groups?
H05: No significant demographic differences exist in the relationships of
knowledge of the environmental and the human-health impact, knowledge of
recommended disposal practices, and locally available disposal options to
actual disposal practices.
H15: Significant demographic differences exist in the relationships of knowledge
of the environmental and the human-health impact, knowledge of
recommended disposal practices, and locally available disposal options to
actual disposal practices, when controlling by demographic variables (e.g.,
age, race, education level).
Pilot Study
I first conducted a pilot study with two objectives: to assess the legibility of the
questions to be used in the actual survey, and to estimate the number of respondents who
did not meet the inclusion criteria, enabling me to adjust the study’s target sample size
(see Appendix C). Given these objectives, only descriptive statistics and related figures
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are being reported for the pilot study. In contrast, I employed descriptive- and inferentialstatistical procedures to address the research questions of the actual study.
Participants
Participants for the pilot study consisted of 71 adults aged 18 to 75 years, 37 of
whom were female, living in the northeast United States (Connecticut, Maine,
Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York,
Pennsylvania). Pilot participants completed the survey using the SurveyMonkey webbased data-collection platform between April 17, 2017, and April 19, 2017. I excluded
data from six participants (8.5% of the data) because they had not taken a prescription
drug in the past 2 years and I excluded data from an additional three participants (4.2% of
the data) because they did not complete the survey (see Figure 1). As a result of the
information on these exclusions, the target sample for the study was adjusted and
increased from 385 to 485 to account for participants potentially not meeting inclusion
criteria or not completing the survey.

8.5%

4.2%

Met inclusion critera
Did not meet inclusion critera
87.0%

Figure 1. Participants in the Pilot Study.
Note. Figure shows inclusion criteria and data breakdown.

Incomplete data
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Of the remaining 62 adults, the largest number were aged 30 to 44 years (see
Figure 2). A large majority (41) of participants identified themselves as Caucasian (see
Figure 3). More than half had completed college (n = 13) or graduate school (n = 18; see
Figure 4).

30
41.9%
Number of Participants

25
20
25.8%
15
10

21.0%
11.3%

5
0
18-29

30-44

45-59

60+

Number of Participants

Figure 2. Pilot Study Participants by Age Group.
Note. Percentage of total participants presented above each bar.
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66.1%

Caucasian

8.1%

6.5%

6.5%

African
American

Asian/Pacific
Islander

Hispanic

11.3%
1.6%
American No Response
Indian/Alaska
Native

Figure 3. Pilot Study Participants by Race/Ethnicity.
Note. Percentage of total participants presented above each bar.
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Figure 4. Pilot Study Participants by Education Level.
Note. Percentage of total participants presented above each bar.
Survey: Assessment of Legibility
After every survey question, participants indicated if the question was easy to
understand. If the participant answered “no,” they had the opportunity to explain how the
question could be improved. The vast majority of the time (96.6% of all responses for all
questions combined), respondents indicated the question was legible. Thus, I considered
the survey suitable to use to collect a full sample, with only minor changes in wording.
Figure 5 depicts, for each question, the percentage of respondents who considered the
questions easy to comprehend.

120
Percentage of Yes/No responses to "Is this question easy to understand?"
0% 10% 20% 30% 40% 50% 60% 70% 80% 90%100%
Inclusion questions (Q1-Q3)
Actual Disposal Practices (Q6)
Availability of Disposal Options 1 (Q9)
Availability of Disposal Options 2 (Q12)
Knowledge of Environment & Health Impact
(Q15)
Knowledge of Disposal Practices 1 (Q18)
Knowledge of Disposal Practices 2 (Q21)
Knowledge of Disposal Practices 3 (Q24)
Knowledge of Disposal Practices 4 (Q27)
Demographic questions (Q30-Q34)

Yes

No

Figure 5. Legibility Assessment by Question.
Data Collection
A total of 681 individuals completed the survey using the SurveyMonkey webbased data-collection platform between April 21 and 24, 2017. Of the total number of
respondents, 515 met the inclusion criteria: they were at least 18 years of age, had taken a
prescription drug in the past 2 years, and resided in the northeast United States. Data
from an additional 30 respondents were excluded for not completing the survey in its
entirety.
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Thus, the final sample consisted of 485 participants. This target sample size is
above the previously calculated one of 385 and can be considered representative of the
target population. The target 95% confidence level and the 5% margin of error remained
unchanged. Survey participants were aged 19 to 87, 265 of whom were female. Of these
485 adults, 174 were aged 60 or older (see Figure 6). Identified as Caucasian were 410 of
the 485 participants (see Figure 7). A third had completed college (n = 105) and a quarter
had a graduate degree (n = 122). By state of residence, 39 participants lived in
Connecticut, 19 in Maine, 78 in Massachusetts, 20 in New Hampshire, 79 in New Jersey,
138 in New York, 94 in Pennsylvania, 8 in Rhode Island, and 9 in Vermont (1 declined to
respond). Graphical representation of the study’s key demographic variables follows:
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Figure 6. Study Participants by Age Group.
Note. Percentage of total participants presented above each bar.
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Figure 7. Study Participants by Race/Ethnicity.
Note. Percentage of total participants presented above each bar.
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Figure 8. Study Participants by Education Level.
Note. Percentage of total participants presented above each bar.

123
Results
After providing a description of the sample and its demographic characteristics in
the previous sections, Table 1 shows the study variables and their attributes, as they were
used in the data-analysis process.
Table 1
Dependent and Independent Variable Key Characteristics

Variable name

Dependent/
independent

Variable type

Variable
code
name

Comments

Actual disposal
practices

Dependent

Dichotomous categorical

ADP

Coded as either “recommended
disposal practice” or
“unrecommended disposal
practice.”

Knowledge of
environment and
human-health
impact

Independent
predictor

Ordinal

KEH

Represents knowledge and
beliefs regarding impact of
medications disposal practices
on the environment and human
health.

Knowledge of
Independent
disposal practices predictor

KDP1 = Dichotomous
Categorical
KDP2 = Dichotomous
Categorical
KDP3 = Ordinal
KDP4 = Dichotomous
Categorical

KDP1–4 The survey had four questions
addressing knowledge of
disposal practices, hence
variable names: KDP1–4.

Availability of
disposal options

ADO1 = Dichotomous
Categorical
ADO2 = Ordinal

ADO1–2 The survey had two questions
addressing the availability of
disposal options, hence variable
names: ADO1–2.

Independent
predictor

Note. ADP = actual disposal practices.

Descriptive Statistics
Descriptive statistics for the dependent variable as well as each independent
variable are presented here, with missing data discussed.
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Actual disposal practices (ADP). Responses to the question, “What is your most
used method for disposing of unused or expired medications?” represented the dependent
variable of interest, ADP. I coded the eight possible response options either as a
recommended disposal practice (I return them to the pharmacy or to another designated
take-back location, I mix them with coffee grounds or kitty litter or dirt and then in the
trash, using a non-permeable container to avoid spill, I follow the disposal instructions
that accompany the medicine, Not applicable—I always take my medications as
prescribed; n = 226) or un-recommended disposal practice (I flush them down the toilet, I
rinse them down the sink drain, I simply put them in the trash, I store them in my house
for possible future use of family or friends, Other; n = 259). Therefore, I treated ADP in
all analyses as a dichotomous categorical variable.
Knowledge of environment and human health impact (KEH). I coded
participants’ responses to the question, “Do you believe that improper disposal of
medications in the environment could have negative consequences on human health?” on
an ordinal scale to represent the independent variable Knowledge of Environment and
Human Health Impact. Participants had four possible response choices: Not sure—no
idea (n = 25), No—not at all (n = 174), Yes—somewhat (n = 158), and Yes—definitely (n
= 228).
Knowledge of disposal practices (KDP1–4). Participants answered four
questions that represented the independent variable Knowledge of Disposal Practices.
The first question (KDP1) was, “To your knowledge, are there any local, or state, or
federal guidelines for the proper disposal of unused or expired medications?” I treated
responses as a dichotomous categorical variable: No/I don’t know (n = 350) or Yes (n =
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135). I treated responses to the second question (KDP2), “Do you know what the current
recommended disposal practices are?” as a dichotomous categorical variable, with
possible answer choices being No (n = 185) and Yes (n = 300). The third question
(KDP3) asked, “How often has a health care provider informed you about the proper way
to dispose of your unused or expired medications, in the past two years?” I treated
responses to this question as an ordinal variable with four levels: Never (n = 421),
Sometimes (n = 41), Often (n = 13), and Always (n = 10). Finally, Question 4 (KDP4)
asked, “Are you aware of any promotion material (such as pamphlets, posters, web info)
that deal with the proper disposal of unused or expired medications?” Respondents had
two possible response options, No (n = 375) and Yes (n = 110), making this a
dichotomous categorical variable.
Availability of disposal options (ADO1–2). Responses to two questions
represented the independent variable Availability of Disposal Options. The first question
was, “In your area, is there a designated collection location where you can dispose of
your unused or expired medication?” I treated responses to this question (ADO1) as a
dichotomous categorical variable with possible responses of No/I don’t know (n = 350)
and Yes (n = 185). I also treated responses to the second question (ADO2), “How
convenient is it for you to reach the designated disposal location?” as an ordinal variable
with three levels: Almost impossible to reach (n = 6), It takes some effort (n = 76), and
Convenient (n = 128). Due to the high amount of missing data for variable ADO2 (n =
210 total observations), it was excluded from further analyses.
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Assumptions
I chose a binary logistic regression as the statistical method to answer Research
Questions 1–4, with ADP as the dependent variable and KEH, KDP1-4, and ADO1 as
independent variables. A binary logistic regression assumes independence of errors,
which was true for the present data, as each case represents a single unrelated participant.
Additionally, a binary logistic regression assumes that none of the independent variables
in the present data set highly correlated with one another. To assess whether
multicollinearity was an issue in the present data set, I obtained the VIF and tolerance
statistics, as suggested by Zuur, Ieno, and Elphick (2010). As shown in Table 2, all VIF
values were well under 10 and tolerance values were more than 0.1, thereby indicating
that multicollinearity was not an issue (Bowerman & O’Connell, 1990; Myers, 1990),
and the analysis could proceed.
Table 2
Questions 1–4: Variance Inflation Factors and Tolerance Values
Variable

VIF

Tolerance

KEH

1.053

0.950

KDP1

1.201

0.832

KDP2

1.186

0.843

KDP3

1.162

0.860

KDP4

1.223

0.818

ADO1

1.216

0.822

Research Question 5 asked whether ADP differ by demographic group. Thus, I
conducted an additional binary logistic regression with the demographic variables of
gender, race, education, and age included. To assess multicollinearity for this model, I
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carried out VIF and tolerance statistics. The obtained values indicated that the variable,
age, was causing an issue with perfect collinearity and the VIF statistics could not be
computed. Consequently, I removed this variable from further analyses. The VIF and
tolerance statistics for a model without age appear in Table 3 and indicate that
multicollinearity is not an issue for this model (i.e., VIF values are below 10 and
tolerance values are above 0.1).
Table 3
Question 5: Variance Inflation Factors and Tolerance Values
Variable

VIF

Tolerance

KEH

1.223

0.818

KDP1

1.217

0.821

KDP2

1.211

0.825

KDP3

1.282

0.780

KDP4

1.253

0.798

ADO1

1.261

0.793

Gender

1.375

0.727

Race

1.948

0.513

Education

1.849

0.541

Research Questions 1–4
To determine whether KEH, KDP, or ADO align with ADP (Research Questions
1–4), I performed a binary logistic regression with ADP as the dependent variable and
KEH, KDP1–4, and ADO1 as the independent predictor variables. Logistic regression is
the ideal tool for modeling a binary-response variable; in this case ADP, which can be
either categorized as “recommended disposal practices” or “unrecommended disposal
practices” on the independent variables KEH, KDP1–4, and ADO1. I used the Hosmer–
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Lemeshow test, best suited for a sample size greater than 400, to assess the goodness of
fit of the model (Bewick, Cheek, & Ball, 2005). Table 4 shows the result of the model
analysis.
Table 4
Actual Disposal Practices and Knowledge of Environment and Human-Health Impact,
Knowledge of Disposal Practices 1–4, and Availability of Disposal Options
Variable

B

SE

p

95% confidence intervals

Constant

-2.937

0.453

< .001

0.021

0.126

KEH

0.724

0.129

< .001

1.612

2.670

KDP1

0.280

0.258

.278

0.799

2.200

KDP2

0.685

0.231

.003

1.262

3.122

KDP3

-0.114

0.203

.575

0.607

1.353

KDP4

0.137

0.281

.626

0.661

1.200

ADO1

0.970

0.241

< .001

1.652

4.253

Note. Model as a whole: R2 = .171 (Hosmer–Lemeshow). Model X2(6) = 114.522, p < .001, Table shows
the unique impact of each predictor toward explaining ADP, KEH = knowledge of environment and
human-health impact, KDP = knowledge of disposal practices, ADO = availability of disposal options.

Research Question 1 asked whether ADP align with an individual’s KEH. The
regression analysis indicated a significant and positive relationship between the variables
ADP and KEH (p < .001), in line with hypothesis H12. People who believe that
improperly disposed pharmaceuticals will harm the environment or human health are
more likely to practice recommended disposal practices. This trend can be further
observed in Figure 9.

129
1

Proportion of Recommended Disposal Practices

0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
No - not at all

Not sure - no idea

Yes - somewhat

Yes - definitely

Figure 9. Proportion of Actual Disposal Practices by Knowledge of Environment and
Human Health Impact.
Note. Error bars represent -/+ 1 standard error of the mean.
Research Question 2 asked whether an individual’s KDP aligns with their ADP.
The results of the regression show partial support for Hypothesis H12; three of the four
variables meant to represent KDP do not significantly align with ADP. Specifically, those
are KDP1 (“To your knowledge, are there any local, or state, or federal guidelines for the
proper disposal of unused or expired medications?”), KDP3 (“How often has a health
care provider informed you about the proper way to dispose of your unused or expired
medications, in the past two years?”), and KDP4 (“Are you aware of any promotion
material (such as pamphlets, posters, web info) that deal with the proper disposal of
unused or expired medications?”). However, KDP2 (“Do you know what the current
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recommended disposal practices are?”) did significantly and positively align with ADP
(p = .003, see Table 4). Figures 7–10 display the relationships between ADP and KDP1,
KDP3, KDP4, and KDP2. However, only KDP2 significantly aligned with ADP.

Proportion of Recommended Disposal Practices

1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
No

Yes

Figure 10. Proportion of Actual Disposal Practices by KDP1.
Note. Answering, “To your knowledge, are there any local, or state, or federal guidelines
for the proper disposal of unused or expired medications?” Error bars represent -/+ 1
standard error of the mean.
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Proportion of Recommended Disposal Practices

1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
No

Yes

Figure 11. Proportion of Actual Disposal Practices by KDP2.
Note. Answering “Do you know what the current recommended disposal practices are?”
Error bars represent -/+ 1 standard error of the mean.
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Proportion of Recommended Disposal Practices

0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
Never

Sometimes

Often

Always

Figure 12. Proportion of Actual Disposal Practices by KDP3.
Note. Answering “How often has a health care provider informed you about the proper
way to dispose of your unused or expired medications, in the past two years?” Error bars
represent -/+ 1 standard error of the mean.
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Proportion of Recommended Disposal Practices

0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
No

Yes

Figure 13. Proportion of Actual Disposal Practices by KDP4.
Note. Answering “Are you aware of any promotion material (such as pamphlets, posters,
web info) that deal with the proper disposal of unused or expired medications?” Error
bars represent -/+ 1 standard error of the mean.
Research Question 3 concerns the hypothesized association between ADP and
ADO (as measured by the question “In your area, is there a designated collection location
where you can dispose of your unused or expired medication?”). The regression model
shows a significant positive relationship between ADP and ADO (p < .001, see Table 4).
Participants who were aware of the existence of a designated pharmaceutical-collection
location were more likely to practice recommended disposal practices, in line with
Hypothesis H13. This trend can be further observed in Figure 14.
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Proportion of Recommended Disposal Practices

0.9
0.8
0.7
0.6
0.5
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0.2
0.1
0
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Yes

Figure 14. Proportion of Actual Disposal Practices by Available Disposal Options.
Note. Error bars represent -/+ 1 standard error of the mean.
Research Question 4 asked to what degree variance in ADP can be explained by
the three independent variables KEH, KDP, and ADO. The results of the regression
model showed that, in support of Hypothesis H14, ADP is predicted significantly better
by a model that includes KEH, KDP, and ADO as compared to a model that includes the
intercept only (i.e., a model without the predictor variables), X2(6) = 114.522, p < .001,
R2 = .171.
Research Question 5
Research Question 5 asked whether ADP varied by demographic variables. To
that purpose, I conducted a binary logistic regression with ADP as the dependent variable
and KEH, KDP1-4, ADO1, gender, race, and education as independent predictor
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variables. As shown in Table 5, the model is not significantly better than a model without
the demographic variables included, X2(16) = 21.994, p = .143, R2 = .033. Thus, I
concluded that no demographic differences exist in the present data set, in line with
Hypothesis H05.
Table 5
Model Coefficients for Logistic Regression
Variable

B (SE)

SE

p

95% Confidence Intervals

Constant
-2.331
2.834
.411
0.001
40.122
KEH
0.844
0.143
<.001
1.769
3.105
KDP1
0.290
0.266
.276
0.794
2.258
KDP2
0.673
0.239
.005
1.227
3.140
KDP3
-0.222
0.216
.306
0.530
1.247
KDP4
0.283
0.292
.332
0.750
2.365
ADO1
0.943
0.251
<.001
1.575
4.229
Gender: Female
0.610
2.812
.828
0.020
741.364
Gender: Male
1.199
2.812
.670
0.037
1357.401
Race: American Indian
-0.663
2.438
.786
0.004
63.113
Race: Asian/Pacific Islander
-0.704
1.938
.717
0.009
22.952
Race: Black or African American -0.761
1.756
.665
0.011
14.818
Race: Hispanic
-2.489
1.823
.172
0.002
2.889
Race: Other
-0.446
1.821
.806
0.014
23.011
Race: Prefer not to answer
-0.696
1.749
.691
0.012
15.537
1.317
Education: Completed graduate
-1.134
.389
0.013
3.336
school
Education: Some graduate school
-0.610
1.380
.659
0.020
6.537
Education: Completed College
-1.133
1.315
.389
0.013
3.316
Education: Some college
-0.456
1.320
.730
0.025
6.653
1.340
Education: Completed high
-0.833
.534
0.017
4.733
school
Education: Some high school
-1.920
2.057
.351
0.002
7.761
Education: Prefer not to answer
0.045
1.626
.978
0.028
23.822
Note. KEH = knowledge of environment and human-health impact, KDP = knowledge of disposal
practices, ADO = availability of disposal options. R2 = .033 (Hosmer-Lemeshow). Model X2(16) = 21.994,
p = .143.
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Kruskal–Wallis Rank-Sum Test (Nonparametric Equivalent of One-Way ANOVA)
An additional set of analyses determined whether ADP differed across levels of
individual demographic variables, irrespective of other factors. I ran a series of one-way
ANOVAs, one for each demographic variable (education, race, age, and gender) with
ADP as the dependent variable. I considered only the 453 participants who had provided
responses for the four demographic questions for inclusion in the analyses. However,
ANOVA procedures can be effectively carried out if the two key assumptions are met:
homogeneity of variances and normal distribution of the residuals of the dependent
variable at each level of the independent one. I assessed the assumption for homogeneity
of variances using Levene’s tests (Levene, 1960). These tests provided a p value greater
than .05 (statistically nonsignificant), indicating that the assumption was met for all
planned analyses (see Table 6). I assessed the ANOVA assumption for normal
distribution of the residuals of the dependent variable at each level of the independent
variable using Shapiro–Wilk tests. The obtained p values were smaller than .05
(statistically significant), indicating that this assumption was violated in all cases (see
Table 7). Consequently, I could not use the ANOVA procedure and conducted the
Kruskal–Wallis rank-sum tests—the nonparametric equivalent of the one-way
ANOVA—instead.
The Kruskal–Wallis test with education as the independent variable and ADP as
the dependent variable did not reach significance, 𝜒𝜒2(5) = 4.811, p = .439, suggesting that
pharmaceutical disposal practices do not differ by education level (see Figure 15). The
corresponding Kruskal–Wallis test for race was also nonsignificant, 𝜒𝜒2(5) = 6.286,
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p = .279, indicating that the race of an individual does not affect pharmaceutical disposal
practices (see Figure 16).
Table 6
Levene’s Tests for Demographic Changes in Actual Disposal Practices
df

F

p

Education

6

0.491

.783

Race

6

0.710

.616

Age

3

0.410

.746

Gender

1

0.557

.456

Table 7
Shapiro-Wilk Tests for Demographic Changes in Actual Disposal Practices
W

p

Education

0.721

< .001

Race

0.672

< .001

Age

0.723

< .001

Gender

0.661

< .001

Proportion of Recommended Disposal Practices
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Proportion of Recommended Disposal Practices

Figure 15. Actual Disposal Practices by Education Level.
Note. Error bars represent -/+ 1 standard error of the mean.
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Figure 16. Actual Disposal Practices by Race.
Note. Error bars represent -/+ 1 standard error of the mean.
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The Kruskal–Wallis test with age as the independent variable and ADP as the
dependent variable did not reach significance, 𝜒𝜒2(3) = 5.789, p = .122 (see Figure 17). In

other words, ADP did not vary across age groups. Finally, the Kruskal–Wallis test for
gender indicated that ADP did not differ between men and women, 𝜒𝜒2(1) = 0.557, p
= .455 (see Figure 18).
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Proportion of Recommended Disposal Practices
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0
18-29

30-44

45-59

Figure 17. Actual Disposal Practices by Age Group.
Note. Error bars represent -/+ 1 standard error of the mean.
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Proportion of Recommended Disposal Practices

1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
Female

Male

Figure 18. Actual Disposal Practices by Gender.
Note. Error bars represent -/+ 1 standard error of the mean.
In conclusion, the Kruskal–Wallis rank-sum test confirmed the results obtained
using the logistic regression procedure. In the sampled population, the demographic
variables (i.e., education level, age, ethnicity, gender) do not have a significant impact on
people’s behavior with respect to their disposal practices of unwanted pharmaceuticals.
Summary
The results of a large-scale survey spanning the northeast United States showed
significant associations between an individual’s knowledge of environmental and humanhealth impacts, knowledge of recommended disposal practices, and locally available
disposal options, with a person’s likelihood to practice recommended pharmaceutical
disposal practices. Specifically, people who are more knowledgeable about recommended
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disposal practices, the environmental and health impacts of improper disposal, and who
live in an area with official disposal options are more likely to practice recommended
disposal of prescription drugs. These three factors significantly predict an individual’s
likelihood to practice recommended prescription-drug disposal. Moreover, these
relationships are stable across various demographic groups, suggesting no specific group
should be targeted with, for example, promotional material explaining how to properly
dispose of unwanted pharmaceuticals. Rather, interventions may seek to focus on
increasing knowledge of environmental and health impact for people of all demographics,
as well as increasing the availability of official disposal locations.
In the next chapter, I discuss the findings of the study through the perspective of
the conceptual framework, the implications for social change, and recommendations for
potential actions. In addition, I discuss the limitations of the study and provide
recommendations for future research.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
For decades, recommendations for disposing of unused or expired medications
were guided by concerns about inadvertent or intentional poisoning. Flushing them down
the toilet or rinsing them down the drain were considered safe and simple ways to dispose
of unwanted drugs (McCullagh et al., 2012; Ortner & McCullagh, 2010). A 2008 report
entitled PharmaWater I (Donn, Mendoza, & Pritchard, 2008) described how at least 41
million Americans were served by water supplies with evidence of pharmaceuticals
including anticonvulsants, antibiotics, mood stabilizers, and hormones. Researchers have
documented the consequences of pollution by pharmaceuticals on the environment’s
ecosystems and its potential effects on human health and studied the disposal practices of
specific populations (e.g., nurses and pharmacists). However, a gap existed in the
scholarly literature regarding the disposal practices for pharmaceuticals in the general
population.
I conducted this study to address the disposal practices of unused or expired
prescription medications in a sample of the general population residing in the northeast
United States. In this study, I examined people’s disposal practices, local availability of
disposal options, awareness of proper disposal practices, and the potential correlations
between people’s ADP and their knowledge of the impact that disposal practices may
have on the environment and human health.
My aim in this study was to identify the key factors that may influence
compliance with the recommended disposal practices (e.g., returning unused
pharmaceuticals to a pharmacy), so future work can take steps to promote safe disposal
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practices. My final goal for this study was to acquire the necessary data to support a
social-change strategy that could translate into an actual behavioral shift. To select an
appropriate study design, I had to identify a conceptual framework so research questions
could align with time-tested behavioral models. To this end, an extensive literature
review pointed to the HBM and the TPB to support the behavior-inquiry aspect of this
study. The HBM was applicable for its approach in defining barriers to the adoption of
health-related behavior (Strecher & Rosenstock, 1997). The TPB was relevant from the
perspective of motivation factors that precipitate the intention to perform an action or
behavior (i.e., proper disposal practices). In summary, the HBM and the TPB conceptual
frameworks guided the development of the study design and the survey tool for data
collection.
I used a cross-sectional approach to investigate measurable hypothesized
associations at a specific point in time, despite the difficulties in definitively determining
cause–effect relationships (Pine et al., 1997). The research questions, and the key
findings of the study follow:
Finding 1
RQ1: Is there an association between knowledge of the environmental and the
human-health impact of pharmaceutical disposal and actual disposal
practices?
Greater knowledge of the environmental and health threats resulting from
improperly disposed drugs aligned with higher rates of proper disposal practices.
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Finding 2
RQ2: Is there an association between knowledge of recommended disposal
practices and actual disposal practices?
Greater knowledge of recommended disposal practices aligned with higher rates
of proper disposal practices.
Finding 3
RQ3: Is there an association between availability of disposal options and rates of
actual disposal practices?
Having safe disposal options available aligned with higher rates of proper
disposal practices.
Finding 4
RQ4: To what degree can actual disposal practices (the dependent variable) be
explained by the combined and differential contribution of the three
independent variables: knowledge of the environmental and human health
impact, knowledge of recommended disposal practices, and locally available
disposal options?
A statistically significant model using the independent variables (predictors)
combined, and differential contribution of knowledge of the environmental and health
impact, knowledge of recommended disposal practices, and locally available disposal
options could predict the dependent variable: participants’ disposal practices. These
findings suggest that participants’ disposal practices aligned with the combined
contribution of the independent variables.
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Finding 5
RQ5: Do differences exist among RQ1, RQ2, and RQ3 across demographic
groups?
No significant differences emerged with respect to knowledge of the
environmental and human-health impact of pharmaceuticals, knowledge of recommended
disposal practices, and locally available disposal options across demographic variables.
Discussion
The purpose and the results of this study need to be viewed through the optics of a
larger context. Environmental contaminants generated by the inappropriate disposal of
prescription drugs by consumers may be merely a portion of the total pharmaceutical
contaminants that reach the environment through various routes. The results of this study
suggested that social and organizational programs need to take appropriate steps,
discussed in this chapter, to facilitate broad social change and improve disposal practices.
In practice, pharmaceutical companies and governmental agencies, at federal and local
levels, will need to demonstrate their commitment to social responsibility by ensuring the
entire development and marketing lifecycle of pharmaceutical products are controlled and
pose minimal environmental and human-health risks. In line with these considerations,
Daughton (2014a) considered the lifecycle development by defining upstream and
downstream approaches to minimizing environmental contamination by pharmaceutical
products.
The upstream approach consists of minimizing the amount and toxicity that a
given pharmaceutical product would release when discarded in the environment. From
the upstream approach, pharmaceutical companies should prioritize adopting the so-
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called green pharmacy or ecofriendly pharmacy” in their development portfolio to adopt
and design drugs with maximum absorption potential, ensuring that smaller traces would
be excreted in the environment. For drugs currently on the market, an upstream approach
would leverage on the social responsibility of pharmaceutical companies in various
activities to improve patient adherence to the prescribed drug regimen. For example, field
staff, during their routine interactions with health care personnel (e.g., physicians and
nurses), could promote not only the drugs, but also the drugs’ optimal disposal practices.
The downstream approach focuses on promoting the safe and proper disposal of
unused, unwanted, and expired medications (Ruhoy & Daughton, 2008). From a socialchange perspective, this approach would leverage on the social responsibility of local
health departments to ensure they have the budget and the resources to support drug takeback programs, media campaigns on proper disposal practices, and conveniently located
disposal options (e.g., malls, supermarkets, pharmacies, and post offices). To ensure
consistency, various stakeholders—local health departments, schools, pharmacies,
hospitals, clinics, and health care providers—would coordinate effort to communicate
strategy on drug disposal standards that clearly align with current research. Such
strategies should be designed to be easily adaptable to change, and customizable to local
as well as specific populations’ needs.
The HBM and the TPB conceptual-framework models were quite helpful in the
design of this study. The HBM model, which has been used in previous studies of
environmental and health-related behaviors, was employed in the past to explore how
consumers perceive the potential benefits of safe pharmaceutical disposal at take-back
centers. Perceived barriers crucially limit the likelihood of safe disposal practices as well
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as other health-related preventive behaviors (Strecher & Rosenstock, 1997), a finding
confirmed by this study. In the TPB model, ethical norms (Cote et al., 2012) are key
predictive factors. The TPB model relates to the motivations that trigger certain
environmental behaviors; in the present study, I used the TPB to explore and identify
factors that may precipitate, inhibit, or be of no consequence to specific drug disposal
practices. One key finding from this study was that the ease of access to disposal options
increases the likelihood of proper disposal. This finding is consistent with the outcome of
Ruhoy’s (2009) study, determining that the ready availability of medication disposal
options was a significant predictor of safe medication disposal behaviors. Similarly, Ma
et al. (2014) found that the majority of participants in a take-back program in Hawaii
would have discarded drugs improperly without this program and the instructions
received on best practices, again underscoring the significance of convenient safe
disposal options and clear disposal instructions as predictors of safe disposal practices.
Examining prior research conducted on drug disposal helps provide context for
the interpretation of the present study findings. For example, Gray and Hagemeier (2012)
surveyed 752 participants in the Appalachian regions of Tennessee and Virginia between
2009 and 2011. The researchers considered demographic factors such as race, age, and
gender, along with reasons for participation in the take-back program. Gender stood out
as a demographic factor predicting higher return rates, as more women than men
participated in the take-back program (Gray & Hagemeier, 2012). This result stands in
contrast to the present study, in which particular demographic factors did not align with
higher rates of safe disposal practices.
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The present study supported the finding of Kotchen et al. (2009), who determined,
in a survey of consumers in California, that those with higher levels of environmental
awareness were more likely to practice safe disposal. Comparing the rates of safe
disposal in Sweden and Poland underscored this study’s findings regarding the
significance of environmental awareness, knowledge of safe disposal methods, and
available safe disposal options in predicting environmentally sound disposal behaviors
(Zimmermann et al., 2011). In addition to the United States, several European countries,
Australia, and New Zealand have initiatives in place to safely dispose of unused drugs
(Ruhoy & Daughton, 2008). Swedish consumers have high levels of environmental
awareness and knowledge of safe disposal methods due to effective public education
campaigns by a government-owned pharmacy chain with a convenient take-back
program; as a result, more than 70% of Swedish consumers with unused drugs returned
them to local pharmacies. In Poland, in contrast, consumers had lower levels of
environmental awareness and few safe disposal options, resulting in high rates of unsafe
drug disposal (Zimmermann et al., 2011).
A high degree of knowledge about environmental impacts has not always resulted
in optimal disposal practices. Even trained, knowledgeable health care professionals such
as pharmacists (Abahussain et al., 2012) and nurses (McCullagh et al., 2012) did not
always practice safe drug disposal, underscoring that knowledge is not invariably the
only driving force in behavior change (Bandura, 1997; Nisbet & Gick, 2008; Strecher &
Rosenstock, 1997). Seehusen and Edwards (2006), who surveyed 301 consumers at a
medical center in Washington State, discovered gaps between knowledge and safe
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disposal practice, and highlighted the lack of access to safe disposal options in reducing
the likelihood of safe disposal practices.
Implications of the Findings: Potential Impact for Social Change
The envisioned outcome of this research is to inspire positive social change by
improving the rates of safe pharmaceutical disposal, and, in doing so, increase the ease
and availability of safe disposal options, enhance patient adherence to medication
recommendations, and advocate for “green pharmacy”, all of which will help protect the
environment and reduce the risks to human health. One key finding of the present study
was that the availability of safe medication disposal options was a significant predictor of
safe medication disposal behaviors. This finding confirmed the research of Ruhoy and
Kaye (2010), who investigated a program in Maine called Safe Medicine Disposal and
found that convenient safe disposal options predicted a higher likelihood of safe disposal
practices. In Maine, a state in the present study’s geographic focus that was hard hit by
the opioid crisis and high death rates from prescription medication (Stewart et al., 2015),
patients were able, through this drug take-back program, to anonymously mail back
medications at no cost. The program was remarkable for providing an easily available
option for medication disposal, and also provided helpful data on returned drugs and
program participants (Ruhoy & Daughton, 2008). Significantly, without the program, the
majority of participants indicated they would have either disposed of the unused
medications by flushing them down the toilet or throwing them away in the trash. Ruhoy
and Kaye concluded that Safe Medicine Disposal for ME was a user-friendly, low-cost,
effective program that could serve as a model for initiatives elsewhere. The research,
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then, is clear about the importance of taking steps to ensure safe, convenient disposal
methods in promoting the envisioned social change.
The key findings of the present study have advanced knowledge of a significant
public health and environmental problem by demonstrating, in the general population of
the northeast United States, the significant association between the dependent variable
(recommended methods of pharmaceutical disposal) and the three dependent variables:
knowledge of the impact of unused prescription drugs on the environment and human
health, knowledge of best practices in drug disposal, and easily available, user-friendly
disposal options. No significant associations emerged between demographic factors and
pharmaceutical disposal practices; rather, consistency arose across the demographic
cohorts surveyed. Key findings confirmed the importance of knowledge of environmental
and health impacts, safe disposal practices, and availability of user-friendly take-back
programs and disposal options in increasing adherence to recommended pharmaceutical
disposal practices.
This study extends knowledge of disposal practices to the general population of
the northeast United States and complements findings previously obtained in studies
conducted in specific populations (e.g., nurses and pharmacists) in other regions of the
United States. Recommendations for practice include promoting awareness of the impact
of improperly disposed pharmaceuticals on the environment and human health across
demographic cohorts, and promoting user-friendly return programs and disposal
locations. The potential impact for positive social change at the levels of individuals,
families, organizations, and policymaking is significant. With safer disposal methods
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involving multiple stakeholders, the harm caused by improper pharmaceutical disposal to
the environment and to public health will diminish.
The data for this study was collected by administering an Internet questionnaire to
a sample of adult residents of the northeast United States who had taken a prescription
medication within the previous 2 years. I designed the study to learn about the disposal
practices in the general population, and how these practices could be linked to people’s
knowledge of the environmental and health effects resulting from improper disposal. It
was also important to explore the degree to which the availability of locally available
disposal options could be linked to disposal practices. By studying current disposal
practices in the sample and learning about what promotes or inhibits the likelihood of
safe disposal practices, this study has contributed to a better understanding of the problem
and to ways to increase a collective social-change process.
The ultimate goal of this study was to provide the data, and the rationale to
promote a series of actions, including additional research, that encompass a broad
strategy, at multiple organizational and functional levels, in both the private and public
domains. The strategy for optimal disposal will have to include broad public education
campaigns aimed at all demographic groups, as well as to health care providers. Equally
important, the strategy will have to engage pharmaceutical companies, policymakers, and
the DEA, for providing the budgets and the scientific support for a coordinated, effective,
and efficient approach at reducing and ultimately eliminating the human health risk
associated with pharmaceutical entering the environment. Educating the public on the
risks of improper disposal is not enough. There has to be an infrastructure (i.e., scientific,
organizational, budget, staff) in place to adequately sustain and monitor the health of our
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environment, which directly and indirectly supports human health, and the life of the ecosystems that sustain global health on the planet.
Limitations of the Study
I adapted a questionnaire administered online by SurveyMonkey, using items by
Seehusen and Edwards (2006), following these authors’ formal approval (see Appendix
A). Given widespread Internet use and availability, an online questionnaire was ideal for
this study, though some authors have noted that some cohorts of Americans may lack
access to the Internet (Cottrell & McKenzie, 2010).
This study had some limitations and the results may be generalizable with
caution. The northeast United States has unique demographic factors, such as more
favorable socioeconomic characteristics (U.S. Census Bureau, 2011), that may limit to
the degree to which it may be possible to generalize the results of this study to other
geographic regions of the United States or to other countries. Researchers have cited the
role of socioeconomic factors such as income and health insurance coverage in
individuals’ interactions with the health care system (Blackwell et al., 2009), which, in
turn, may impact the information they receive about recommended pharmaceutical
disposal. This study was also limited to prescription drug disposal practices; therefore,
the study generated no new information about disposal practices pertaining to widelyused OTC drugs, which also impact the environment and human health. Because this
study involved an Internet survey in English, two subpopulations—those who do not use
the Internet and individuals with limited English—were excluded from the population
sample and no new knowledge was gained about their disposal practices.
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In spite of these limitations, this study surveyed a significant sample of the
general population of the northeast; the target sample size was exceeded by 100
participants, as 485 successfully completed the survey compared to the calculated target
sample of 385. Furthermore, I successful examined the survey’s content validity by using
a pilot survey, and addressed validity of the statistical conclusions by assessing, a priori,
the assumptions of the statistical tests leading to the acceptance or rejection of the null
hypotheses and answering the research questions.
This study’s theoretical framework involved the use of the HBM and TPB
models. The study was innovative in bridging the knowledge gap between health and
environmental behavior. Despite being related fields, models used to study health
behavior change have not often been used in environmental studies (Nisbet & Gick,
2008).
Recommendations for Future Research
When considering the original scope of this study, its research questions, findings,
and potential limitations, a number of future lines of research have emerged. In the
northeast, new studies could be carried out to determine which kinds of public-education
campaigns are particularly effective, when, as noted, becoming more knowledgeable does
not invariably lead to behavioral change. Researchers could study which messages, and in
which contexts (e.g., schools, pharmacies, hospitals, and health departments) are most
effective in promoting environmentally sound disposal behaviors that focus on increasing
knowledge of the environmental and health impact, recommended disposal practices, or
awareness of safe disposal locations.
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Researchers could conduct comparative studies in other regions of the United
States in order to address regional or population specific needs. The comparative context
could be extended further, with additional studies conducted across countries; ideally
coordinated on a global basis, such studies could use the same study design and protocol
to ensure results could be easily compared. Other populations to consider might be
consumers in developing nations where pollution and public health threats are serious
problems and environmental awareness is low. Previous studies have focused largely on
North America, Western Europe, and Australia and New Zealand. Researchers could use
other research designs, such as interviews, focus groups, rather than Internet surveys, to
investigate drug disposal practices in developing nations where fewer people have access
to the Internet.
The EPA has been tracking pharmaceutical contaminants in public water systems
(in addition to other chemicals used in commerce, agriculture, etc.) in their “Contaminant
Candidate List 4-CCL4,” as part of the EPA’s Federal Register Notices (EPA, 2016).
However, these contaminants are not subject to any national regulation or policy aiming
at reducing them. Future researchers should target this list of contaminants not only to
assess their public health impact, but also to discern the potential synergistic effect that
several contaminants may have when reacting with one another in the same medium (e.g.,
potable water). As noted by the EPA, this synergistic impact is currently unknown, as is
its potential impact on human health.
Summary and Conclusion
Ultimately, the main goal of this study was to promote positive social change by
using research-based evidence to address the knowledge gap on drug disposal in the
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general population, and facilitate the development of strategies that aim at the protection
of the environment, and minimize human health impact. A range of constituencies, from
consumers to health care professionals, health and environmental policymakers, and
leaders of pharmaceutical companies could be interested in this study’s findings. The
greater the knowledge of the environmental and health impact, of recommended disposal
practices, and the availability of convenient disposal options, the greater the likelihood
that safe disposal methods will be implemented effectively and efficiently.
Although the contamination from prescription drugs is only a small portion of the
contaminants that reach and harm the environment, their dissemination remains an issue
that has the potential to impact human health. In retrospect, given the analyses conducted
in this study, the mitigation to this problem area is not difficult and could be achieved if
the appropriate social change were implemented at various levels and across key
stakeholders. Pharmaceutical companies should demonstrate their corporate
responsibility and focus on the green pharmacy drug development process. Local and
federal agencies need to provide the policies, budget, resources, and guidance to facilitate
optimal disposal practices thru education and logistical solutions. Finally, consumers
need to comply with the prescribed medication regimen to optimize efficacy and lessen
the need to discard unused or expired medications.
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